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Foreword 
The majority of the genus Allium species are known for their medicinal applications: for 
example, A. stipitatum shows antibiotic effects against Mycobacterium tuberculosis and some 
other Allium species exhibit antistaphylococcal effects. Furthermore, recent studies have 
provided evidence of various antifungal, antidiabetic, and anticancer effects of some Allium 
species. 
 
Allium is also well known in traditional medicine for its ability to cure various ailments such as 
wounds or acute and chronic bronchitis; additionally, alliums can be used as expectorants due 
to the presence of cysteine sulfoxide and its derivatives. Cysteine sulfoxides, which are some 
of the basic secondary compounds in Allium, have been addressed in various studies. Alliin, 
propiin, methin, marasmin, and thiosulfinate, all of which are alliinase substrates, are of 
particular interest because of their pharmaceutical effects. The enzymatic reaction that occurs 
during the formation of disulfides or thiosufinates results in various compounds that differ 
chemically, physically, and pharmaceutically.The cysteine sulfoxide recently investigated in A. 
giganteum, A. rarolininanum, A. rosenorum, and A. macleani species is the S-(pyrrolyl)cysteine 
S-oxide. 
 
The formation of the red pigment after dissecting tissues in the Allium species indicates a quick 
reaction between cysteine sulfoxides and alliinase. 
The natural acquisition of compounds from the Allium species and their in vitro storage are 
constrained by their high instability. Thus, any further studies on the molecular structure and 
mechanisms of S-(pyrrolyl)cysteine S-oxide required it to be synthesized chemically in 
laboratory settings. This would enable us to obtain the desired product (red pigment) through 
the  laboratory reaction of the pyrrole compounds with alliinase.  
 
To this end, we attempted to synthesize the heteroaromatic 5-ring compounds, which are 
homologous with S-(pyrrolyl)cysteine S-oxide, to understand the red pigment and its reaction 
mechanisms with alliinase. 
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1. General introduction 
In recent decades, organic chemistry has progressed remarkably in biological and medical 
fields. Today, many medicines are made from organic substances to cure a wide range of 
indications. Among the living organisms, plants contain an abundance of organic compounds, 
which play a significant role in organic chemistry and biomedical processes. It is essential to 
understand the biological background and functionality of these biocompounds and their 
application in the medical fields. The biosynthesis of essential compounds of medicinally and 
economically important plant species has been the main focus of pharmaceutical research for 
years. Among the sulfuric plant compounds, cysteine sulfoxides play a significant role as 
precursors in Allium metabolism. These new natural compounds enable us to find a way to 
prevent various human diseases or in some cases postpone their occurrence. Therefore, it is 
important to investigate these bioactive compounds in genera such as Allium, the largest genus 
in the Amaryllidaceae family that has been studied largely for economic and medicinal reasons 
(Friesen et al., 2006). 
 
1.1 The genus Allium: systematics, phylogeny, and distribution  
The combination of plastid DNA sequences including rbcL and trnL-F with nuclear ITS showed 
Amaryllidaceae to be monophyletic with 48 genera and a sister group to asparagalean families 
(Meerow et al., 1999; Meerow et al., 2000). The genus Allium, likely one of the largest 
monocot’s genera, consists of over 900 species (Fritsch & Abbasi, 2013; Seregin et al., 2015). 
It belongs to the order Asparagales, subfamily Allioideae, and family Alliaceae (Fay & Chase, 
1996; Friesen et al., 2000; Chase et al., 2009; APG IV, 2016).  
 
Linnaeus (1753) identified 30 species for the genus Allium. Taxonomy of the genus Allium is 
still controversial after the earliest monograph by Regel (1875). Vvedensky et al. (1935) 
identified nine sections and 228 species for the genus. Later, Traub (1968) introduced three 
subgenera including 36 sections with around 600 species in his revision. The species number 
and their taxonomic rank have been accordingly shuffled with the  morphological, anatomical 
and karyological data (Kamelin, 1973; Stearn et al., 1980; Hanelt et al., 1990; Hanelt et al., 
1992). Later, Allium was classified into 15 subgenera and 56 sections based on cytogeography, 
anatomy, and nuclear sequences (Nguyan et al., 2008). The most recent taxonomic classification 
of the genus was extensively modified according to the molecular phylogenetic study by Friesen 
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et al. (2006), which dramatically changed our understanding about species relationships and 
evolution. In general, the studies mainly based on ITS and ETS in the genus revealed three 
distinct evolutionarily lineages that contain 15 monophyletic subgeneric groups (Figure 1.1), 
among which some traditionally identified sections were raised to the subgeneric level, reaching 
72 sections (Fritsch & Friesen, 2002; Friesen et al., 2006; Li et al., 2010; Choi et al., 2012; 
Mukherjee, 2013). Nevertheless, some groups still remain non-monophyletic (Friesen et al., 
2006).  
 
Figure 1.1 Infrageneric classification of the genus Allium (adopted from Friesen et al., 2006). 
 
Morphologically, Allium species are perennial and characterized by their relatively globose to 
tunicate bulbs and mostly narrow basal leaves. The inflorescence is umbellate or head-like with 
usually straight to pendent flowers that are positioned on rigid scapes, and each flower usually 
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contains six free tepals, which form a free or basally connate calyx. Superior ovary includes one 
to many ovules in each locule and one entire or three-cleft stigma. The style is subgynobasic, 
capsules are loculicidal and seeds are rhomboidal black (Friesen et al., 2006; Fritsch et al., 
2010). In general, leaf epidermal cell types (anticlinal), distribution, density, and type of stomata 
and trichomes are strong taxonomical traits for species delimitations (e.g. Ahmed et al., 2010). 
According to the latest studies, the genus Allium has a wide distribution (Figure 1.2) in 
seasonally dry areas with the highest diversity in Southwest, Central, and East Asia, Eastern 
Mediterranean, and North America (Fritsch & Friesen, 2002). The Irano-Turanian region has 
the highest concentration of endemic Allium species (Matin, 1992). 
 
A narrow distribution has been reported for certain species, such as A. schoenoprasum from the 
subarctic belt, and some other species from Sri Lanka, Ethiopia, and Central America (Hanelt 
et al., 1990; Fritsch & Friesen, 2002). The occurrence of only one species, A. dregeanum in 
South Africa, is still debatable (Wilde-Duyfjes, 1976). 
 
 
Figure 1.2 General worldwide distribution pattern of wild species of Allium. The numbers on the map correspond 
to the number of reported species in each region (Fritsch & Friesen, 2002).  
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Majority of Allium species are known for their vegetables and usage, and some others are 
economically important. Also, more than 100 species are ornamentals (Kamentsky and Fritsch, 
2002). 
 
 
Figure 1.3 Phylogenetic relationships within the species of subgen. Melanocrommyum (adopted from Gurushidze 
et al., 2008). 
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1.2 A. subgen. Melanocrommyum taxonomy and phylogeny 
Although most of the infrageneric groups are paraphyletic or polyphyletic according to the latest 
phylogenetic relationships based on ITS or plastid trnL-trnF sequences, the subgen. 
Melanocrommyum is determined to be monophyletic (Figure 1.3) (Gurushidze et al., 2008; 
Gurushidze et al., 2010). 
 
Subgen. Melanocrommyum is one of the main subgenera of genus Allium comprising roughly 
140 species (Khassanov & Fritsch, 1994; Fritsch et al., 2006). This number has increased to 
around 160 species that are mainly native to dry Mediterranean, Middle East, Northwestern 
China, and Central Asia (Fritsch et al., 2007; Seregin, 2007; Gurushidze et al., 2008; Fritsch et 
al., 2010). 
 
Generally, it is mostly qualitative characteristics rather than the quantitative ones that have been 
used to delimit the species in the subgenus. According to previous studies, the most useful 
taxonomical traits related to qualitative characteristics include the shape of leaf blades, forms 
of tepals, scape length, shape of inflorescence, and flower density. 
 
The reports referring to different numbers of infrageneric classifications in the genus, however, 
indicate the taxonomic uncertainties of species within the subgenus. Many of its species are 
known only for their ornamental flowers, and they are rarely economically important. 
 
The best-studied species of Allium, such as  A. sativum, A. schoenoprasum, A. ursinum, A. cepa, 
and A. ameloprasum var. porrum (Kucerová et al., 2011), have been used as medicinal plants 
for the treatment of various diseases. They contain steroidal saponins and various organic sulfur 
compounds, such as cysteine sulfoxides (Sobolewska et al., 2016). In this study, A. sativum and 
A. giganteum in subgen. Melanochrommyum, characterized by novel heteroaromatic cysteine 
sulfoxide compounds and metabolites, have been of particular interest (Jedelská et al., 2008; 
Kubec et al., 2011). 
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1.3 Important Allium species used in folk medicine 
 
Allium contains many economically and medically important species such as onion, bunching 
onion, and chives, which are being used mostly as vegetables or spices (Fritsch & Friesen, 2002) 
by local residents (Fritsch & Khassanov, 2008). Medical advantages of Allium species are often 
referred to in relation to their antioxidant effects (e.g. Yin & Cheng, 1998; Tepe et al., 2005). 
Recently, antioxidant biocomposites have been generated from the red onion extract (de 
Dicastillo et al., 2015). Anti-diarrhea and anti-parasite effects of Allium date back to ancient 
Egypt (Keusgen et al., 2002). In Middle Asia and Europe, green Alliums has been largely used 
as a condiment, owing to its characteristic taste and smell. In the food industry, wild onion is 
mainly used as a spice, while in the pharmaceutical industry, it is a common ingredient in food 
supplements. In addition, the consumption of Allium species as a source of therapeutic benefits 
has a long history in common folklore (González et al., 2009). For centuries in ancient Greece, 
A. sativum (garlic), known for its therapeutic and medicinal effects in modern and traditional 
medicine, has been used to treat diseases such as animal bites, leprosy, plague, heart disorders, 
and cancer (Rose et al., 2005). Garlic has a long medicinal history in a fight against heart 
diseases because of its cholesterol-lowering, antibacterial, and antiartherosclerotic properties 
(Keusgen et al., 2002). In some areas of China, garlic is used as a folk medicine for the 
prevention of colds. Some species, such as  A. stipitatum and A. severtzovioides of subgen. 
Melanocrommyum, are useful for curing stomach and duodenum disorders (Keusgen et al., 
2006). The species such as A. stipitatum and A. rosenbachianum are often used as medicinal 
herbs for many ailments (Keusgen et al., 2006). A. cepa has antidiabetic (Bang et al., 2009) and 
antiasthmatic effects (Wagner et al., 1990). Garlic and onion are species rich in sulfur 
compounds, including mainly cysteine derivatives (S-alkyl cysteine sulfoxide). Volatile 
compounds such as thiosulfinate and polysulfinate have antidiabetic, antibiotic, blood sugar 
lowering, and other biological effects (El-Demerdash et al., 2005). Recent folk medicine usage 
of species such as A. pskemense from Uzbekistan and A. saworowi from Tajikistan illustrates 
their impact against tuberculosis (Keusgen et al., 2006). Moreover, A. jodanthum has been 
reported to cure blood fever and toothache, and A. komarowii is used to mitigate problems 
related to anemia, bronchitis, and tuberculosis (Keusgen et al., 2006). Also, A. rosenorum was 
found to have an inhibitory effect on epidermal staphylococcus (Jedelská et al., 2008), and it 
serves as a traditional body tonic (Keusgen et al., 2006) and food since its leaf is used as a spice 
in soups (the so-called atolla and oshi sioalaf). A. carolinianum is also used both as a vegetable 
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to cure swelling, dysentery, and arthritic problems, and as a body tonic (Khan & Khatoon, 
2008).  
1.4 Chemical compounds of genus Allium 
1.4.1 Non-sulfur compounds of Allium  
The most common non-sulfur compounds in alliums include carbohydrates, flavonoids, and 
saponins. Carbohydrates affect largely the flavor of the species, and flavonoids contain phenolic 
groups that exist, for example, as quercetin in A. cepa. Rodríguez Galdón et al. (2008) identified 
five different types of quercetins: isoquercetin, quercetin diglucoside, quercetin monoglucoside 
1, quercetin monoglucoside 2, and free quercetin. In their research, more than 80% of the total 
quercetin was in the form of quercetin monoglucoside 1 and quercetin diglucoside. Also, Inoue 
(1995) found spirostanol and furostanol saponins in some Allium species.  
 
1.4.2 Sulfur compounds of genus Allium 
Sulfur is a key nutrient for plant growth (e.g. Buchner et al., 2004). Onion’s sulfate present in 
roots converts into cysteine, methionine, or peptides such as glutathione in the leaves (Saito, 
2004). The amino acid cysteine and its derivatives, the. S-substituted cysteine sulfoxides and 
the γ-glutamyl peptides, are the most common non-protein sulfur compounds in alliums (Block 
et al., 1993). Relevant gamma-glutamyls were identified in different CSs (Kasai & Larson, 
1980). The first sulfur-containing volatile compound in alliums, the sulfonic acid, is produced 
when alliinase reacts with its substrate (CSs) after the cell dissection (Manabe et al., 1998). In 
addition, metabolites such as thiosulfinate, thiol, and disulfide are produced as secondary 
structures from sulfonic acid under non-enzymatic reaction (Block et al., 1993).  
 
1.4.2.1 Cysteine sulfoxides (CSs) 
Among the numerous compounds related to the genus Allium, the most interesting ones are 
those responsible for the volatile odor. These volatile compounds are formed by the 
hydrolyzation of non-volatile organic sulfur enzymatic compounds, the so-called S-alkenyl 
cysteine sulfoxides (CSs), the main secondary compounds in the cytoplasm of Allium species. 
To date, only positive secondary compounds of (+)-cysteine sulfoxides have been reported in 
Allium species (Krest et al., 2000).  
Many of the economically important Allium species produce CSs (Fritsch & Keusgen, 2006) 
that have various medicinal effects (Block et al., 1993); their contents and chemical structures 
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vary for different species and usually correspond to taxonomic groupings (Fritsch & Keusgen, 
2006). It seems that the relative amount of cysteine sulfoxides in Allium is species-specific 
(Keusgen et al., 2002). Also, it is supposed that S-substituted cysteine derivatives in alliaceous 
species are often used as storage compounds for sulfur or nitrogen (Kubec et al., 2011). For 
instance, S-(2-pyrrolyl) cysteine S-oxide’s presence in the intact bulbs of A. giganteum was 
studied by Kubec et al. (2011). Additionally, it has been proven that (N-substituted-2-pyrrolyl) 
cysteine S-oxides have possible antifungal and antibiotic activities. 
 
The findings of Krest et al. (1997) indicate that different amounts of alliinase can determine the 
presence and estimate the amount of cysteine sulfoxides that are described further in the text. 
According to some research, different odors in different Allium species, such as onion and 
garlic, can be due to varying methods of storage of CSs or their different substrates resulting 
from the reaction of alliinase with CSs (Nock and Mazelis, 1987; Jansen et al., 1989; Fujita et 
al., 1990). 
 
1.4.2.2 Different type of cysteine sulfoxides 
Although many Allium species contain one or two cysteine sulfoxides (Krest et al., 2000; Fritsch 
& Keusgen, 2006), A. tuberosum contains more (Manabe et al., 1998). Figure 1.4 shows the 
most famous types of cysteine sulfoxides in tribe Alliaceae including S-(2-pyrrolyl)cysteine-S-
oxide, (+)-S-(ethyl)-L-cysteine sulfoxide or ethiin, (+)-S-(methylthiomethyl)-L-cysteine 
sulfoxide or marasmin, (+)-S-(butyl)-L-cysteine sulfoxide or butiin, (+)-S-(benzyl)-L-cysteine 
sulfoxide or petiveriin A, (+)-S-(benzyl)-L-cysteine sulfoxide or petiveriin B, (+)-S-(3-
pentenyl)-L-cysteine sulfoxide, (+)-S-(2-hydroxyethyl) cysteine sulfoxide, and (+)-S-(3-
pyrrolyl)-L-cysteine sulfoxide (Kubec et al., 2000; Kubec and Musah, 2001; Kubec et al., 2002; 
Kubec et al., 2002b; Kubec et al., 2013; Dini et al., 2008; Jedelská et al., 2008).  
 
The four main basic compounds of cysteine sulfoxides are: (i) alliin or (+)-S-C2-(2-propenyl)-
L-cysteine sulfoxide, present in high amount in garlic; (ii) methiin (MCSO) or (+)-S-methyl-L-
cysteine sulfoxide, present in low amount in garlic; (iii) isoalliin (TPCSO) or S-(1-propenyl)-
L-cysteine sulfoxide; and (iv) propiin (PCSO) or (+)-S-propyl-L-cysteine sulfoxide in onions 
and leeks (Virtanen & Matikkala, 1959; Granroth, 1970; Freeman & Whenham, 1975; Lancaster 
& Kelly, 1983; Block et al., 1993; Breu, 1996; Fritsch & Keusgen, 2006). 
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S-allyl-cysteine sulfoxide (ACSO) or alliin was the first precursor compound identified in vitro 
by Stroll & Seebrook (1947). Alliin attaches to pyridoxal-phosphate (pxy-p) and converts to S-
alk(en)yl-cysteine sulfoxide and volatile compounds in Allium. Alliin is one of the non-volatile 
thiosulfinate compounds responsible for the flavor of A. sativum (Block et al., 1993; Hornickova 
et al., 2010). 
S-Methyl-L-cysteine sulfoxide (methiin) is the most ubiquitous compound that shows in 
varying amounts in the intact tissues of all Allium species, mainly in A. sativum, A. cepa, A. 
porrum, and A. urisinum. 
 
 
Figure 1.4 Different types of cysteine sulfoxides in tribe Alliaceae (adopted from Kubec et al., 2013). 
 
The amounts or CS products resulting from analysis by alliinase significantly impact the 
severity of taste (Keusgen, 2013). Isoalliin, a source of the lachrymatory factor reference, is the 
major sulfoxide existing in intact "onion-type" tissues including A. schoenoprasum and A. x 
proliferum (top onion) (Fritsch and Keusgen, 2006). The formation of stable primary aroma 
compounds, such as thiosulfinates or the lachrymatory factor, is mediated by alliinase through 
the hydrolysis of S-alk(en)yl cysteine sulfoxides as a precursor (Rose et al., 2005) (Figure 1.5). 
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From these precursor compounds, through the action of alliinase, large amounts of sulfur 
compounds are synthesized. Additionally, A. sativum contains a significant amount of alliin, 
and isolliin is abundant in A. cepa (Koch & Lawson, 1996). 
 
 
Figure 1.5 Hydrolysis of S-alk(en)yl cysteine sulfoxides mediated by alliinase results in the formation of sulfenic 
acids, which produces thiosulfinates or the lachrymatory compound 1-propanethial-S-oxide (Rose et al., 2005). 
 
Allicin is present in A. sativum and lowers blood cholesterol (Lu et al., 2012). Marasmin, 
containing two sulfur atoms in each molecule, is produced after reaction by alliinase and is one 
of the classical cysteine sulfoxides that is often found in A. stipitatum and A. suworowii 
(Kusterer et al., 2011; Kubec et al., 2011). 
 
1.5 Alliinase and biosynthesis of cysteine sulfoxides 
1.5.1 Alliinase 
Alliinase (EC 4.4.1.4) found in Allium species, commonly belongs to lyase enzymes and in 
particular to carbon-sulfur lyases. Being sensitive to pH and temperature, alliinase shows the 
best activity in Allium in C-S-lyzing TPCSO in comparison with MCSO or PCSO (cf. Nock & 
Mazelis, 1987). The first described alliinase was found in garlic (Nock and Mazelis, 1987; Fujita 
et al., 1990). Krest et al. (2000) found that in all studied Allium species, alliinase is activated in 
a pH range 5–8 and at an optimal temperature range  34°C–40°C, and is species-specific. In 
garlic, there are two different types of alliinase: one C-S-lyzes PCSO and TPCSO in pH = 4.5, 
and the other specific for MCSO action in pH = 6.5. 
Jansen et al. (1989) indicated that metal cations including Fe+2 or Zn+2 as well as other cofactors 
such as ATP, FAD, and NADH, were not significantly correlated to alliinase activity or 
modifications. They also found that alliinase activity increases only in the presence of 10% 
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glycerol and pyridoxal phosphate. Kuettner et al. (2002) identified the structure of alliinase after 
Stroll and Seebeck (1947)  first detected its action in A. sativum. It is assumed that alliinase 
likely exists in all species of Allium (Tsuno, 1958a; Lancaster, 2000). Its activity is commonly 
studied in A. cepa, A. sativum, A. ampeloprasum, A. porrum, A. tuberosum, A. ursinum, and A. 
fitulosum (Fujita et al., 1990). 
 
Numerous studies have demonstrated that volatile sulfur compounds are responsible for the 
taste and flavor of Allium species. This is mainly caused by enzymatic hydrolyzing mediated 
by alliinase alk (en) yl-thiosulfinat S-alk (en) yl-2-cysteine sulfoxide (Block et al., 1993; Sendl 
et al., 1995; Koch & Lawson, 1996). The findings of Lancaster and Collin (1981) show that 
when an onion’s tissue is damaged, the alliinase from vacuole breaks the CSs from the cytosol 
into sulfur and alpha carbon bonds. As Figure 1.6 illsutrates, alliinase catalyzes the conversion 
of amino acid alliin ((+)S-allylcysteine sulfoxide) to allicin (diallyl thiosulfinate), pyruvate, and 
ammonia by utilizing pyridoxal-5′-phosphate (PLP) as a cofactor (Lancaster & Collin, 1981; 
Weiner et al., 2009). Alliinase breaks the C-S bond in the reaction of CSs and pyridoxal-5′-
phosphate by means of beta-elimination using a shiff base (Breu, 1996). Alliinase has specificity 
for alliin and isoalliin (Nock & Mazelis, 1987; Rabinkov et al., 1995; Krest et al., 2000). In 
addition, using isoelectric focusing (IEF) method, Nock and Mazelis (1987) have separated 
isoenzymes in alliinase that are chemically and physically different from each other. 
 
 
Figure 1.6 Reaction of alliinase on alliin (after Weiner et al., 2009). 
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In addition to Allium, some other species such as Petiveria alliacea (Musah et al., 2009), Albizia 
lophanta (Schwimmer & Kjær, 1960), broccoli, and other Brassicaceae, (e.g. Hall & Smith, 
1983) contain alliinase with a significantly different structure from that of the Allium species 
(Hamamoto & Mazelis, 1986). Moreover, alliinase and its relevant compounds are also found 
in some bacteria (Reily, 1980; Kamitani et al., 1990; Chhabria & Krutika, 2016) and fungi 
(Iwami and Yasumoto, 1980). 
 
Ellmore and Feldberg (1994) showed that aliinase is placed in sheath cells also available in 
these cells .They also found that the existence of alliinase in epidermic cells of onion, confirmed 
by auto-fluorescence, may act as an antimicrobial defense through stomata. According to some 
other studies, the type of alliinase and its activity reaction to cysteine sulfoxides differs in the 
bulb and root of the onion (Ramírez and Whitaker, 1998; Lancaster et al. 2000). Also, different 
isozymes of alliinase found in Allium differ not only physically and chemically, but also in terms 
of their enzymatic activity (Nock & Mazelis, 1987). Additionally, being composed of 1470 base 
pairs, genome sequences of allinase, with a circular DNA shape, have been identified in some 
Allium species using cloning approaches (Van Damme et al., 1993; Clark et al., 1993). Alliinase 
activity can be inhibited by cysteine sulfoxide derivations, carboxyl methyl amine, and hydroxyl 
amine (Jansen et al., 1989).  
 
Alliinase, for instance in an allium’s bulb, is active as a monomer that reacts with cysteine 
sulfoxide and catalyzes the reaction. It also links the amine group of cysteine sulfoxides to 
aldimine and subsequently makes electron emission to break cysteine sulfoxide into sulfur-
carbon. Breaking aldimine activates cofactor-enzyme and forms - aminoacrylic acid through 
pyridoxal-5′-phosphate (Krest et al., 2000). Following this reaction and after cleavage of 
cysteine sulfoxides, sulfuric and -aminoacrylic acids are formed as primary products followed 
by primary flavor compounds (Krest et al., 2000). 
The effect of alliinase on different cysteine sulfoxides results in various secondary compounds. 
For instance, different compounds including methyl propyl trisulfide, di-2-propenyl disulfide, 
methyl-2-propyl-disulfide, and methyl-1-propyl-disulfid are produced in A. ursinum (Schmitt 
et al., 2005). The other types of mono-, di-, and trisulfides in A. ursinum are responsible for its 
odor and flavor (Keusgen, 2013). The red pigment is also produced as the result of the cleavage 
reaction by alliinase. The occurrence of red pigments in some alliums, for example in A. 
giganteum (subgen. Melanochrommyum) is due to the enzymatic reaction accumulating 2-
lactyl-3′-pyrrolyl sulfoxide to 3,3′-dithio-2,2′-dipyrrole. Consequently, L-(+)-S-(3-
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pyrrolyl)cysteine sulfoxide is first degraded and then natural red pigments are formed in A. 
macleani after bulb disruption (Jedelská et al., 2008). These types of cysteine sulfoxides, 
consisting of two structures, can be polymerized to dark red under oxidative reaction (Keusgen, 
2011). 
 
 
1.5.1.1 Effect of pH on enzymatic activity and substrate stability 
Jansen et al. (1989) used the optimum pH of 6.7–7 to estimate the alliinase enzymatic activity 
extracted from A sativum. Nevertheless, previous studies reveal that the optimum pH depends 
on the species from which the enzyme is obtained. For example, the pH of 7 is determined to 
be optimum for A. altyncolicum (Keugen et al., 2002) and A. fistulasum (Fujita et al., 1990). In 
different species of subgen. Melanocrommyum, for example A. macleanii, two optimum pHs 
were identified due to the existence of two subunits or isoforms of alliinase, representing 
different activities in pH = 7.5 and pH = 5 (Vogt, 2008-doctoral thesis). The maximum activity 
of A. macleanii was reported in the pH = 10 (Vogt, 2008-doctoral thesis). The pyrrolyl cysteine 
sulfoxides existing in subgen. Melanocrommyum are similar to the substrate used in this test. 
Also, the enzyme alliinase extracted from A. stipitatum contains two different optimum pHs, 
pH = 7.7 and pH = 8.2, while A. rosenorum has only the optimum pH = 7.7 (Mielke, 2015-
doctoral thesis).  
 
1.5.1.2 Effect of temperature on enzyme activity and substrate stability 
Reactivity temperatures for the alliinse extracted from A. sativum, A. altyncolicum, and A. 
stipitatum are 33°C (Jansen et al., 1989), 36°C (Keusgen et al., 2002), and 36°C (Mielke, 2015-
doctoral thesis), respectively. Generally, the optimum temperature of alliinase for different 
species of Allium varies between 30–40°C (Keusgen et al., 2002). This optimum temperature 
reported for A. rosenorum is 39°C (Mielke, 2010) and for A. macleanii 36°C (Vogt, 2008-
doctoral thesis). These two species contain pyrrole cysteine sulfoxide compounds and are 
considered important. 
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1.5.2 Biosynthesis pathway of cysteine sulfoxides 
Chemically unstable metabolites of CSs make it relatively difficult to analyze them and their 
pathways. Nowadays, we appreciate various methods and techniques such as HPLC or GC for 
direct analysis of different CSs or their derivatization in plant tissues (Rose et al., 2005) and it 
is very common to use various synthetic methods including HPLC, NMR, IR, and photometry 
to find biosynthetic pathways (kusterer et al., 2011).  
 
Cysteine is a water-soluble amino acid required for the biosynthetic pathway in the plant 
species. Moreover, direct chemical investigation and radiolabel feeding help us understand the 
biosynthesis pathway of CSs. Radiolabeled carbon and sulfur sources show that cysteine 
sulfoxides are rapidly incorporated into the glutamyl peptides (GPs) (Rose et al., 2005). All 
types of CSs have a primary source of sulfur (SO42-) to be synthesized (Hesse et al., 2004). 
Later, the synthesized SO42- is converted into 5-adenylysulfate (APS) in a reaction catalyzed by 
the enzyme ATP sulfurylase in the plastids. Next, the APS is converted into sulfide through the 
enzyme sulfide reductase. Sulfide reacts with O-acetlyserine and forms cysteine utilizing the 
enzyme OAS thiol-lyase (Leustek et al., 2000). So far, nearly 24 sulfur-containing glutamyl 
peptides (GPs) have been identified in Allium species playing an intermediate role in CSs 
biosynthesis (Hesse et al., 2004). 
 
Further studies show that γ-glutamylcysteine and glutathione are essential start-up compounds 
for CSs biosynthesis. Removing the glutamyl group by oxidation results in parental CSs (Rose 
et al., 2005). Granroth (1970) proposed an alternative pathway, in which cysteine reacts with 
methacrylic acid and forms S-2-carboxyproplyl cysteine, and S-2-carboxypropyl glutathione 
(containing radiolabel 14C) results in ACSO, TPCSO and PCSO. In another study, Randle and 
Lancaster (2002) introduced a biosynthesis pathway for different peptides and S-alk(en)yl 
cysteine sulfoxides (ACSOs) in Allium. Additionally, according to Lancaster and Show (1989), 
gamma-glutamyl-cysteine sulfoxides intermediate the synthesis of CSs. 
  
15 
 
1.5.2.1 Biosynthesis pathway of known cysteine sulfoxides 
Since the 1940s, many studies have been conducted to understand the biogenesis pathways of 
compounds like methiin, alliin, and propiin, although they remained relatively poorly 
understood.  
 
 
Figure 1.7 Assimilation of sulfate in plants (after Luestek and Saito, 1999). 
 
However, Rose et al. (2005) identified many compounds together with the related enzymes 
incorporated in their biogenesis pathway including gamma-glutamyl peptide. The gamma-
glutamyl peptide compound, as a storage for sulfur and nitrogen, plays a key role in the 
formation of cysteine sulfoxide (Rose et al., 2005). 
Lancaster and Show (1989) proposed one of the most accepted theories regarding the formation 
of cysteine and glutathione in the plants. They also described the biosynthetic pathway required 
for the formation of methiin, propiin, and isoalliin from glutathione (Figure 1.7 and Figure 
1.8). Moreover, it is estimated that nearly one-third of the formed cysteine is immediately 
transferred to glutathione’s cycle (Jones et al., 2004).  
e 
e 
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Figure 1.8 Proposed biosynthetic pathway of isoalliine, methiine, and propiine (after Lancaster and Show, 1989). 
 
1.5.3 Biosynthesis pathway of pyrrolyl cysteine sulfoxide 
As is the case for other cysteine sulfoxides, no biosynthetic pathway has been suggested for 
(pyrrolyl)cysteine sulfoxide compound. This compound is available in subgen. 
Melanocrommyum species such as A. macleani (Jedelská et al., 2008), A. rosenorum (Jedelská 
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et al., 2008), A. giganteum (Kubec et al., 2011), and A. carolinianum. Also, glutathione 
compounds and precursor substances play an important role in the biosynthesis of this new 
compound (Vogt, 2008-doctoral thesis). In order to present a biosynthesis model for the 
(pyrrolyl)cysteine sulfoxide compound, it is necessary to first describe some of its related 
primary compounds. 
 
1.5.3.1 Prodigiosin 
Prodigiosin is one of the important pyrrole compounds (Figure 1.9) in plants, and its 
biosynthesis from aminolevulinic acid (ALA) was described by Williamson et al. (2006). 
 
 
Figure 1.9 Molecular structure of prodigiosin. 
 
1.5.3.2 L-tryptophan 
Tryptophan, an essential amino acid, is one of pyrrole compounds in plants (Figure 1.10).
 
Figure 1.10 Molecular structure of L-tryptophan. 
 
 
18 
 
Figure 1.11 illustrates the formation of amino acid L-tryptophan from n-(5'-phosphoribosyl) 
anthranilate and L-serine (Crawford, 1989). 
 
 
Figure 1.11 Biosynthesis of tryptophan from N-(5phosphoribosyl)anthranilate (adopted from Crawford, 1989). 
 
1.5.3.3 Porphobilinogen  
 
Although porphobilinogen (PBG) (Figure 1.12) does not have any effect on the 
abovementioned biosynthetic pathway in plants, it is one of the significant compounds 
containing pyrrole. It is worth noting that the amino acid glycine and acetate are both involved 
in the formation of PGB. 
 
 
Figure 1.12 Molecular structure of porphobilinogen. 
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Acetate is transferred to the citrate cycle and converted into succinyl-CoA, which is converted 
into ALA following decarboxylation of glycine. This substrate is the primary substrate for 
formation of PGB (Lehninger, 1987), (Figure 1.13). 
 
 
Figure 1.13 Biosynthesis of porphobilinogen and formation by ALA dehydratase (Jordan, 1991). 
 
1.5.3.4 Pyrrole-2-carboxylate 
 
The enzymatic oxidation of proline during a complex reaction (Figure 1.14) results in the 
formation of pyrrole-2-carboxylate that is one of the precursors for many pyrrole compounds in 
plants (Williamson et al., 2006). 
 
 
Figure 1.14 Molecular structure of pyrrole-2-carboxylate. 
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1.5.3.5 Methylpyrrole-2,4 dicarboxylic acid 
 
3-Methylpyrrole-2,4 dicarboxylic acid (Figure 1.15) as a central pyrrole moiety is one of the 
essential compounds in the synthesis of coumermycin A1, an amino coumarin antibiotic 
consisting of Streptomyces rishiriensis and containing 3-pyrrole rings with 5-methylpyrrole-2-
carboxylomoieties at terminals, and 3-methylpyrrole-2,4 dicarboxylic acid moiety at the center 
(Siebenberg et al., 2011). 
 
 
Figure 1.15 Molecular structure of 3-methylpyrrole-2,4 dicarboxylic acid. 
 
1.6 Amino acids involved in the synthesis of cysteine sulfoxides 
1.6.1 Cysteine  
Berg et al. (2002) found that non-essential amino acids such as serine, cysteine, and alanine, 
can be converted into pyruvate. Boyle (2005) showed that among 20 amino acids existing in 
protein structures, aliphatic non-polar alanine contains CH3 side chain, while uncharged polar 
amino acids, including cysteine and serine, contain CH2SH and CH2OH side chains, 
respectively. In addition, the sulfur atom, one of the essential elements of cysteine, plays a 
significant role in plant growth. Cysteine is also an important source of sulfide in human 
metabolism and reduces the toxic effect of alcohol. In plant metabolism, biosynthesis of 
cysteine is one of the key components in the sulfur cycle. Plant’s roots absorb sulfate ions from 
the soil and and these ions enter the biosynthesis of cysteine (Singh, 1998). Cysteine is then 
produced in cytosol, plastids, and mitochondria through the enzymes serine acetyl transferase 
and o-acetylserine(thiol)lyase (Álvarez et al., 2012). Later, the produced cysteine is 
incorporated in protein structure and glutathione as sulfur in methionine or secondary sulfuric 
compounds, such as allyl cysteine sulfoxide (Singh, 1998). Additionally, cysteine is considered 
as a primary precursor for essential biomolecules like vitamins, cofactors, antioxidants, and 
many protective compounds in plants.  
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1.6.2 Serine 
Serine is naturally available as L-isomer in proteins. L-serine belongs to the non-essential amino 
acids that can be synthesized in the human body under normal physiological circumstances. 
Serine can affect the structure of proteins. The hydroxyl group of its side chain enables serine 
to link the compounds via hydrogen bonds (Betts & Russell, 2003). Being the precursor to 
several amino acids including glycine and cysteine, it participates in the biosynthesis of purines 
and pyrimidines during metabolism activities. It also serves a significant role in maintaining the 
immune system (Betts and Russell, 2003). L-serine, whose isoelectric point is at pH 5.68, 
belongs to non-essential amino acids synthesized under normal physiological circumstances in 
human body (Betts and Russell, 2003). It is fully soluble in water, but only slightly soluble in 
ethanol and diethyl ether.  
 
1.6.3 Alanine 
Alanine, a non-essential α-amino acid, appears naturally as an L-stereo isomer in proteins that 
can be produced by the human body. It is distinguished by its α-carbon linked to a methylene 
group and is likely the dullest amino acid that is considered neither hydrophobic nor polar. 
Alanine is rarely directly involved in the protein function. However, alanine shows substrate 
specificity and interacts with non-reactive atoms like carbons (Betts & Russell, 2003). 
 
1.7 Research scope and objectives 
The reaction of alliinase with heteroaromatic cysteine sulfoxides like S-(2-pyrrolyl)cysteine-S-
oxide and S-(3-pyrrolyl)cysteine-S-oxide produces the remarkable red pigment. These cysteine 
sulfoxides can be found in A. carolinianum, A. giganteum, A. macleanii, and A. rosenorum, 
where convert into the red pigment after the cell dissection. The homologous compounds were 
synthesized like furan and thiophene cysteine sulfoxides were synthesiszed , which are usefull 
for comparing their reactivity, synthesis pathways, and structures. Additionally, an alliinase 
bioactivity test was conducted on both sulfoxide and sulfide compounds in order to identify the 
resulting products. Thus, the study aimed to address the following goals: (i) the suitable 
synthetic pathway of pyrrole cysteine sulfoxides and homologous heteroaromatic compounds 
(Figure 1.16); (ii) possible proposed structures of these compounds (Figure 1.17); and (iii) the 
hypothesized biosynthetic pathway of pyrrolyl cysteine sulfoxide. 
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Figure 1.16 The structures of the compounds aimed to be synthesized. (i) S-(2-pyrrolyl)cysteine-S-oxide; (ii) S-
(2-thienyl)cysteine-S-oxide; (iii) S-(2-furanyl)cysteine-S-oxide; (iv)  S-(3-pyrrolyl)cysteine-S-oxide; (v) S-(N-
(PG)pyrrol-2-yl)cysteine-S-oxide; (vi) S-(N-(PG)pyrrol-2-yl)cysteine; and (vii) S-(2-thienyl)cysteine; (viii) S-(2-
pyrrolyl)cysteine; (ix) protected pyrrolyl cysteine; (x) S-(3-furanyl)cysteine-S-oxide. PG can be Me, ph, Boc, or 
Cbz. 
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Figure 1.17 Molecular structures of (i S-(2-thienyl)thiophene-2-sulfinothioate; (ii) 2,2ˊ-(1,2-dioxido-1 λ4, 2 λ4-
disulfane-1,2-diyl)dithiophene;(iii)2-({(E)-2-[(1E,3Z,5Z)-octa-1,3,5,7-tetraen-1yldisulfanyl]ethenyl}sulfanyl)-1 
H-pyrrole; (iv) (3E)-2-amino-4-(1H-pyrrol-2-yldisulfanyl)but-3-enoic acid and; (v) S-propyl 2-(1H-pyrrol-2-
ylsulfinyl)ethanesulfinothioate
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2 Methods and materials  
Stock solvents and reagents were mainly obtained from Sigma-Aldrich (St. Louis, USA or Carl 
Roth, Karlsruhe Germany). The list of chemicals and reagents, and details of the devices are 
provided in Appendixes 1–2. Amounts of chemical reagents used for each experiment are listed 
in Appendix 3. All synthetic methods described here were developed in our lab. Thin layer 
chromatography (TLC), as one of the common approaches, was implemented to separate 
different compounds from the mixture. TLC was conducted on a silica gel plate (0.2 mm, silica 
gel 60) at F254 with a fluorescence indicator (Macherey Nagel, Dueren, Germany). The spots 
were detected using UV light under λmax = 254 nm (n-Butanol:H2O:acetic acid:formic acid, 
28:8:9:2 v/v/v/v) for cysteine sulfoxide (after Keusgen, 1997; Appendixes 2–3). Ninhydrin 
reagent (Keusgen, 1999; Appendix 3) was used to recognize amino acids by TLC. Preliminary 
analysis of TLC was often further confirmed by supplementary analyses including 1H-
NMR,13C-NMR, mass spectrometry (MS), infrared spectrometer (IR, Bruker, Ettlingen, 
Germany) analyses, and HR-MS unless otherwise mentioned. Structure elucidation was 
performed by various techniques, namely NMR, MS-ESI, MS-EI, and MS-HR. The 400 MHz 
NMR spectrometry was conducted with ECX-400 (Jeol, München, Germany) under the 
condition represented in Appendix 2. NMR spectra (1H-NMR and 13C-NMR) of isolated 
compounds were measured in D2O or CD3OD at 25°C. IR spectroscopy (Bruker alpha-P, 
software Opus 6.5) was used for characterization of functional groups and compounds. The 
synthetic methods for the main products in addition to the complementary approaches are 
presented in the following sections.  
 
2.1 Synthesis of 3-chloro-L-alanine hydrochloride or β-chloro-L-alanine 
L-Serine (2.5 g, 238 mmol), as a starting compound, was added to 250 ml tetrahydrofuran 
(THF). Hydrogen chloride was produced through the reaction of sulfuric acid (20–30 ml) with 
NH4Cl (10–20 g) passing through the solution. The mixture was stirred at room temperature for 
24 h until it was saturated with the gas. Thionyl chloride (6.25 g, 52.5 mmol) was slowly mixed 
into the solution. The reaction mixture was stirred at 50˚C for 3–4 days, concentrated (at 40˚C, 
350 mbar) to about half the original volume, and cooled down to precipitate at 0–10˚C for 24 h. 
Eventually, the residue was washed several times with THF (10–20 ml), dissolved in methanol 
(5–10 ml), re-precipitated using diethylether (50–70 ml), and filtrated (after Yamashita et al., 
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2003). Finally, it was analyzed using TLC, 1H-NMR, 13C-NMR, MS, HR-MS, and IR. The 
synthesis is represented as in Figure 2.1. 
The synthesized amount was estimated to be 21.52 g ≈ 0.204 mol. 
 
 
Figure 2.1 Synthesis of 3-chloro-L-alanine hydrochloride. 
 
2.2 Synthesis of aliphatic cysteine sulfoxides 
Aliphatic cysteine sulfoxides were synthesized according to Keusgen (1999): sodium (9.7 g, 
420 mmol) was dissolved in 500 ml dry ethanol; next, L-cysteine (26.6 g, 200 mmol) was added 
to the mixture. Alk(en)yl bromides (220 mmol) were added to the reaction. The reaction’s pH 
was set to 5.5 using acetic acid when the reagent cooled down at RT until full precipitation. The 
solution was stored overnight at 4°C to crystalize. The desired crystal (130 mmol) was dissolved 
in water (180 ml) after filtration. It was oxidized with H2O2 25% (15.2 ml, 130 mmol) to convert 
sulfide to sulfoxide. The solvent was removed under reduced pressure at 40˚C and 70 mbar. 
This method was used to synthesize S-(2-thienyl)cysteine in this study. 
 
2.3 Synthesis of aromatic cysteine sulfoxide 
 
2.3.1 Synthesis of S-(N-benzylpyrrol-2-yl)cysteine  
N-Benzylpyrrole (3.17 ml, 20 mmol), thiourea (3.05 g, 40 mmol), 13 ml ethanol and 5 ml water 
were mixed at 30–40°C (mixture A). Potassium iodide (3.32 g, 20 mmol) and iodine (5.08 g, 
20 mmol) were dissolved in 9 ml ethanol and 6 ml water (mixture B). Mixture B was gradually 
mixed with A and heated up to 30–40˚C for 3 h under argon protection. Two steps followed: i) 
hydrazine hydrate 35% (1 ml, 20 mmol) was added to the mixture of sodium hydroxide (3.00 
g, 75 mmol) and 7 ml distilled water; ii) 3-chloro-L-alanine hydrochloride (3.84 g, 24 mmol) 
was dissolved in 8 ml distilled water. The mixtures obtained in these two steps were added to 
the previous mixture of A and B. The resulting reaction mixture was heated up to 90–100˚C for 
2 h, purified using activated charcoal (1‒2 g) for 30–60 min., filtrated, and its pH was adjusted 
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to 5.5 by adding HCl 10% to precipitate the product. The obtained mixture was stored at 5˚C 
for 12 h. The product was preliminarily dried using rotary evaporator (at 40˚C, 70 mbar and 175 
mbar for H2O and ethanol, respectively) and further dried in the desiccator (containing P2O5) 
by applying the vacuum. Then it was dissolved in 10 ml methanol and centrifuged at 5,000 rpm 
at 4˚C for 10 min. The supernatant was precipitated with diethylether (50–100 ml) and stored 
at 4˚C for 24 h. Subsequently, the product was analyzed using TLC, 1H-NMR, 13C-NMR, MS, 
HR-MS, and IR (after Rudyakova et al., 2008). The synthesized amount was estimated to be 
2.58 g ≈ 9.3 mmol. 
 
2.3.2 Synthesis of S-(N-methylpyrrol-2-yl)cysteine 
The mixture of N-methylpyrrole (2.7 ml, 30 mmol), thiourea (4.56 g, 60 mmol), 15 ml ethanol 
and 8 ml water were heated up to 30–40˚C (mixture A). Potassium iodide (4.98 g, 30 mmol) 
and iodine (7.61g, 30 mmol) were dissolved in 16 ml 50% alcohol/water (1:1 v/v) (mixture B). 
Mixtures A and B were gradually passed through argon and heated up to 30–40˚C for 3 h. 
Hydrazine hydrate 35% (1 ml, 20 mmol) was mixed with sodium hydroxide (4.78 g, 75 mmol) 
in 8 ml distilled water, and added to the mixture produced in the former step. 3-Chloro-L-alanine 
hydrochloride (5.77 g, 36 mmol) was dissolved in 15 ml distilled water, added to the reaction 
mixture from the previous step and heated up to 90–100˚C for 2 h. The product was purified 
using activated charcoal (1‒2 g) for 30–60 min., filtrated, and the pH was reduced to 5.5 using 
HCl 10% to obtain precipitation. The mixture was stored at 5˚C for 12 h under argon protection. 
The resulting product was preliminarily dried using rotary evaporator (at RT, 40 mbar and 110 
mbar for H2O and ethanol, respectively) and further dried in the desiccator (containing P2O5) 
through the vacuum. It was then dissolved in methanol (10 ml) and centrifuged at 5,000 rpm at 
4°C for 10 min. Re-precipitation was conducted using diethylether (50–100 ml) and the residue 
was stored at 4˚C for 24 h. Finally, it was analyzed using TLC, 1H-NMR, 13C-NMR, MS, HR-
MS, and IR (after Rudyakova et al., 2008). The synthesized amount was estimated to be 1.35 g 
≈ 6.75 mmol. 
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2.3.3 Synthesis of S-(2-pyrrolyl)cysteine 
The mixture containing pyrrole (1.42 ml, 20 mmol) in addition to thiourea (3.05 g, 40 
 mmol) plus 13 ml ethanol and 5 ml water was heated up to 30–40˚C. Potassium iodide (3.32 g, 
20 mmol) and iodine (5.07 g, 20 mmol) were dissolved in ethanol/water (9:6 v/v). The two 
reagents were gradually mixed under argon at 30–40˚C for 3 h. Hydrazine hydrate 35% in H2O 
(1 ml, 20 mmol) was mixed with sodium hydroxide (3.00 g, 75 mmol) in 7 ml distilled water. 
All chemicals mentioned above were added to the mixture resulted from the former step. 3-
Chloro-L-alanine hydrochloride (3.84 g, 24 mmol) was dissolved in 8 ml distilled water, added 
to the previous one, and heated up to 90–100˚C for 2 h. The product was purified using activated 
charcoal (1‒2 g) for 30–60 min, filtrated, and the pH was reduced to 5.5 using HCl 10%. The 
resulted precipitation in the mixture was stored at 5˚C for 12 h. The end product was 
preliminarily dried using rotary evaporator (at RT, 40 mbar and 110 mbar for H2O and ethanol, 
respectively) under argon protection and further dried in the desiccator (containing P2O5) 
through vacuum. Afterwards, it was dissolved in 10 ml methanol and centrifuged at 5,000 rpm 
at 4˚C for 10 min. Re-precipitation of the methanolic solution was conducted using diethylether 
(50–100 ml) and followed by 24-hour storage at 4˚C. The reaction was analyzed using TLC, 
1H-NMR, 13C-NMR, MS, HR-MS, and IR (after Rudyakova et al., 2008). The synthesis is 
shown in Figure 2.2. The synthesized amount of the product was estimated to be 1.30 g ≈ 7 
mmol. 
 
2.3.4 Synthesis of S-(N-Bocpyrrol-2-yl)cysteine 
 N-Boc-pyrrole (3.4 ml, 20 mmol) and thiourea (3.05 g, 40 mmol) were added to 7.5 ml ethanol 
and 2.5 ml water while stirring. When thiourea was fully dissolved, the mixture of potassium 
iodide (3.32 g, 20 mmol) and iodine (5.07 g, 20 mmol) was added dropwise to the 10 ml 
ethanol/water solution (1:1 v/v). The temperature was controlled at 37°C under argon shield. 
After 3 h, hydrazine hydrate 35% (1 ml, 20 mmol) and sodium hydroxide (3.00 g, 75 mmol) 
were dissolved in 3 ml water and added to the solution while the temperature was maintained 
at 100°C. Next, 3-chloro-L-alanine (3.84 g, 24 mmol) was dissolved in 2.5 ml distilled water 
and the mixture was added to the reaction. The reaction lasted 2 h at 100°C. The resulting 
solution was purified using activated charcoal (1‒2 g) for 30 min. To precipitate, HCl 10% was 
added to set the pH of the solution to 5.5. Then the liquid was removed by centrifugation (at 
5,000 rpm at 4˚C for 10 min.) and consequently the residue dissolved in 10 ml methanol. Re-
precipitation was implemented using diethylether (50–100 ml), centrifuged, and the mixture 
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was subjected to 1H-NMR analysis (after Rudyakova et al., 2008). The synthesis is shown in 
Figure 2.2. 
 
Figure 2.2 Synthesis of S-(N-Bocpyrrol-2-yl)cysteine. “R” in the structure of compounds indicates H, Me, ph, 
and Boc. 
 
2.3.5 Synthesis of S-(2-thienyl)cysteine 
The reaction conditions were derived from the synthesis of the aliphatic S-alkenyl-l-cysteine 
(Keusgen, 1999). Argon was used as the protecting gas. Due to the poor solubility of 3-chloro-
L-alanine, the reaction mixture was heated up to 100˚C. In a three-necked flask, 20 ml pure 
ethanol was dried using sodium (386 mg, 1.68 mmol). Potassium hydroxide (561 mg, 10 mmol) 
was dissolved in the solution under argon protection before 2-thiophenethiol (2 mmol, 0.19 ml) 
was added. 3-Chloro-L-alanine (320 mg, 2 mmol) was mixed with the reagent and heated up to 
100˚C for 2 h. The solution was filtered, its pH set on 5.5 with HCL 10%, evaporated (at 4˚C, 
175 mbar) to reach 1 ml of total volume, and precipitated using 10 ml acetone. To obtain 
crystals, the precipitation was washed using ethanol and stored at 4˚C for 24 h. Consequently, 
the reaction was analyzed and visualized using TLC, 1H-NMR, 13C-NMR, MS, HR-MS, and 
IR. The synthesis is represented in Figure 2.3. 
The synthesized amount was estimated to be 378 mg ≈ 1.86 mmol. 
 
Figure 2.3 Synthesis of S-(2-thienyl)cysteine.  
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2.3.6 Synthesis of S-(3-furanyl)cysteine 
In a three-necked flask, 2.5 ml ethanol was dried with sodium (48 mg, 2 mmol). L-Cysteine 
(120 mg, 1 mmol) was dissolved, 3-bromofuran (0.1 ml, 1.1 mmol) was added dropwise and 
the reaction stored under cold conditions for 12 h. The pH was reduced to 5.5 with HCL 10% 
and washed using ethanol after filtration. 1H-NMR analysis was conducted on the reaction 
mixture (after Keusgen, 1999). The synthesis is shown in Figure 2.4. 
 
 
Figure 2.4 Synthesis of S-(3-furanyl)cysteine. 
 
2.3.7 Synthesis of 1H-pyrrole-sulfonyl chloride  
Chlorosulfonic acid (6.7 ml, 100 mmol) was carefully added dropwise to a mixture of pyrrole 
(3.5 ml, 50 mmol) and 12.5 ml chloroform (CHCl3) at –10°C (as the reaction is exothermal 
reaction). The reaction was stirred at RT for 20 min. The yielded product was placed on ice, 
filtrated, and weighed to give a yield of 4.17 g. The reaction mixture was subjected to 1H-NMR 
analysis. The synthesis is shown in Figure 2.5 (Organikum, 2001, page 364).  
 
 
Figure 2.5 Synthesis of 1-H-pyrrole-sulfonyl chloride. 
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2.3.8 Synthesis of furan-3-sulfonyl chloride 
Lithium was replaced with bromide in this reaction. 3-Bromofuran (0.9 ml, 1 mmol) was stirred 
in 20 ml THF at –78°C. t-Buli (0.19ml, 2 mmol) was added dropwise to the reaction over 10 
min. The mixture was stirred at –78°C  over 3 h.  An electrophile (ClHSO3, 0.07 ml, 1 mmol) 
was added dropwise and stored overnight at RT. The following steps were carried out under 
argon protection: 5 ml pentane and an equal amount of saturated sodium chloride were mixed 
together; the water phase was separated using 5 ml pentane; then, the organic phase was washed 
with 5 ml KOH 70% plus 5 ml saturated NaCl. It was further dried with MgSO4 overnight at 
RT. The reaction mixture was analyzed using 1H-NMR. The synthesis is shown in Figure 2.6 
(Kurth et al 1987, Organikum, 2001, page 364).  
 
Figure 2.6 Synthesis of furan-3-sulfonyl chloride. 
 
2.3.9 Synthesis of S-(2-furanyl)cysteine 
The synthesis followed the similar approach used for the synthesis of S-(N-benzylpyrrol-2-
yl)cysteine (described in section 2.3.1). Instead of N-benzylpyrrole, furan (0.04 ml, 50 mmol) 
was used in this reaction. Furan has a boiling point of about of 32°C and does not need to be 
heated up to 90°C. Unlike the synthesis of S-(N-benzylpyrrol-2-yl)cysteine, a colorless solution 
was obtained. After turning over the decanter, two phases (one whitish and water-soluble; one 
brown and methanol-soluble) were obtained (after Rudyakova et al., 2008). The mixture 
underwent 1H-NMR and further analyses. The synthesis is shown in Figure 2.7. 
 
Figure 2.7 Synthesis reaction of S-(2-furanyl)cysteine.  
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2.3.10 Synthesis of N-Cbz-L-serine benzylester-O-trifilate 
The purpose of the synthesis of this compound was to find an alternative compound to 3-chloro-
L-alanine. N-Cbz-L-serine benzylester (329 mg, 1 mmol) in 0–2°C dry THF was added 
dropwise to 1.1 Eq trifluoromethanesulfonic anhydride 99% (0.18 ml, 1.1 mmol). The reaction 
was stirred for at least 30 min at RT. The volatile compounds were evaporated (at 40°C, 350 
mbar). The solution was separated using a decanter in the mixture of ether and water. The 
organic phase was washed with water and HCl and consequently subjected to MS-EI analysis 
after evaporation. The synthesis is shown in Figure 2.8 (Hirschmann et al., 1996).  
 
 
Figure 2.8 Synthesis of N-Cbz-L-serine benzylester-O-trifilate. 
 
2.3.11 Synthesis of lithium furan-2-thiolate 
Furan (14.40 ml, 200 mmol) was added to 70 ml dry THF under argon protection. t-Buli (58.8 
ml, 100 mmol) in pentane was added portionwise to the reaction mixture. The temperature was 
increased to 35°C in the first 30 min and the reaction was stirred at RT for 2 h. Small portions 
of elemental sulfur (3.20 g, 100 mmol) were added and stirred at –20°C for 20 min; next, the 
solution was stored at –4°C for 24 h and evaporated (at RT, 250 mbar). The product obtained 
through the replacement of furan with lithium or sulfur (or sulfur-lithium) was analyzed using 
MS-EI. The synthesis is shown in Figure 2.9 (after Holland et al., 1999). 
 
 
Figure 2.9 Synthesis of lithium furan-2-thiolate.  
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2.3.12 Synthesis of 2-[(tert-butoxycarbonyl)amino]-3-(1-H-pyrrole-2-
ylsulfanyl)propanoic acid 
To the suspension of Boc-cystine (1.20 g, 2.7 mmol) in 50 ml CH2Cl2 at –80°C, 0.13 ml bromide 
was added while stirring for 10–15 min. Pyrrole (0.38 ml, 5 mmol) and imidazole (340 mg, 5 
mmol) dissolved in 10 ml CH2Cl2, were added to the first mixture and mixed for 30 min at 20–
22°C. Purification of the reaction mixture was carried out using column chromatography (silica 
gel; 3 cm x 50 cm), which was eluted with 3% methanol in CH2Cl2. After the evaporation (at 
RT, 750 mbar) of CH2Cl2, the product was analyzed using TLC (after Zhang and Parkin, 2013). 
The synthesis is shown in Figure 2.10.  
 
 
Figure 2.10 Synthesis of 2-[(tert-butoxycarbonyl)amino]-3-(1-H-pyttol-2-ylsulfanyl)propanoic acid. 
 
2.3.13 Synthesis of 1-(triisopropylsilyl)pyrrole 
Potassium (9.70 g, 248 mmol) in 500 ml THF was intensively heated up to 100°C. Pyrrole 
(17.20 ml, 248 mmol) was added dropwise (1 ml per min) to 100 ml THF. After 15 min at 
100°C, the mixture was stirred at RT for 12 h. While stirring at 0–2°C, chlorotriisopropylsilane 
(47.80 g, 248 mmol) was added dropwise to the mixture. The reaction was stirred at RT for 12 
h, filtered, and washed with THF several times. Next, THF was evaporated (at 30°C, 250 mbar) 
and the resultant colorless oil residue was analyzed using MS-ESI (after Stefan et al., 1989). 
The synthesis is shown in Figure 2.11. 
 
Figure 2.11 Synthesis reaction of 1-(triisopropylsilyl)pyrrole.  
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2.3.14 Synthesis of S-(2-pyrrolyl)cysteine using Allyl iso-thiocyanate 
To a stirred solution of lithium diisopropylamide (1.50 g, 140 mmol) and t-BuOK (15:70 g, 140 
mmol) in THF (60 ml), one solution of n-buLi (9.10 ml, 100 mmol) in 65 ml hexane was added 
under argon atmosphere at around –50˚C. A solution of allyl iso-thiocyanate (5.40 g, 50 mmol) 
in THF (40 ml) was added dropwise to the reaction during approximately 30 min at –20 to –
15˚C. The reaction was stirred for 30 min at 45˚C; next, H2O (8.00 g, 440 mmol) was added, 
intensively stirred for 20 min at approximately 30˚C. One portion of 3-chloro-L-alanine (14.00 
g, 100 mmol) was further added and stirred for 40 min at 50˚C. The resultant reaction mixture 
was quenched on 100 ml ice, and aqueous phase was removed with pentane (2  30 ml) and 
Et2O (2  30 ml).The organic phase was washed with H2O (3  40 ml), dried with potassium 
carbonate (K2CO3), and evaporated (at RT, 750 mbar) (after Nedolya et al., 2013).  The 
synthesis is shown in Figure 2.12. 
 
 
Figure 2.12 Synthesis of S-(2-pyrrolyl)cysteine. 
 
2.3.15 Synthesis of S-(N-methylpyrrol-2-yl)cysteine 
Method A) N-Methylpyrrole (0.05 ml, 0.5 mmol), N-Boc-cystine as disulfide (110 mg, 0.25 mmol) and 
copper(I) iodide or CuI (3 mol %) were mixed in DMSO (0.5 ml) and stirred for 20 h at 110°C. The reaction was 
evaporated (using high vacuum pump with liquid N2) and then analyzed.  
 
Method B) N-methylpyrrole (0.05 ml, 0.5 mmol), N-Boc-cysteine (606 mg, 0.5 mmol) and 
copper(I) iodide or CuI (5 mol %), as the reaction catalyzer were mixed in DMSO (0.5 ml) and 
stirred for 20 h at 110℃. The reaction was evaporated (using high vacuum pump) and then 
analyzed (after Alves et al., 2012) using TLC. The synthesis is shown in Figure 2.13. 
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Figure 2.13 Synthesis of S-(N-methylpyrrol-2-yl)cysteine. 
 
2.3.16 Synthesis of O-trifluoromethylsulfonyl-serine with triethylamine 
Trifluoromethanesulfonic anhydride (3.00 g, 10.6 mmol) was added under argon atmosphere to 
20 ml dichloromethane. L-Serine (1.11 g, 10.6 mmol) was added to the solution. When the 
solution was quenched to 0°C, a second solution of triethylamine (1.57 ml, 11 mmol) and 
dichloromethane (10 ml) was added dropwise. The reaction mixture was stirred at 0°C for 1 h. 
Dichloromethane was removed by evaporation (at 40°C, 1 atm). The residue was separated and 
purified by column chromatography (silica gel, 3 cm x 50 cm) (adopted from Ayad et al., 2005). 
TLC and MS-ESI were implemented to analyze the reaction mixture. The synthesis is shown in 
Figure 2.14. 
 
 
Figure 2.14 Synthesis of O-trifluoromethylsulfonyl-serine with triethylamine.  
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2.3.17 Synthesis of O-trifluoromethylsulfonyl-serine with 2,6-lutidine 
A suspension of L-serine (66 mg, 0.63 mmol), 2,6-lutidine (134 mg, 1.25 mmol) and 50 ml 
dichloromethane was prepared under argon atmosphere. The suspension was stirred and the 
temperature was reduced to –40°C. Subsequently, a solution of trifluoromethanesulfonic 
anhydride (263 mg, 0.93 mmol) and 40 ml dichloromethane were added dropwise within 5 min. 
The mixture was stirred at –40°C for 1.5 h and analyzed using TLC (Kyasa et al., 2015). The 
synthesis is shown in Figure 2.15. 
 
 
Figure 2.15 Synthesis of O-trifluoromethylsulfonyl-serine with 2,6-lutidine. 
 
2.3.18 Synthesis of S-(3-thienyl)cysteine 
In a three-necked flask, n-buli was added to the mixture of hexane (0.65 ml, 6.87 mmol), water-
free THF (20 ml), and TMEDA (1.0 ml, 6.87 mmol). After cooling the solution mixture down 
to –78°C, 3-bromothiophene (0.56 ml, 6.24 mmol) was added dropwise in approximately 5 min. 
The reaction mixture was stirred at –78°C for 1 h. Subsequently, a suspension of L-cystin (1.65 
g, 6.87 mmol) was produced, dried using THF (5 ml) and added dropwise to the reaction mixture 
over 10 min. The reaction was stored at RT for 4 h. Afterwards, the solution mixture was 
hydrolyzed with water (25 ml) and the organic phase was extracted using diethylether (3 x 20 
ml). The extract was dried over Na2SO4 and the solvent was removed by a rotary evaporator 
under reduced pressure (40°C, 1 atm) (after Li et al., 2013, Nichols and Williard, 1993). 
 
Figure 2.16 Synthesis of S-(3-thienyl)cysteine. 
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Boc-cystin was replaced by L-cystine, and the reaction followed as described above. The 
quantities of other reagents were chosen in accordance with the amount of Boc-cystine. The 
product was analyzed using 1H-NMR and MS-ESI. The synthesis is shown in Figure 2.16. 
 
2.3.19 Synthesis of 2-[(tert-butoxycarbonyl)amino]-3-[(1-methyl-1 H-pyrrol-2-
yl)sulfanyl]propanoic acid 
2-Bromo-N-methylpyrrole was synthesized first. N-Methylpyrrole (380 mg, 4.7 mmol) was 
dissolved in 20 ml THF and the solution was cooled down to –78°C. N-Bromosuccinimide (840 
mg, 4.7 mmol) was added under argon protection. The reaction mixture was stirred at –78°C 
for 1 h and then mixed with triethylamine (470 mg, 4.7 mmol) and 50 ml cyclohexane. After 
being stirred for 5 min, the precipitate was filtered through a layer of Al2O3 (10.00 g, 98 mmol) 
and the solution dried with anhydrous Na2SO4. The solvent and the excessive amount of 
triethylamine were removed under reduced pressure (40°C, 90 mbar).  
The next step started with the synthesis of N-(tert-Butoxycarbonyl)-S-(N-methylpyrrol-2-
yl)cysteine. 2-Bromo-N-methylpyrrole (230 mg, 1.4 mmol) was obtained from the first step. 
The rest of the reaction was the same as the reaction described in section 2.3.18, which used 2-
bromo-N-methylpyrrole instead of 3-bromothiophene (adopted from Dvornikova & 
Kamienska-Trela, 2002). The reaction mixture was analyzed using TLC and MS-ESI (+Q and 
–Q). The synthesis is shown in Figure 2.17. 
 
 
 
 
Figure 2.17 Synthesis of 2-[(tert-butoxycarbonyl)amino]-3-[(1-methyl-1 H-pyrrol-2-yl)sulfanyl]propanoic acid. 
2.3.20 Synthesis of N- (tert-butoxycarbonyl)-O-trifluoromethylsulfonyl-serine with 2,6-
lutidine 
Under argon atmosphere, Boc-serine (307 mg, 1.5 mmol) was added to 10 ml dichloromethane. 
2,6-Lutidine (0.19 ml, 1.65 mmol) and trifluoromethanesulfonic anhydride (0.27 ml, 1.65 
mmol) were added dropwise at –40 °C over 5 min. After 20 min, the mixture was extracted with 
water and dichloromethane. The organic extract was dried over anhydrous magnesium sulfate 
and filtered. The solvent was removed under reduced pressure (40°C, 1 atm) (after Kyasa et al., 
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2015). The solution was analyzed using TLC and 1H-NMR. The synthesis is shown in Figure 
2.18. 
 
Figure 2.18 Synthesis of N-(tert-butoxycarbonyl)-O-trifluoromethylsulfonyl-serine with 2,6-lutidine. 
 
2.3.21 Synthesis of S-(3-furanyl)cysteine 
A 12.5 ml amount of dry ethanol in a three-necked flask was stirred with sodium under argon 
protection. After dissolving, sodium (242 mg, 105 mmol), NaOH (463 mg, 11.5 mmol), and L-
cysteine (605 mg, 5 mmol) were added and stirred. The mixture was heated up to 100˚C for 
10 min and 3-bromofurane (0.5 ml, 5.5 mmol) was added slowly, after which an orange 
precipitate formed. The reaction mixture was filtrated and the yellow residue was dissolved in 
10 ml water and centrifuged for 10 min at 5,000 rpm at 3˚C. Following the acidification of the 
filtrate with acetic acid 70% (pH 5.5), it was mixed with 100 ml acetone and stored on ice 
overnight. After the yellow acetone solution evaporated (at RT, 480 mbar), a white solid mass 
appeared (after Keusgen, 1999). The reaction was analyzed using TLC and 1H-NMR. The 
synthesis is shown in Figure 2.19. 
 
 
Figure 2.19 Synthesis of S-(3-furanyl)cysteine.  
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2.3.22 Synthetic of S-(N-triisopropylsilypyrrol-2-yl)cysteine 
After thiourea (304 mg, 4 mmol) had fully dissolved in the mixture of water and ethanol (3 ml 
and 6 ml, respectively), triisopropylsylilpyrrol (446 mg, 2 mmol) was added slowly. A mixture 
of iodine (508 mg, 2 mmol) and potassium iodide (312 mg, 2 mmol) was added slowly to the 
water and ethanol (3 ml: 3 ml), until it turned green. The reaction mixture was stirred for 3 h at 
35˚C. Next, NaOH (420 mg, 10.5 mmol) was dissolved in water and hydrazine hydrate 35 % 
(0.1 ml, 2 mmol) was dropped slowly into the mixture: as a result, the color transformed from 
greenish yellow to red. 3-Chloro-L-alanine (384 mg, 3.21 mmol) was dissolved in 5 ml water 
and added gradually to the reaction mixture, which was then heated up to 90–100˚C for 2 hr. 
The color remained unchanged after one hour. The mixture (with pH = 11) was washed, filtered 
over activated charcoal (1‒2 g), acidified with HCL 10% to pH = 5.5 and stored overnight at 
4˚C. A black precipitate was formed and the solvents were slowly removed using vacuum. The 
solution was centrifuged at 5000 rpm for 15 min and the black precipitate was cooled down to 
4°C (after Rudyakova et al., 2008). TLC was performed to analyze the reaction. The synthesis 
is shown in Figure 2.20. 
 
 
 
Figure 2.20 Synthesis of S-(N-triisopropylsilypyrrol-2-yl)cysteine.  
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2.3.23 Synthesis of S-(2-imidazolyl)cysteine 
The reaction conditions were derived from the synthesis of the aliphatic S-alkenyl-l-cysteine 
(Keusgen, 1999). Argon was used as a protective gas. In a three-necked flask 20 ml DMF was 
dried using sodium (386 mg, 160 mmol). Potassium hydroxide (10 mmol) was dissolved under 
argon protection, and 2-imidazolethiol (200 mg, 2 mmol) were added to it. 3-Chloro-L-alanine 
(320 mg, 2 mmol) was mixed to the reagent and heated up to 100˚C for 2 hr. The solution was 
filtered and its pH adjusted to 5.5 with HCl 10%. Then it was evaporated (at 50˚C, 30 mbar) to 
reach 1 ml of total volume and precipitated using 10 ml acetone. To obtain crystals, the 
precipitate was washed with ethanol at 4˚C for 24 h (after Keusgen, 1999). Consequently, the 
reaction was analyzed using MS-ESI (+Q and –Q). The synthesis is shown in Figure 2.21. 
 
 
Figure 2.21 Synthesis of S-(2-imidazolyl)cysteine. 
 
2.3.24 Synthesis of S-(N-methylimidazol-2-yl)cysteine 
The reaction conditions were derived from the synthesis of the aliphatic S- alkenyl-l-cysteine 
(Keusgen, 1999). Argon was used as a protective gas. In a three-necked flask 20 ml, DMF was 
dried using sodium (386 mg, 0.16 mol). Potassium hydroxide (10 mmol ) was dissolved in the 
solution under argon protection; next, 2-mercapto-1-methylimidazole (228 mg, 2 mmol) was 
added. 3-Chloro-L-alanine (320 mg, 2 mmol) was mixed to the reagent and heated up to 100˚C 
and then kept at that temperature for 2 hours. After the solution was filtered and its pH adjusted 
to 5.5 with HCl 10%, it was evaporated (at 50˚C, 30 mbar) to reach 1 ml of total volume. 
Precipitation was performed with 10 ml acetone. In order to obtain crystals, the precipitate was 
washed with ethanol and stored at 4˚C for 24 hr (after Keusgen, 1999). Subsequently, the 
reaction was analyzed using MS-ESI (+Q and –Q). The synthesis is illustrated in Figure 2.22. 
 
Figure 2.22 Synthesis of S-(N-methylimidazol-2-yl)cysteine. 
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2.3.25 Synthesis of S-(2-thiazolinyl)cysteine 
The reaction conditions were derived from the synthesis of the aliphatic S- alkenyl-L-cysteine 
(Keusgen, 1999). Argon was used as a protecting gas. In a three-necked flask 20 ml, DMF was 
dried using sodium (386 mg, 0.16 mol). Potassium hydroxide (10 mmol) was dissolved under 
argon protection, after which 2-thiazolin-2-thiol (234 mg, 2 mmol) was added. 3-Chloro-L-
alanine (320 mg, 2 mmol) was mixed with the reagent and refluxed for 2 hr. After the solution 
was filtered and its pH adjusted to 5.5 with HCl 10%, it was evaporated (at 50˚C, 30 mbar) to 
reach 1 ml of total volume and precipitated using 10 ml acetone. To obtain crystals, the 
precipitate was washed using ethanol at 4˚C for 24 h (after Keusgen, 1999). Subsequently, the 
reaction was analyzed using MS-ESI. The synthesis is illustrated in Figure 2.23. 
 
 
Figure 2.23 Synthesis of S-(2-thiazolyl)cysteine. 
 
2.3.26 Synthesis of S-(3-thienyl)cysteine  
With a slight modification, reaction was synthesized by the addition of potassium iodide and 
iodine (Rudyakova et al., 2008). 
Thiourea (7.61 g, 100 mmol) was dissolved in 70 ml methanol, followed by the addition of 
KOH and 3-bromothiophene 97% (9.66 ml, 100 mmol). The solution was heated up to 100˚C 
for 3 h. Iodine (25.40 g, 100 mmol) and potassium iodide (16.60 g, 100 mmol) were dissolved 
in a mixture of ethanol and water (7 mL and 10 ml, respectively) and added to the reaction 
mixture. A white solid precipitate was dissolved after the mixture was heated to 70–80˚C. The 
solution was stirred for 7 h at 30–40˚C, while the mixture color remained unchanged. Figure 
2.24 illustrates the synthesis. 
 
 
Figure 2.24 Synthesis of S-(3-thienyl)cysteine. 
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2.4 Oxidation 
2.4.1 Oxidation of S-(N-benzylpyrrol-2-yl)cysteine 
2.4.1.1 Synthesis of S-(N-benzylpyrrol-2-yl)cysteine-S-oxide (oxidation with H2O2 in 
acetic acid) 
1Eq reagent (2.58 g, 9.3 mmol) and 3/4 Eq H2O2 35% (0.6 ml, 7 mmol) were mixed with 3 ml 
acetic acid for 15 h under the light protection and the solvent was evaporated (at 40˚C, 30 mbar). 
Afterwards, it was dissolved in water and analyzed using MS-ESI. 
 
2.4.1.2 Oxidation with FeCl3 and H5IO6 
Sulfide (358 mg, 1.3 mmol) solved in acetonitrile (3 ml, 0.04 mmol) was stirred for 5 min, after 
which 1.43 mmol H5IO6 was added. The excessive amount of H5IO6 was neutralized with 
Na2S2O3 (3 g in 5 ml water). The mixture was washed with CH2Cl2 (4 x 5 ml) and the oil phase 
was dried with Na2SO4 by being gently turned over. The MS-ESI analysis using both the oil 
and the residue phases did not present acceptable results (after Kim et al. 2003). 
 
2.4.1.3 Oxidation with Magnesium monoperoxyphthalate hexahydrate 
Magnesium monoperoxyphthalate hexahydrate (MMPP) consists of water, ethanol, and 
methanol soluble. Sulfide (472 mg, 1.71 mmol) was added to ½ Eq MMPP (424 mg, 0.86 
mmol).  Methanol (3ml) was used as solvent. The solution was centrifuged and stored at 4°C. 
A white precipitate appeared in the solution after 2 h. TLC was performed separately to test the 
solution and the precipitate. The solvent has been evaporated (at 40˚C, 337 mbar) and dissolved 
in methanol for MS-ESI analysis (Mielke, 2015-doctoral thesis). 
 
2.4.2 Oxidation of S-(N-methylpyrrol-2-yl)cysteine 
2.4.2.1 Oxidation with H2O2 in water 
The reaction was performed under argon atmosphere because of its high instability. 1 Eq S-(N-
methylpyrrol-2-yl)cysteine (2.00 g, 10 mmol) was stirred in 2 ml H2O and 1 Eq H2O2 35% (0.09 
ml, 1 mmol) for 18 h. The reaction was controlled by TLC. The solvent was evaporated (at RT, 
20 mbar) under argon protection in the next step and the water-soluble residue was analyzed 
using MS-ESI. 
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2.4.2.2 Oxidation with H2O2 in acetic acid 
1 Eq S-(N-methylpyrrol-2-yl)cysteine (200 mg, 1 mmol) was fully dissolved in 3 ml acetic acid. 
0.5 Eq H2O2 35% (0.6 ml, 0.7 mmol) was slowly added and stirred under argon protection for 
15 h. In addition, TLC was performed to control the reaction’s procedure. The solvent was 
evaporated (at 30˚C, 10 mbar) and the water-soluble residue underwent the MS-ESI analysis. 
 
2.4.2.3 Oxidation with cumene hydroperoxide in H2O 
1 Eq S-(N-methylpyrrol-2-yl)cysteine (320 mg, 1.6 mmol) was dissolved in 3 ml water under 
argon protection. It was slowly stirred with 0.5 Eq cumene hydroperoxide (0.12 ml, 0.8 mmol) 
for 6 h. TLC confirmed the reaction progress. The solvent was evaporated (at RT, 20 mbar) and 
the water-soluble residue was subjected to MS-ESI analysis. 
 
2.4.2.4 Oxidation with MMPP in H2O 
1 Eq S-(N-methylpyrrol-2-yl)cysteine (400 mg, 2 mmol) was fully dissolved in 4 ml water under 
argon protection. One-third of Eq MMPP (346 mg, 0.7 mmol) was added to the reagent and 
stirred thoroughly for 6 h. The reaction was analyzed by TLC. The solvent was evaporated (at 
RT, 20 mbar) afterwards and the water-soluble residue analyzed using MS-ESI ( Mielke, 2015-
doctoral thesis). 
  
2.4.2.5 Oxidation with TAPC in H2O2 (35%) 
1 Eq S-(N-methylpyrrol-2-yl)cysteine (200 mg, 1 mmol) was mixed with 0.1 Eq TAPC (35 mg, 
0.1 mmol) as catalyzer. The reaction was performed by adding 0.1 ml H2O2 (35%). The solvent 
evaporated (at RT, 20 mbar) afterwards and the water-soluble residue underwent MS-ESI 
analysis (Bahrami et al., 2010).  
 
2.4.3 Oxidation of S-(2-thienyl)cysteine with H2O2 
1 Eq of S-(2-thienyl)cysteine (203 mg, 1 mmol) was dissolved in 3 ml H2O and 1 Eq H2O2 35% 
(0.09 ml, 1 mmol) was added gradually to the reaction mixture. In-process control was 
performed using TLC analysis. The reaction was stirred for 12 h. The solvent was evaporated 
(at 40˚C, 60 mbar) until fully dried. ESI-MS, HNMR, IR, CNMR, HR-MS and TLC analyses 
were performed. The amount of product after oxidation was determined 105 mg = 0.48 mmol, 
which was fully dissolved in water. 
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2.5 Hydrogenation 
2.5.1 Hydrogenation of S-(N-benzylpyrrol-2-yl)cysteine-S-oxide 
 
2.5.1.1 Hydrogenation with pd/c and hydrogen 
S-(N-benzylpyrrol-2-yl)cysteine-S-oxide (137 mg, 0.47 mmol) was dissolved in 15 ml 
methanol with slight amount of catalytic 10% Pd/C and hydrogenated at a pressure of 4 bar for 
3 h. The reaction mixture was centrifuged at 5,000 rpm for 10 min, after which the solution was 
evaporated (at RT, 280 mbar) and washed with acetone (20–30 ml) (Bhosale et al., 2012). The 
water-soluble product was analyzed using MS-ESI.  
 
2.5.1.2 Hydrogenation with ammonium formate 
Ammonium formate (1.53 g, 24.3 mmol) was added portionwise to S-(N-benzylpyrrol-2-
yl)cysteine-S-oxide (233 mg, 0.801 mmol) in combination with Pearlman’s catalyst (129 mg) 
and ethanol (16 ml) under argon shield at RT. The reaction mixture was heated up to 100˚C for 
2 h, cooled down to RT and passed through a pad of celite. The solution was filtrated, evaporated 
(at 40˚C, 175 mbar), and analyzed by MS (Fukuda et al., 2009).  
 
2.5.2 Catalytic transfer hydrogenation of S-(N-benzylpyrrol-2-yl)cysteine-S-oxide 
S-(N-benzylpyrrol-2-yl)cysteine-S-oxide (64 mg, 0.22 mmol) and ammonium formate (75 
mg,1.2 mmol) were mixed with 4 ml ethanol and 0.5 ml water, and stirred under argon 
atmosphere at RT for 1 h after 10% Pd/C (40 mg) had been added. The reaction mixture was 
filtered over celite pad, evaporated (at 40˚C, 175 mbar), and analyzed by MS-ESI (Chadwick 
and Hodgson, 1983). 
 
2.5.3 Hydrogenation of N-benzyl pyrrole 
N-Benzylpyrrole 97% (0.318 ml, 2 mmol) was dissolved in 5 ml methanol, after which a slight 
amount (as big as spatula) of catalyst 10% Pd/C was added and hydrogenation performed at a 
pressure of 4 bar for 3 h. The reaction mixture was centrifuged (at 5,000 rpm, 4˚C), and the 
solvent was evaporated (at 40˚C, 175 mbar) and washed with acetone. The water-soluble 
reagent was conducted for 1H-NMR analysis (Bhosale et al., 2012).  
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2.6 HPLC  
2.6.1 Analytical HPLC method for identification and purification of synesthetic product 
S-(N-benzylpyrrol-2-yl)cysteine 
The detailed description of the HPLC device is provided in Appendix 2. Water and methanol 
were used as an HPLC solvent with the column (EC 250/4. RT-NUCLEOSIL® 100-5 C18; 
flow rate: 0.7 mm/min). Optimal isocratic conditions to separate the desired product from the 
impurities and unwanted products were obtained by using the water-methanol mixture (60:40 
v/v) (Appendix 4). 
 
2.6.1.1 Preparative HPLC 
Product purification and separation followed the same procedure as the analytical HPLC with 
the column (VP 250/10. RT-NUCLEODOR® C18 HTce, 5 µm; flow rate: 7 mm/min). The 
device is described in detail in Appendix 2. 
 
2.6.2 Analytical HPLC method for identification and purification of synesthetic product 
S-(N-benzylpyrrol-2-yl)cysteine-S-oxide 
Water and methanol were used as an HPLC solvent with the column (EC 250/4. RT-
NUCLEOSIL® 100-5 C18; flow rate: 0.7 mm/min). The optimal isocratic conditions were 
obtained by using the water-methanol mixture (63:37 v/v) (Appendix 5). 
 
2.6.2.1 HPLC-MS 
To ensure peak accuracy for a better purification, HPLC-MS analysis was carried out before the 
preparative HPLC under the condition described for analytical HPLC. The setting is described 
in detail in Appendix 2. 
 
2.6.2.2 Preparative HPLC 
This method was used to separate the oxidized and non-oxidized products from the unwanted 
products under similar chromatographic conditions as analytical HPLC with the column (VP 
250/10. RT-NUCLEODOR® C18 HTce, 5 µm; flow rate: 7 mm/min). 
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2.6.3 Analytical HPLC method for identification of enzymatic activity test 
Analytical HPLC (column: EC 250/4. RT-NUCLEODOR® C18 ce, 1 ml/min) has to be 
conducted to optimize the method for HPLC-MS analysis using water and methanol as an HPLC 
solvent (Appendix 6). 
 
2.6.3.1 HPLC-MS 
To determine the molecular weight of each visible peak in analytical HPLC, HPLC-MS analysis 
was performed (column: EC 250/2. NUCLEODOR® 100-5 C18 ce, 0.25 ml/min). Water and 
methanol mixture was used as a solvent and the device is described in detail in Appendix 2. 
 
2.7 Alliinase enzymatic activity test 
The enzymatic activity of alliinase was tested on six synthesized products to determine whether 
they show substrate specificity to alliinase. The products obtained from alliinase reaction with 
each of the synthesized products were analyzed using HPLC-MS. Two out of six products were 
substrate specific for aliinase and four remained non-oxidized. 
 
2.7.1 Alliinase enzymatic activity test on S-(2-thienyl)cysteine-S-oxide 
HPLC-MS was conducted to estimate the optimal reaction time and conditions for the analysis, 
which resulted in separation and identification of the obtained compounds. The most stable 
compound S-(2-thienyl)cysteine-S-oxide was selected for the enzymatic digestion. In 2 ml 
Eppendorf Snap-Cap, 50 mg of S-(2-thienyl)cysteine-S-oxide was dissolved in 0.5 ml H2O. The 
pH was adjusted to 7–7.4 for A. sativum alliinase by adding 0.5 ml of alliinase buffer (Appendix 
3). A 50 µl amount of alliinase (Krest & Keusgen, 1999b) was then added to the Eppendorf cap. 
As a positive control, 50 mg alliin was dissolved in 0.5 ml H2O in the second tube. The pH was 
set to the optimum by adding 0.5 ml of buffer and 50 µl of enzyme. In the third tube, as a 
negative control, 50 µl enzyme was added to 1 ml H2O. As organic phase, 1 ml cyclohexane 
was added to each tube. The organic layer was analyzed after 2, 4, and 6 hours. Later, 1 ml of 
cyclohexan phase was separated and dried using 50 mg MgSO4. It was evaporated (at RT, 180 
mbar), reducing volume to approximately 200 µl. The mixture was analyzed with HPLC-MS 
after the optimization method using analytical HPLC (Appendix 2). A column (RT-
NUCLEOSIL® 100-5 C18) was used for HPLC. An optimal approach is represented in 
Appendix 6. Details of HPLC-MS analysis are shown in Appendix 2. 
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2.7.2 Alliinase enzymatic activity test on the other five main products  
The analysis was also performed on the other five products as mentioned above. In each tube, 
50 mg of each compound was dissolved in 0.5 ml H2O and pH was optimized (7–7.4) by adding 
0.5 ml alliinase buffer. A 50 µl buffer of alliinas extracted from A. sativum was added to each 
tube in addition to 1 ml organic phase. The reaction mixture was incubated for 2 h while being 
shaken. After 2 h, organic phase was separated and dried using 50 mg MgSO4. Afterwards, the 
solvent was evaporated as mentioned in section 2.7. annd HPLC-MS analysis was conducted.
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3. Results 
In this research, 3-chloro-L-alanine hydrochloride was used as the primary compound for the 
synthesis of other products that are combined with the amino acid cysteine and 5-ring aromatic 
heterocycles including pyrrole-compounds and thiophene rings. The results of the analyses of 
these products, (3-chloro-L-alanine, S-(N-benzylpyrrol-2-yl)cysteine, S-(N-methylpyrrol-2-
yl)cysteine, S-(2-pyrrolyl)cysteine, S-(N-benzylpyrrol-2-yl)cysteine S-oxide,  S-(2-
thienyl)cysteine and S-(2-thienyl)cysteine-S-oxide), which were carried out using TLC, C-
NMR, H-NMR, MS, and HR-MS are listed in Table 3.1(a,b) and Figs. 3.1–3.35. All NMR 
spectra details including signals such as δ, chemical shift, ppm and J, coupling constant, Hz,  as 
well as peaks and splits are illustrated in Table 3.1(a). The obtained multiplicities include: 
singlet; d: doublet; dd: doublet of doublets; and md: multiple of doublets. The numbers 
highlighted in the molecular structure next to NMR spectra correspond to the number of 
hydrogen and carbon atoms listed in Table 3.1(a) and 3.1(b). The results of IR spectra and ESI-
MS analyses including stretching bands and molecular weight of each product are shown in 
Table 3.2 The results of the methods that fully or partially failed are presented in the 
Appendixes (18 – 52) of the method section. Appendixes 4–5 contain analytical and 
preparative HPLC results. 
 
3.1 Synthesis of 3-chloro-L-alanine hydrochloride 
3-Chloro-L-alanine hydrochloride, having an estimated yield of 86%, was synthesized first as 
the main primary compound used in synthesis of other products. 
 
3.1.1 TLC analysis 
3-Chloro-L-alanine has no chromophore; thus, it cannot be detected under UV light. The results 
indicate that serine was used as the main, primary educt, fully consumed in the reaction and 
fully transformed to alanine. The Rf at 0.125 was calculated for L-serein. In the product line, 
the main purple spot appeared with the Rf at 0.38 (Figure 3.1) 
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Figure 3.1 Silica thin-layer chromatography (TLC) of 3-chloro-L-alanine using ninhydrin reagent for detection. 
 
3.1.2 1H-NMR analysis 
As shown in Table 3.1(a) and Figure 3.2, the spectrum illustrates 3 signals all with integral 1, 
which indicates the existence of 3-chloro-L-alanine. The methin hydrogen group at the chiral 
center has a signal at δ = 4.45 ppm (J = 3.43, 4.35 Hz, dd). Two distinguishable diastereotopic 
methylene hydrogens in the spectrum include H4 δ = 4.00 ppm (J = 3.43, 12.82 Hz, dd) and H5 
δ = 4.11 ppm (J = 4.35, 12.82 Hz, dd).
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Table 3.1(a) 1H NMR analyses of six main synthesized products. 
 
    1H NMR         
Products Hydrogen nr. Chemical shift (in ppm) Multipilicity Coupling constent J [Hz] Number of hydrogen atoms   
3-Chloro-L-alanine         
 1 
     
  
 
 
                             
                             
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2    
  
  
 
3 4.45 dd 4.35, 3.43 1 
 
  
 4 4.00 dd 12.80, 3.43 1    
 5 4.11 dd 12.80, 4.35 1    
         
         
        
         
         
         
         
S-(N-benzylpyrrol-2-yl)cysteine          
 1        
 2        
 3 3.498 dd 3.21, 10,53 1    
 4 2.63 dd 10,53, 14,43 1    
 5 3.06 dd 3.21, 14,43 1    
        
 1´ 6.144 dd 2.98, 3.66 1    
 2´ 6.524 dd 1.83, 3.66 1    
 3´ 6.949 dd 1.83, 2.98 1    
 4´ 5.315 dd 15.57, 39.15 2    
 5´ 7.25 md  5    
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    1H NMR         
Products Hydrogen nr. Chemical shift (in ppm) Multipilicity Coupling constent J [Hz] Number of hydrogen atoms   
S-(N-methylpyrrol-2-yl)cysteine           
1 
     
  
 
 
 
 
 
 
2 
     
  
 
3 3.785 dd 8.70, 3.43 1 
 
  
 
4 3.00 dd 8.70, 14,43 1 
 
  
 
5 3.66 dd 5.40, 14.43 1 
 
  
 
 
 
1´ 6.20 dd 2.75, 5.72 1 
 
  
 
2´ 6.51 dd 1.14, 2.98 1 
 
  
 
3´ 7.02 md 
 
1 
 
  
 4´ 3.76 s  3    
         
         
         
S-(2-pyrrolyl)cysteine          
 1        
 2        
 3 3.85 dd 3.89, 8.70 1    
 4 3.11 dd 8.70, 14.65 1    
 5 3.36 dd 3.66, 14.65 1    
 1´ 6.319 dd 3.21, 1.60 1    
 2´ 6.550 dd 1.60, 3.43 1    
 3´ 7.095 dd 1.60, 2.75 1    
         
         
         
         
         
         
Table 3.1(a) continued 
 
        
1 
1 
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    1H NMR         
Products Hydrogen nr. Chemical shift (in ppm) Multipilicity Coupling constent J [Hz] Number of hydrogen atoms   
S-(N-benzylpyrrol-2-yl)cysteine S-oxide         
 1        
 
2 
     
  
 
3 3.95 dd 4.58, 7.33 1 
 
  
 
4 3.36 dd 8.01, 13.97 1    
 
5 3.67 dd 4.58, 13.97 1    
 
1´ 7.146 md  1    
 
2´ 6.42 md  1    
 
3´ 7.04 d 7.33 1    
 
4´ 5.373 md  2    
 5´ 7.3 md  5    
         
         
         
S-(2-thienyl)cysteine         
 1        
 2        
 3 3.75 dd 8.70, 3.89 1    
 4 3.15 dd 14.65, 8.70 1    
 5 3.40 dd 14.65, 3.89 1    
 1´ 7.07 dd 5.27, 3.66 1    
 2´ 7.30 dd 3.66, 1.37 1    
 3´ 7.56 dd 5.27, 1.37 1    
         
         
         
         
         
Table 3.1(a) continued 
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    1H NMR         
Products Hydrogen nr. Chemical shift (in ppm) Multipilicity Coupling constent J [Hz] Number of hydrogen atoms   
S-(2-thienyl)cysteine-S-oxide         
1 4.16 md 2.52,9.62 1 
 
  
 
2 3.65 md 2.52,6.41 1 
 
  
 3 3.91 md 5.72,9.62 1 
 
  
 
1 7.41 md 
 
1 
 
  
 
2 7.23 md 
 
1 
 
  
 
3 7.93 md 
 
1 
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Table 3.1(b) 13C NMR analyses of six main synthesized products. 
 
 
 
 
    13C NMR    
Products Carbon nr. Chemical shift (in ppm) 
 
   
3-Chloro-L-alanine 
   
   
                                   
                               
 
 
 
 
1 
 
169.04    
 
 
                             
                             
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 
 
54.03    
 
3 
 
42.11    
       
       
       
       
       
       
S-(N-benzylpyrrol-2-yl)cysteine        
 1  171.518    
 2  53.528    
3  37.898    
 4  117.645    
 5  119.101    
 6  108.340    
 7  125.656    
 8  49.972    
 9  126.60    
 10  128.08    
 11  126.94    
 12  128.358    
 13  127.112    
 14  138.861    
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    13C NMR    
Products Carbon nr. Chemical shift (in ppm)    
S-(N-methylpyrrol-2-yl)cysteine        
 
1 
 
172.56    
 
 
 
 
 
 
2 
 
53.748    
 
3 
 
36.92    
 
4 
 
117.913    
 
5 
 
118.431    
 
6 
 
108.32    
 
 
 
 
 
7 
 
127.29    
 
 
 
 
 
 
 
 
 
 
 
 
 
8 
 
33.826    
 
 
 
   
   
       
S-(2-pyrrolyl)cysteine        
 1  172.57    
 2  54.150    
 3  34.851    
 4  123.00    
 5  117.376    
 6  109.624    
 7  119.657    
       
       
       
       
       
       
      
       
       
Table 3.1(b) continued       
      
NH2 
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    13C NMR    
Products Carbon nr. Chemical shift (in ppm)    
S-(N-benzylpyrrol-2-yl)cysteine S-oxide        
1 
 
171.94    
 
2 
 
47,28    
 
3 
 
56.36    
 
4 
 
137.49    
 
5 
 
115.22    
 
6 
 
105.88    
 7  120.69    
 
8 
 
49.32    
 
9 
 
127.00    
 
10 
 
128.80    
 
11 
 
127.50    
 
12 
 
129.30    
 
13 
 
127.10    
 
14 
 
135.00    
 
 
  
   
 
 
  
   
S-(2-thienyl)cysteine 
 
  
   
 1  173.12    
 2  53.84    
 3  30.58    
 4  135.60    
 5  128.42    
 6  131.42    
 7  130.90    
       
       
       
       
Table 3.1(b) continued       
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    13C NMR    
Products Carbon nr. Chemical shift (in ppm)    
S-(2-thienyl)cysteine-S-oxide       
1 
 
171.04    
 
2 
 
54.72    
 3 
 
56.88    
 
4 
 
140.90    
 
5 
 
129.88    
 
6 
 
127.40    
 7  132.90    
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Table 3.2 IR and ESI-MS analyses of the synthesized products. 
 
    IR       
 
  ESI-MS      
  C-H Alkane 
(Cm-1) 
C-H Aromat 
(Cm-1) 
C=C Alromat 
(Cm-1) 
C=O (Cm-1) OH (Cm-1) NH2 (Cm-1)   [M+H]+ [M+Na]+ [M+K]+ [2M+H]+ Molecular Structure 
3-Chloro-L-alanine 2704 ― ― 1739 3200 2873 & 2950 
 
124.03 ― ― 247.09  
             
             
             
S-(N-benzylpyrrol-2-
yl)cysteine 
2900 3025 1427 1605 3606 3200 & 3300 
 
277.09 299.10 ― 553.30  
             
             
             
             
S-(N-methylpyrrol-2-
yl)cysteine 
2950 3000 1457 1614 3242 3214 & 3156 
 
201.06 223.08 239.07 ―  
             
             
             
S-(2-pyrrolyl)cysteine 2900 3000 1388 1608 3300 3134 
 
187.13 209.01 ― ―  
             
             
             
             
S-(N-benzylpyrrol-2-
yl)cysteine S-oxide 
 
 
 
2603 2900 1496 1706 3400 2927 & 3100 
 
293.15 315.15 331.17 ―  
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    IR       
 
  ESI-MS      
  C-H Alkane 
(Cm-1) 
C-H Aromat 
(Cm-1) 
C=C Alromat 
(Cm-1) 
C=O (Cm-1) OH (Cm-1) NH2 (Cm-1)   [M+H]+ [M+Na]+ [M+K]+ [2M+H]+ Molecular Structure 
             
S-(2-thienyl)cysteine 2600 2950 1510 1581 3450 2977 & 3100 
 
204.08 ― 242.30 ―  
             
             
             
             
S-(2-thienyl)cysteine-S-oxide 2900 2992 1496 1626 3380 3088 & 3250 
 
220.07 242.10 258.08 ―  
59 
 
 
Figure 3.2 1H NMR spectra of 3-chloro-L-alanine. 
 
3.1.3 13C-NMR analysis 
This compound formed of three atoms of carbon and hereby three signals were observed. 
 
 
Figure 3.3 13C NMR spectra of 3-chloro-L-alanine. 
The signal attributed to carboxyl carbon was recognizable at δ=169.04 ppm. In addition, carbons 
2 at δ=54.036 ppm and 3 δ=42.115 ppm was readily visible (Table 3.1(b) and Figure 3.3). 
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3.1.4 IR analysis 
The IR analysis revealed several stretching bands in the IR spectrum at 1739, 2704, 2873, 2950 
and 3200 cm-1. The strong band at 1739 cm-1 corresponded to the carbonyl C=O group, and the 
weak band at 2704 cm-1 was related to C-H in the alkane group. The other weak bands 
corresponding to the NH2 group were visible at 2873 and 2950 cm
-1. In addition, the presence 
of the hydroxyl (OH) group displayed a weak band at 3200 cm-1 (Figure 3.4).  
 
 
Figure 3.4 IR spectrum of 3-chloro-L-alanine. 
 
3.1.5 ESI-MS analysis 
Considering the ESI-MS analysis, the molecular weights assigned to 3-chloro-L-alanine were 
m/z 124 [M+H]+ and m/z 126 [M+H]+, in which the chloride was represented by the isotopes Cl 
= 35.5 g/mol and Cl = 37.5 g/mol, respectively (Figure 3.5).  
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Figure 3.5 ESI-MS analysis of 3-chloro-L-alanine. 
 
3.1.6 HR-MS analysis 
Regarding HR-MS, the analysis of the accurate mass shows a molecular weight of m/z 124.0149 
[M+H]+ corresponding to the formula C3H7ClNO2, consistent with the proposed structure (m/z 
124.0160) that differs by 1.1 mDa (Figure 3.6). 
 
 
Figure 3.6 HR-MS analysis of 3-chloro-L-alanine.  
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3.2 Synthesis of S-(N-benzylpyrrol-2-yl)cysteine 
As the N-benzylpyrrole group is more stable than the free pyrrole, the compound S-(N-
benzylpyrrol-2-yl)cysteine can be used prior to the synthesis of S-(2-pyrrolyl)cysteine S-oxide, 
the yield of which is 47%. 
 
3.2.1 TLC analysis 
Using 3-chloro-L-alanine and thiourea as references, TLC was successfully performed in two 
steps. Product and thiourea spots were observed under the UV light at Rf = 0.63 and Rf = 0.64, 
respectively. Moreover, the spot of 3-chloro-L-alanine was formed at Rf = 0.38 after the plate 
had been sprayed by ninehydrin. In the product line, no 3-chloro-L-alanine was detected and 
the product was fully reacted (Figure 3.7). 
 
 
Figure 3.7 Analysis by TLC of S-(N-benzylpyrrol-2-yl)cysteine: a) UV light detection (254 nm) and b) plate 
sprayed with ninhydrin.  
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3.2.2 1H-NMR analysis 
From Figure 3.8, which contains the 1H-NMR spectra obtained in CD3OD, one can observe the 
following details: a) in the aliphatic part of the molecule, H3 with integral 1 at δ = 3.498 ppm 
(J = 3.21, 10.53 Hz, dd); b) diastereotopic methylenee hydrogens 4 and 5, each with integral 1 
at δ = 2.63 ppm (J = 10.53, 14.43 Hz, dd) and δ = 3.06 ppm (J = 3.21, 14.43 Hz, dd), respectively; 
c) methylene hydrogens H4 of the benzyl group δ = 5.315 ppm (J = 15.57, 39.15 Hz, dd) with 
integral 2; and d) hydrogens 1, 2 and 3 of the pyrrol group each with integral 1 at δ = 6.14 
ppm (J = 2.98, 3.66 Hz, dd), δ = 6.52 ppm, (J = 1.83, 3.66 Hz, dd), and δ = 6.945 ppm (J = 1.83, 
2.98 Hz, dd), respectively. All hydrogens belonging to the benzyl group were multiplets and 
were observed at δ = 7.2 ppm with integral 5 (Table 3.1(a) and Figure 3.8). 
 
3.2.3 13C-NMR analysis 
This analysis was conducted using CD3OD as a solvent and fourteen strong signals were 
observed in the 13C-NMR spectrum. The carboxylic carbon showed a characteristic signal at δ 
= 171.5 ppm. Also, methin carbon  and the methylene carbon in the aliphatic part were identified 
at δ = 53.5 ppm and at δ = 37.89 ppm, respectively. The signal at δ = 49.97 ppm was related to 
benzyl carbons. Carbons 4, 5, and 6, which correspond to the pyrrole group showed chemical 
shifts at δ = 117.64 ppm, δ = 119.01 ppm and δ = 108.340 ppm, respectively. The carbons of 
the benzyl group indicated a typical chemical shift at δ = 125–138 pm. (Table 3.1(b) and Figure 
3.9). 
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Figure 3.8 1H NMR spectra of S-(N-benzylpyrrol-2-yl)cysteine  
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Figure 3.9 13C NMR spectra of S-(N-benzylpyrrol-2-yl)cysteine. 
 
3.2.4 IR analysis 
Concerning the bands related to IR analysis, main bands resonated at 1427, 1605, 2900, 3025, 
3200, 3300 and 3606 cm-1, the last of which was attributed to the functional stretching band of 
the hydroxyl (OH) groups. The weak bands at 3200 and 3300 cm-1 corresponded to the NH2 
group. The band related to the carbonyl C=O group was visible at 1605 cm-1 and the stretching 
bands at 1427 and 3025 cm-1 belonged to the C=C aromatic and C-H aromatic groups, 
respectively. The weak band at 2900 cm-1 was assigned to the C-H alkane group (Figure 3.10). 
 
Figure 3.10 IR spectrum of S-(N-benzylpyrrol-2-yl)cysteine.  
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3.2.5 ESI-MS analysis 
The mass spectrum related to ESI-MS analysis showed positive molecular ions at m/z 277 
[M+H]+, m/z 299 [M+Na]+, and m/z 553 [2M+H]+, matching the expected molecule S-(N-
benzylpyrrol-2-yl)cysteine (Figure 3.11). 
 
 
Figure 3.11 ESI-MS analysis of S-(N-benzylpyrrol-2-yl)cysteine. 
 
3.2.6 HR-MS analysis 
 
 
Figure 3.12 HR-MS analysis of S-(N-benzylpyrrol-2-yl)cysteine.  
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The high-resolution mass HR-MS analysis showed a peak at m/z 277.0994 [M+H]+ indicating 
the existence of C14H17N2O2S with a theoretical value of m/z 277.1005. Nevertheless, the 
difference of 1.1 mDa was considered negligible (Figure 3.12). 
 
3.2.7 Analytical HPLC method for identification and purification of synesthetic 
product S-(N-benzylpyrrol-2-yl)cysteine 
3.2.7.1 HPLC chromatogram  
According to the HPLC chromatogram given in Appendix 4 and Appendix 7, a relatively 
strong and distinct peak was visible at 22.99 min, which corresponds to the product S-(N-
benzylpyrrol-2-yl)cysteine. 
 
3.2.7.2 Preparative HPLC 
3.2.7.2.1 HPLC chromatogram after preparative HPLC  
The purification of the synthesized product with the application of preparative-HPLC is given 
in Appendix 8, in which the peak at 23.87 min characterizes the analyzed product. 
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3.3 Synthesis of S-(N-methylpyrrol-2-yl)cysteine 
S-(N-methylpyrrol-2-yl)cysteine synthesized with a yield of 22.5% analogous to S-(2-
pyrrolyl)cysteine is a worthy of attention.  
 
3.3.1 TLC analysis 
 
Figure 3.13 TLC analysis of S-(N-methylpyrrol-2-yl)cysteine: a) UV light detection (254 nm) and b) plate 
sprayed with ninhydrin. 
During the TLC analysis and under a UV light, the spot related to S-(N-methylpyrrol-2-
yl)cysteine was observed at Rf = 0.84 and the spot of thiourea occurred at Rf = 0.86. After 
spraying the plate with ninehydrin, the spot of S-(N-methylpyrrol-2-yl)cysteine appeared at Rf 
= 0.84, and 3-chloro-L-alanine at Rf = 0.56. In addition, 3-chloro-L-alanine was not visible at 
the product line indicating its full consumption (Figure 3.13).  
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3.3.2 1H-NMR analysis 
Using D2O as a solvent in H-NMR analysis, one peak was shown for the methin hydrogen group 
at δ = 3.78 ppm (J = 8.70, 3.43 Hz, dd) with integral 1. The methylene hydrogen groups 4 and 
5 presented signals at δ = 3.00 ppm (J = 14.43, 8.70 Hz, dd) and δ = 3.66 ppm (J = 14.43, 5.04 
Hz, dd), respectively, each with integral 1. The methyl hydrogens linked to nitrogen showed a 
chemical shift at δ = 3.76 ppm; this was a singlet with integral 3. Hydrogens 1, 2, and 3 
belonging to the pyrrole group each with integral 1 were observed at δ = 6.20 ppm (md), δ = 
6.51 ppm (md), and δ = 7.02 ppm (md), respectively (Table 3.1(a) and Figure 3.14). 
 
3.3.3 13C-NMR analysis 
13C-NMR analysis of S-(N-methylpyrrol-2-yl)cysteine using D2O as the analysis solvent was 
not straightforward because of its high instability and unexpected peaks. The carboxylic carbon 
showed a typical chemical shift at δ = 172.5 ppm for the aliphatic part. Moreover, the methin 
and methylene groups were observed at δ = 53.74 ppm and δ = 36.92 ppm, respectively. In the 
heteroaromatic part, carbons 4, 5, 6, and 7 corresponding to the pyrrole group showed sharp 
signals at δ = 117.91 ppm, δ = 118.43 ppm, δ = 108.32 ppm and δ = 127.29 ppm, respectively 
(Table 3.1(b) and Figure 3.15). 
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Figure 3.14 1H NMR spectra of S-(N-methylpyrrol-2-yl)cysteine.  
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Figure 3.15 13C NMR spectra of S-(N-methylpyrrol-2-yl)cysteine. 
 
3.3.4 IR analysis 
Diverse stretching bands relevant to the IR analysis appeared at 1427, 1614, 2950, 3000, 3156, 
3214 and 3242 cm-1, the strongest of which was visible at 1614 cm-1-, which corresponds to the 
carbonyl C=O group. The bands at 3156 and 3214 cm-1 belonged to the NH2 group. The 
stretching bands at 1457 and 3000 cm-1 referred to the C=C aromatic and C-H aromatic groups, 
respectively. The stretching bands at 3000 and 3242 cm-1 were attributed to the C-H alkane and 
hydroxyl (OH) groups, respectively (Figure 3.16). 
 
 
Figure 3.16 IR spectrum of S-(N-methylpyrrol-2-yl)cysteine.  
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3.3.5 ESI-MS analysis 
The mass spectrum in ESI-MS analysis showed positive molecular ions at m/z 201 [M+H]+, m/z 
223 [M+Na]+ and m/z 239 [M+K]+confirming the expected molecule S-(N-methylpyrrol-2-
yl)cysteine (Figure 3.17). 
 
 
Figure 3.17 ESI-MS analysis of S-(N-methylpyrrol-2-yl)cysteine. 
 
3.3.6 HR-MS analysis 
The high-resolution mass spectrum consistent with the molecular formula C8H13N2O2S showed 
a signal at m/z 201.0692 [M+H]+ with a difference of 0.5 mDa in comparison to the one 
measured  at m/z 201.0687 [M+H]+), which was not significant (Figure 3.18). 
 
 
Figure 3.18 HR-MS analysis of S-(N-methylpyrrol-2-yl)cysteine.  
[M+H]+ 
[M+Na]+ 
[M+K]+ 
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3.4 Synthesis of S-(2-pyrrolyl)cysteine 
Synthesis of S-(2-pyrrolyl)cysteine with a yield of 35% was the desired product leading to the 
formation of S-(2-pyrrolyl)cysteine S-oxide after oxidation.  
 
3.4.1 TLC analysis 
Following a TLC analysis, one spot indicating S-(2-pyrrolyl)cysteine was observed under UV 
light (Figure 3.19) after the plate had been sprayed by ninhydrin at Rf = 0.63. Although the 
lack of 3-chloro-L-alanine in the product line (Rf = 0.39) represented a fully progressive 
reaction, thiourea was still visible (Rf = 0.81). 
 
 
Figure 3.19 Analysis by TLC of S-(2-pyrrolyl)cysteine. a) UV light detection (254 nm) and b) plate sprayed with 
ninhydrin.  
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3.4.2 1H-NMR analysis 
In order to perform the H-NMR analysis, we used D2O since this compound is readily water-
soluble. The methin hydrogen in the aliphatic part with integral 1 was observed at δ = 3.85 ppm 
(J = 3.89, 8.70, Hz, dd). Additionally, the methylene hydrogens 4 and 5, each with integral 1, 
appeared at δ = 3.11 ppm (J = 8.70, 14.65 Hz, dd) and δ = 3.36 ppm (J = 3.66, 14.65 Hz, dd), 
respectively. 
 
 
Figure 3.20 1H NMR spectra of S-(2-pyrrolyl)cysteine.  
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In the aromatic part of the molecule, hydrogens 1, 2 and 3 corresponding to the pyrrole group, 
each with integral 1, were shown at δ = 6.32 ppm, (J = 3.21, 1.60 Hz, dd), δ = 6.55 ppm (J = 
1.60, 3.43 Hz, dd), and δ = 7.09 ppm (J = 1.60, 2.75 Hz, dd), respectively. Other unknown 
signals can be considered by-products due to the instability of the S-(2-pyrrolyl)cysteine in the 
presence of light, oxygen, and room temperature. Table 3.1(a) and Figure 3.20 illustrate the 
analysis results related to this compound. 
 
3.4.3 13C-NMR analysis 
The solvent used for C-NMR analysis was D2O because of its high water-solubility. In this 
analysis, S-(2-pyrrolyl)cysteine appeared as the most unstable compound among all the 
synthesized products. As a result, seven peaks were observed for this compound. In addition, 
the carboxylic carbon demonstrated a typical chemical shift at δ = 172.57 ppm. The carbons of 
the aliphatic methin and methylene groups were distinguished at δ = 54.15 ppm and δ = 34.85 
ppm, respectively. The carbons 4, 5, 6, and 7 in the aromatic part, corresponding to the pyrrole 
group, displayed chemical shifts at δ = 123 ppm, δ = 117.37 ppm, δ = 109.62 ppm, and δ = 
119.65 ppm, respectively (Table 3.1(b) and Figure 3.21). 
 
 
Figure 3.21 13C NMR spectra of S-(2-pyrrolyl)cysteine. 
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3.4.4 IR analysis 
In this analysis, the stretching bands emerged at 1388, 1608, 2900, 3000, 3134, and 3300 cm-1. 
The two last ones belonged to the OH and NH2 groups, respectively. Additionally, the strong 
and weak bands corresponding to the carbonyl (C=O) and C-H alkane groups were visible at 
1608 and 2900 cm-1, respectively. The weak bands of 1388 and 3000 cm-1 were related to the 
C=C and C-H aromatic groups, respectively (Figure 3.22). 
 
 
Figure 3.22 IR spectrum of S-(2-pyrrolyl)cysteine. 
 
3.4.5 ESI-MS analysis 
Figure 3.23 shows the mass spectra at m/z 187 [M+H]+ and m/z 209 [M+Na]+, confirming S-(2-
pyrrolyl)cysteine as the end product. 
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Figure 3.23 MS analysis of S-(2-pyrrolyl)cysteine. 
 
3.4.6 HR-MS analysis 
The ratio of molecular weight to molecular charge measured through HR-MS analysis was m/z 
187.0545 [M+H]+. It corresponds to the molecular formula of C7H11N2O2S and is consistent 
with the theoretical m/z ratio of 187.0536 and an acceptable difference in value of 0.9 mDa 
(Figure 3.24). 
 
 
 
Figure 3.24 HR-MS analysis of S-(2-pyrrolyl)cysteine.  
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3.5 Synthesis of S-(N-benzylpyrrol-2-yl)cysteine S-oxide 
S-(N-benzylpyrrol-2-yl)cysteine S-oxide was synthesized with a yield of 30% after purification 
using preparative HPLC. 
 
3.5.1 TLC analysis 
Using thin-layer chromatography, the possible existence of S-(N-benzylpyrrol-2-yl)cysteine S-
oxide was first confirmed and then detected using ninhydrin reagent and UV light. The lack of 
any spot at Rf = 0.737 can be interpreted as the full oxidization of the primary product. The 
calculated Rf for the product was 0.5 after ninhydrin spraying (Figure 3.25). 
 
 
Figure 3.25 TLC analysis of S-(N-benzylpyrrol-2-yl)cysteine S-oxide: a) UV light detection (254 nm) and b) 
plate sprayed with ninhydrin.  
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3.5.2 1H-NMR analysis 
The solvent used in this analysis was D2O. 
 
Figure 3.26 1H NMR spectra of S-(N-benzylpyrrol-2-yl)cysteine S-oxide. 
 
According to the results, the hydrogens H1-H5 related to the aliphatic part, each with integral 
1, appeared as follows: H3 at δ = 3.95 ppm (J = 4.58, 7.33 Hz, dd), H4 at δ = 3.36 ppm (J = 
8.00, 13.97 Hz, dd), and H5 at δ = 3.67 ppm (J = 4.50, 13.97 Hz, dd). In the heteroaromatic part 
of the compound, hydrogens 1, 2 and 3 belonging to the pyrrole ring, each with integral 1, 
were observed at δ = 7.14 ppm(md), δ = 16.42 ppm (md), and δ = 7.04 ppm (J = 7.33 Hz, dd), 
respectively. Hydrogens 4 of the benzyl group with integral 2 were observed at δ = 5.37 ppm 
(md) while hydrogens 5 of the aromatic part  with integral 5 showed a peak at δ = 7.3 ppm (md) 
(Table 3.1(a) and Figure 3.26). 
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3.5.3 13C-NMR analysis 
D2O was used in the 
13C-NMR analysis of the S-(N-benzylpyrrol-2-yl)cysteine S-oxide. The 
analysis demonstrated a typical chemical shift at δ = 171.90 ppm for the carboxylic carbon 1. 
As shown in Table 3.1(b), methin carbon and methylene carbon were identified at δ = 47.20 
ppm and at δ = 56.30 ppm, respectively. Additionally, the carbon of the benzylic group was 
visible at δ = 49.32 ppm. In the hetero aromatic part, the carbons 4–7 of the pyrrole group with 
low density were recognized at δ = 137.49 ppm, δ = 115.22 ppm, δ = 105.88 ppm, and δ = 
120.69 ppm, respectively. In the phenyl ring, carbons 9–14 with chemical shifts at 127.00, 
128.80, 127.50, 129.30, 127.10, and 135.00 ppm were distinguished (Table 3.1(b) and Figure 
3.27). 
 
 
Figure 3.27 13C NMR of S-(N-benzylpyrrol-2-yl)cysteine S-oxide.  
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3.5.4 IR analysis 
The stretching bands resulting from this analysis were observed at 1240, 1496, 1706, 2603, 
2900, 2927, 3100, and 3400 cm-1. The band at 1240 cm-1  represented the S=O group. The bands 
at 1706 and 3400 cm-1 were representative of the C=O and OH groups. The weak bands at 2927 
and 3100 cm-1 were related to the NH2 group, and the stretching bands corresponding to the 
aromatic C=C and C-H groups were visible at 1496 and 2900 cm-1, respectively. Additionally, 
the weak band at 2603 cm-1 was associated with the C-H alkane group (Figure 3.28). 
 
 
Figure 3.28 IR spectrum of S-(N-benzylpyrrol-2-yl)cysteine S-oxide. 
 
3.5.5 ESI-MS analysis 
The ESI-MS analysis revealed a basic remarkable peak related to the compound S-(N-
benzylpyrrol-2-yl)cysteine S-oxide at m/z ratio of 293 [M+H]+. In addition, the peaks m/z 315 
[M+Na]+ and m/z 331 [M+K]+ confirmed the formation of the desired product (Figure 3.29). 
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Figure 3.29 MS analysis of S-(N-benzylpyrrol-2-yl)cysteine S-oxide. 
 
3.5.6 Analytical HPLC method for identification and purification of synesthetic 
product S-(N-benzylpyrrol-2-yl)cysteine-S-oxide  
3.5.6.1 HPLC chromatogram  
The results of the HPLC analysis of S-(N-benzylpyrrol-2-yl)cysteine S-oxide, supported by 
HPLC-MS analysis, are shown in Appendix 9, in which the peak at 23.8 min describes the 
intended product S-(N-benzylpyrrol-2-yl)cysteine-S-oxide (Appendix 5). 
 
3.5.6.2 ESI-MS analysis 
Appendix 10 contains the results of the ESI-MS analysis before the preparative-HPLC. The 
ions at m/z 277 [M+H]+ and m/z 293 [M+H]+ corresponded to S-(N-benzylpyrrol-2-yl)cysteine  
and S-(N-benzylpyrrol-2-yl)cysteine S-oxide, respectively. 
 
3.5.6.3 HPLC-MS analysis 
The HPLC-MS analysis revealed a visible peak at 28.57 min with m/z 293 [M+H]+ 
corresponding to the oxidized form of the compound S-(N-benzylpyrrol-2-yl)cysteine. The peak 
at 33.98 min with m/z 277 [M+H]+ correlated to S-(N-benzylpyrrol-2-yl)cysteine (Appendices 
11–12). Preparative-HPLC was used to separate and purify these compounds. 
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3.5.6.4 Preparative HPLC 
The HPLC chromatogram illustrated in Appendix 13 shows the peak of the purified product at 
5.46 min corresponding to S-(N-benzylpyrrol-2-yl)cysteine S-oxide.   
 
3.5.6.4.1 ESI-MS analysis after preparative-HPLC   
Regarding the ESI-MS analysis, various peaks of the purified product S-(N-benzylpyrrol-2-
yl)cysteine S-oxide at  m/z 293 [M+H]+, m/z 315 [M+Na]+, m/z 331 [M+K]+, m/z 585 [2M+H]+, 
m/z 607 [2M+Na]+, and m/z 899 [3M+Na]+ confirmed the existence of the desired product 
(Appendix 14). 
 
3.6 Synthesis of S-(2-thienyl)cysteine 
The synthesis of S-(2-thienyl)cysteine was obtained with a yield of 93%.  
 
3.6.1 TLC analysis 
 
 
Figure 3.30 TLC analysis by of S-(2-thienyl)cysteine: a) UV light detection (254 nm) and b) plate sprayed with 
ninhydrin.  
84 
 
In this analysis, 3-chloro-L-alanine (Rf = 0.462) and 2-thiophene thiol (Rf = 0.98) were used as 
reference. After it was sprayed with ninhydrin, the S-(2-thienyl)cysteine stained at Rf = 0.69 
and the 3-chloro-alanine was no longer visible in the product line (Figure 3.30). 
 
3.6.2 1H-NMR analysis 
Using D2O as solvent for this analysis, the signals 1–3 were attributed to the heteroaromatic 
thiophene ring and the signals H1–H5 were allocated to the aliphatic amino acid, all with 
integral 1: H3 at δ = 3.75 (J = 8.70, 3.89 Hz, dd), H4 at δ = 3.15 (J = 14.65, 8.70 Hz, dd), H5 at 
δ = 3.4 (J = 14.65, 3.89 Hz, dd), H2 at δ = 7.30 (J = 3.66, 1.37 Hz, dd), H1 at δ = 7.07 (J = 
5.27, 3.66 Hz, dd), and H3 at δ = 7.56 (J = 5.27, 1.37 Hz, dd) (Table 3.1(a) and Figure 3.31). 
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Figure 3.31 1H NMR spectra of S-(2-thienyl)cysteine. 
 
3.6.3 13C-NMR analysis 
The solvent used to conduct the C-NMR analysis was D2O. The carboxylic carbon was observed 
at δ = 173.12 ppm, the methin carbon 2 at δ = 53.84 ppm, and the methylene carbon 3 at δ = 
30.58 ppm. Moreover, carbons 4-7 in the aromatic part of the thiophene group caused the 
chemical shifts at δ = 135.6 ppm, δ = 128.42 ppm, δ = 131.42 ppm, and δ = 130.90 ppm, 
respectively (Table 3.1(b) and Figure 3.32). 
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Figure 3.32 13C NMR spectra of S-(2-thienyl)cysteine. 
 
3.6.4 IR analysis 
The stretching bands resulting from the IR analysis were observed at 1510, 1581, 2600, 2950, 
2977, 3100, and 3450 cm-1. The most intense band at 1581 cm-1 belonged to the C=O group. 
The weak bands at 2977 and 3100 cm-1 corresponded to the NH2 group and the stretching bands 
related to the aromatic C=C and C-H groups were observed at 1510 and 2950 cm-1, respectively. 
Additionally, the bands at 2600 and 3450 cm-1 represented the C-H alkane and OH groups, 
respectively (Figure 3.33). 
 
 
Figure 3.33 IR spectrum of S-(2-thienyl)cysteine.  
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3.6.5 ESI-MS analysis 
The positive ion peaks related to the compound S-(2-thienyl)cysteine were formed in the mass 
spectrum of ESI-MS analysis at m/z 204.08 [M+H]+ and m/z 242 [M+K]+ (Figure 3.34). 
 
 
Figure 3.34 MS analysis of S-(2-thienyl)cysteine 
 
3.6.6 HR-MS analysis 
 
Figure 3.35 HR-MS analysis of S-(2-thienyl)cysteine. 
 
Based on the results of the HR-MS analysis, the ratio of molecular weight to molecular charge 
was m/z 204.0138, which correlated to the molecular formula of C7H10NO2S2 with the value of 
m/z 204.0147 and an acceptable difference of about 0.9 mDa (Figure 3.35). 
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3.7 Synthesis of S-(2-thienyl)cysteine-S-oxide 
 
3.7.1 TLC analysis 
The TLC plate displays 3 different spots related to the desired product S-(2-thienyl)cysteine-S-
oxide (47.3%) at Rf = 0.81, the sulfonic product (48.9%) at Rf = 0.73, and the non-oxidized 
product (3.7%) at Rf = 0.89. The volume of spots was measured by the TLC plate (Figure 3.36 
and Appendix 15). 
 
 
Figure 3.36 TLC analysis of S-(2-thienyl)cysteine-S-oxide. a) UV light detection (254 nm) and b) plate sprayed 
with ninhydrin.  
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3.7.2 1H-NMR analysis 
The result of the TLC was further confirmed by the 1H-NMR analysis. In the heteroaromatic 
part of the compound, protons H1 δ = 7.41 ppm (md), H2 δ = 7.23 ppm (md), and H3 δ = 7.93 
ppm (md), each with integral 1, were observed. Moreover, the signals H1–H3 belonging to the 
aliphatic part, each with integral 1, were detected: H1 at δ = 4.16 ppm (J = 2.52, 9.62 Hz, dd); 
the diastropic methylene hydrogens H2 and H3 at δ = 3.65 ppm (J = 2.52, 6.41 Hz, dd) and at δ 
= 3.91 ppm (J = 9.62, 5.72 Hz, dd), respectively (Figure 3.37). 
 
3.7.3 13C-NMR analysis 
When D2O was used as a solvent, the mixture of sulfide, sulfoxide, and sulfonic compounds 
appeared in the 13C-NMR spectrum (Figure 3.38). The chemical shift corresponding to 
carboxylic carbon was oberved at δ = 171.04 ppm. The carbons 4–7 belonging to the aromatic 
part of the thiophene group demonstrated strong chemical shifts at δ = 140.90 ppm, δ = 129.88 
ppm, δ = 127.4 ppm, and δ = 132.9 ppm. The carbons of the methin and methylene groups 
showed the chemical shifts at δ = 50.72 ppm and δ = 56.88 ppm, respectively. 
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Figure 3.37 1H NMR spectra of S-(2-thienyl)cysteine-S-oxide. 
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Figure 3.38 13C NMR spectra of S-(2-thienyl)cysteine-S-oxide. 
 
3.7.4 IR analysis 
The IR analysis revelaed stretching bands at 1138, 1496, 1626, 2900, 2992, 3088, 3250, and 
3388 cm-1. The band at 1138 cm-1 was related to the S=O group. The bands related to the C=C 
and C-H aromatic groups were visible at 1496 and 2992 cm-1, respectively. The bands at 1626 
and 3380 cm-1 corresponded to the C=O and NH2 groups. The bands relating to the NH2 group 
were observed at 3088 and 3250 cm-1, respectively. The weak band at 2900 cm-1 belonged to 
the C-H alkane group (Figure 3.39). 
 
 
Figure 3.39 IR spectrum of S-(2-thienyl)cysteine-S-oxide. 
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3.7.5 ESI-MS analysis 
During the ESI-MS analysis, the mass spectrum displayed the positive ion peak of the product 
S-(2-thienyl)cysteine-S-oxide at m/z 220 [M+H]+, m/z 242 [M+Na]+, and m/z 258 [M+K]+ 
(Figure 3.40). 
 
 
Figure 3.40 MS analysis of S-(2-thienyl)cysteine-S-oxide. 
 
3.7.6 HR-MS analysis 
According to the results of the HR-MS analysis, the ratio of molecular weight to molecular 
charge (m/z) correlated with the molecular formula of C7H10NO3S2. Its proposed value was 
equal to m/z 220.0097 and the measured value was m/z 220.0088 with an acceptable difference 
of about 0.9 mDa (Figure 3.41). 
 
 
Figure 3.41 HR-MS analysis of S-(2-thienyl)cysteine-S-oxide. 
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3.8 1-(Triisopropylsilyl)pyrrole 
 
 
Figure 3.42. 1-(Triisopropylsilyl)pyrrole 
 
 
 
3.8.1 1H-NMR analysis  
The H-NMR analysis was conducted using CDCl3 (chloroform D) as the solvent. The chemical 
shifts indicating a pyrrole ring, each with integral 2, were characterized by the signals at δ = 
6.57 ppm and δ = 6.7.04 ppm. In addition, hydrogens 3 of the isopropyl group were identified 
with integral 18 at δ = 1.38 ppm and hydrogen 3 of the methyl group with integral 3 at δ = 1.72 
ppm (Appendix 16). 
 
3.8.2 ESI-MS analysis  
As shown in Appendix 17, the basic peak in ESI-MS analysis was observed at m/z 224.25 
[M+H]+ corresponding to the desired product 1-(triisopropylsilyl)pyrrole. 
 
3.9 Hydrogenation 
3.9.1 Hydrogenation of S-(N-benzylpyrrol-2-yl)cysteine-S-oxide 
3.9.1.1 Hydrogenation with pd/C and hydrogen  
3.9.1.1.1 ESI-MS analysis  
The ESI-MS analysis conducted in a mixture of S-(N-benzylpyrrol-2-yl)cysteine-S-oxide and 
(2-amino-3-[(1-benzyl-1H-pyrrol-2yl)sulfonyl]propanoic acid) did not result in the expected 
product at m/z 203 [M+H]+. However, the results showed two peaks: a peak at m/z 277 [M+H]+ 
correlated to S-(N-benzylpyrrol-2-yl)cysteine-S-oxide, while the other one. at m/z 309 [M+H]+, 
indicated the occurrence of 2-amino-3-[(1-benzyl-1H-pyrrol-2yl)sulfonyl]propanoic acid 
(Appendix 18). 
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3.9.1.2 Hydrogenation of N-benzylpyrrole 
 
3.9.1.2.1 1H-NMR analysis  
The 1H-NMR analysis was performed with CDCl3 as a solvent. The 
1H-NMR spectrum 
displayed the signals of a pyrrole ring with integral 2 at δ = 6.17 and δ = 6.67 ppm. Additionally, 
the aromatic toluene ring was characterized by the signals at δ = 7.1 and δ = 7.3 ppm, each with 
integral 2. The signals present at δ = 2.14 ppm with integral 3 corresponded to the methyl 
hydrogen group of the toluene ring, which indicated the successful removal of the benzyl group 
from the N-benzylpyrrole compound (Appendix 57) (Figure 3.43). 
 
 
Figure 3.43. Hydrogenation of N-benzylpyrrole 
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Table 3.3 ESI-MS and TLC analyses of further synthesized products. The peaks observed following the analysis indicated as * in the table. 
Compound 
Molecular 
weight (g/mol) 
  
Expercted 
peak (m/z) 
  TLC 
Appendix 
Nr. 
  
    Q+  (m/z)   Q- (m/z)  
 
  [M+H]+ [2M+H]+ [M+Na]+ [M+K]+  
 
 
 
S-(N-Bocpyrrol-2-yl)cysteine 284 285 
 
307 323 
 
 20 
S-(3-furanyl)cysteine 
      
 
 
1-H-pyrrole-sulfonyl chloride  
      
 
 
Furan-3-sulfonyl chloride 
      
 
 
S-(2-furanyl)cysteine 
      
 
 
Cbz-serine benzylester-O-trifilate  461 462 
 
484 
  
 21 
Lithium furan-2-thiolate  106 107 
 
129 
  
 22 
2-[(tert-butoxycarbonyl)amino]-3-(1-H-pyrrole-2-ylsulfanyl)propanoic acid       Not applicated  
S-(2-pyrrolyl)cysteine 186 187 
 
209 
 
185  23/24 
S-(N-methylpyrrol-2-yl)cysteine       Not applicated  
Trifluoromethylsulfonyl-serine with triethylamine   237 238 
 
260 276 
 
 25 
O-trifluoromethylsulfonyl-serine with 2,6-lutidine       Not applicated  
S-(3-thienyl)cysteine   203 204 
 
226 242 
 
 26 
Boc-S-(N-methylpyrrol-2-yl)cysteine  300 301 
 
323 339 299  27/28 
Bromo-N-methylpyrrole 160 161* 321* 
 
199* 
 
 29 
N- (tert-butoxycarbonyl)-O-trifluoromethylsulfonyl-serine with 2,6-lutidine 237 238 
 
260 276 
 
 30 
S-(3-furanyl)cysteine 
      
 
 
S-(N-triisopropylsilypyrrol-2-yl)cysteine       Not applicated  
S-(2-thienyl)cysteine 
      
 
 
S-(2-imidazolyl)cysteine 187 188 
 
210 
 
186  31/32 
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Compound 
Molecular 
weight (g/mol) 
  
Expercted 
peak (m/z) 
  TLC 
Appendix 
Nr. 
  
    Q+  (m/z)   Q- (m/z)  
 
  [M+H]+ [2M+H]+ [M+Na]+ [M+K]+  
 
 
 
S-(N-methylimidazol-2-yl)cysteine 201 202 
 
224 
 
200  33/34 
S-(2-thiazolinyl)cysteine 206 207 
 
229 
  
 35 
S-(3-thienyl)cysteine       Not applicated  
Oxidation 
      
 
 
S-(N-benzylpyrrol-2-yl)cysteine (oxidation with H2O2 in acetic acid) 292 293* 
 
315* 331* 
 
 36 
S-(N-benzylpyrrol-2-yl)cysteine (oxidation with FeCl3 and H5IO6 ) 292 293 
 
315 
  
 37 
S-(N-benzylpyrrol-2-yl)cysteine (oxidation with MMPP) 292 293* 
    
 38 
S-(N-methylpyrrol-2-yl)cysteine (oxidation with H2O2 in water) 216 217 
    
 39 
S-(N-methylpyrrol-2-yl)cysteine (oxidation with H2O2 in acetic acid) 216 217 
    
 40/41 
S-(N-methylpyrrol-2-yl)cysteine (oxidation with cumene  hydroperoxide in 
H2O) 
216 217 
    
 42 
S-(N-methylpyrrol-2-yl)cysteine (oxidation with MMPP) 216 217 
    
 43 
S-(N-methylpyrrol-2-yl)cysteine (oxidation with TAPC in H2O2) 216 217 
    
 44 
Hydrogenation         
Catalytic transfer hydrogenation of S-(N-benzylpyrrol-2-yl)cysteine-S-oxide 
 
202 203 405 225 241   52 
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Table 3.4 1H NMR and TLC analyses of further synthesized products. 
Compound Solvent 
Chemical shift (ppm)  
TLC Appendix nr. 
Aromatic (δ 6‒8) Aliphatic (δ 1‒4) 
S-(N-Bocpyrrol-2-yl)cysteine D2O unobserved observed  45 
S-(3-furanyl)cysteine D2O unobserved observed  46 
1-H-pyrrole-sulfonyl chloride  D2O unobserved observed  47 
Furan-3-sulfonyl chloride D6-Acetone unobserved observed  48 
S-(2-furanyl)cysteine D2O unobserved observed  49 
Cbz-serine benzylester-O-trifilate   unobserved observed   
Lithium furan-2-thiolate       
2-[(tert-butoxycarbonyl)amino]-3-(1-H-pyrrole-2-ylsulfanyl)propanoic acid    Not applicated  
S-(2-pyrrolyl)cysteine      
S-(N-methylpyrrol-2-yl)cysteine    Not applicated  
Trifluoromethylsulfonyl-serine with triethylamine        
O-trifluoromethylsulfonyl-serine with 2,6-lutidine    Not applicated  
S-(3-thienyl)cysteine   D2O  Observed  50 
Boc-S-(N-methylpyrrol-2-yl)cysteine       
Bromo-N-methylpyrrole      
N- (tert-butoxycarbonyl)-O-trifluoromethylsulfonyl-serine with 2,6-lutidine      
S-(3-furanyl)cysteine D2O unobserved Observed  51 
S-(N-triisopropylsilypyrrol-2-yl)cysteine    Not applicated  
S-(2-thienyl)cysteine      
S-(2-imidazolyl)cysteine      
S-(N-methylimidazol-2-yl)cysteine      
S-(2-thiazolinyl)cysteine      
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Compound Solvent 
Chemical shift (ppm)  
TLC Appendix nr. 
Aromatic (δ 6‒8) Aliphatic (δ 1‒4) 
S-(3-thienyl)cysteine    Not applicated  
Oxidation      
S-(N-benzylpyrrol-2-yl)cysteine (oxidation with H2O2 in acetic acid)      
S-(N-benzylpyrrol-2-yl)cysteine (oxidation with FeCl3 and H5IO6 )      
S-(N-benzylpyrrol-2-yl)cysteine (oxidation with MMPP)      
S-(N-methylpyrrol-2-yl)cysteine (oxidation with H2O2 in water)      
S-(N-methylpyrrol-2-yl)cysteine (oxidation with H2O2 in acetic acid)      
S-(N-methylpyrrol-2-yl)cysteine (oxidation with cumene hydroperoxide in 
H2O) 
   
 
 
S-(N-methylpyrrol-2-yl)cysteine (oxidation with MMPP)      
S-(N-methylpyrrol-2-yl)cysteine (oxidation with TAPC in H2O2)      
Hydrogenation      
Catalytic transfer hydrogenation of S-(N-benzylpyrrol-2-yl)cysteine-S-oxide      
99 
 
3.9.2 Catalytic transfer hydrogenation of S-(N-benzylpyrrol-2-yl)cysteine-S-oxide  
3.9.2.1 MS analysis 
The peaks representing 2-amino-3-[(1-benzyl-1H-pyrrol-2yl)sulfonyl]propanoic acids, which 
indicate the primary compound of S-(N-benzylpyrrol-2-yl)cysteine, were observed at m/z 309 
[M+H]+ and at m/z 277 [M+H]+, respectively. As illustrated in the MS spectrum, the expected 
peak associated with S-(N-benzylpyrrol-2-yl)cysteine-S-oxide at m/z 203 [M+H]+ was not 
detected (Appendix 52). 
 
Tables 3.3 and 3.4 illustrate unsuccessful attempts to synthesize some heteroaromatic cysteine 
and cysteine sulfoxides.  
 
3.10 Enzymatic digestion  
All of the synthesized products described in the above sections were tested by alliinase from A. 
sativum.  
 
3.10.1 Enzymatic digestion of S-(2-thienyl)cysteine-S-oxide  
According to the results of the HPLC-MS analysis (see Appendixes 53–61), the results of three 
different HPLC-MS analyses, conducted after 2, 4, and 6 hours, respectively, demonstrated that 
the optimal test was  performed within a time period of 2 h. 
The enzymatic digestion was performed including the reaction test, and the positive and 
negative control.  
 
The reaction test consists of S-(2-thienyl)cysteine-S-oxide plus alliinase in the alliinase buffer, 
the positive control consists of alliin plus alliinase in the alliinase buffer, and the negative 
control consists of alliinase in the allinase buffer. 
 
Unexpectedly, in the negative control, peaks emerged at 11.10 min.(+), 27 min (+), 28.6 min 
(+), and 21.6 min (++++). The most significant peak formed at 21.6 min (++++), which 
indicated a compound with the molecular weight of 135 g/mol (Table 3.5a and Appendix 62). 
In the positive control (Appendix 63), the compounds allicin at m/z 163 [M+H]+ (Table 3.5b) 
and ajoene at m/z 235 [M+H]+ (Table 3.5c) were detected at 21.8 min. (++++) (Appendix 64) 
and 25.8 min. (+++) (Appendix 65), respectively; this indicated a compound with the molecular 
weight of 135 g/mol (Table 3.5a and Appendix 66).  In order to check the possible ionization 
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of alliicin, the (-Q)-trap analysis was conducted and the results demonstrated a less intensive 
signal correlated to the molecular weight of 161 (Appendix 67). The findings also confirmed 
that the compound with the molecular weight of 135 g/mol had to be considered in all of the 
calculations. The purity of S-(2-thienyl)cysteine-S-oxide was  calculated to be 47.3% 
(Appendix 15). After the reaction of S-(2-thienyl)cysteine-S-oxide with alliinase extracted 
from A. sativum, considering the compound with the molecular weight of 135 g/mol,  the only 
detected compounds were S-thiophen-2-yl thiophene-2-sulfinothioate at m/z 247 [M+H]+) 
(Table 3.5d) and 2,2´-(1,2,-dioxido-1λ4, 2λ4-disulfane-1,2-diyl)dithiophene at m/z 263 [M+H]+ 
(Table 3.5e),  as expected. The peak that formed at 27 min. (+++) corresponded to the 
compound linked to the sulfoxide group (Appendix 68). The second remarkable peak appeared 
at 26 min. (++) and matched the compound related to the disulfide-S-S´-dioxide group 
(Appendix 69), which is an oxidation product after alliinase reaction. 
 
3.10.2 Enzymatic digestion of other synthesized products 
Enzymatic digestion was performed on S-(2-pyrrolyl)cysteine, S-(N-methylpyrrol-2-
yl)cysteine, S-(N-benzylpyrrol-2-yl)cysteine, S-(N-benzylpyrrol-2-yl)cysteine-S-oxide, and S-
(2-thienyl)cysteine. 
 
3.10.2.1 Enzymatic digestion of S-(2-pyrrolyl)cysteine 
Appendix 70 contains the results of the HPLC-MS analysis of the enzymatic digestion of S-(2-
pyrrolyl)cysteine. None of the expected products corresponded to disulfide-S-oxide (at m/z 213 
[M+H]+), S-dipyrrolyldisulfide (at m/z 197 [M+H]+, or at m/z 313 [M+135+H]+) (Appendix 
71). However, the major peaks were detected at 17 min (++++) (at m/z 222 [M+H]+) (Table 
3.5f and Appendix 72), 18 min (++) (at m/z 231 [M+H]+) (Table 3.5g and Appendix 73), and 
at 21 min (+) (at m/z 231 [M+H]+) (Table 3.5g and Appendix 74), with fragments different 
than those of the previous peaks at 26 min (at m/z 226 [M+H]+) (Table 3.5h and Appendix 75) 
and at 32 min (++) (at m/z 294 [M+H]+) (Appendix 76). 
 
3.10.2.2 Enzymatic digestion of S-(N-methylpyrrol-2-yl)cysteine 
The chromatogram obtained from the HPLC-MS analysis associated with the enzymatic 
digestion of S-(N-methylpyrrol-2-yl)cysteineis is shown in Appendix 77. None of the expected 
products corresponding to disulfide-S-oxide (at m/z 241 [M+H]+), S-disulfide (at m/z 225 
[M+H]+, or even at m/z 360 [M+135+H]+) were detected (Appendix 78).  Nevertheless, 
101 
 
significant peaks related to unexplained products were observed at 23.72 min (+++) (at m/z 231 
[M+H]+) (Table 3.5i and Appendix 79), 24.4 min (++++) (at m/z 222 [M+H]+) (Table 3.5j and 
Appendix 80), 27.5 min (+) (at m/z 266 [M+H]+) (Table 3.5k and Appendix 81), and 33 min 
(+++) (at m/z 294 [M+H]+) (Table 3.5l and Appendix 82). 
 
3.10.2.3 Enzymatic digestion test of S-(N-benzylpyrrol-2-yl)cysteine 
Appendix 83 illustrates the chromatogram obtained through the HPLC-MS analysis relevant to 
the enzymatic digestion test of S-(N-benzylpyrrol-2-yl)cysteine. The evidence indicated that no 
expected products corresponded to disulfide-S-oxide (at m/z 393 [M+H]+), disulfide (at m/z 377 
[M+H]+ and/or even at m/z 512 [M+135+H]+) (Table 3.5m and Appendix 84). However, two 
intensive peaks belonging to unidentified products—both observable in previous compounds— 
were detected at 27 min(+) (at m/z 266 [M+H]+) (Appendix 85) and 33 min (++++) (at m/z 294 
[M+H]+) (Table 3.5n and Appendix 86). 
 
3.10.2.4 Enzymatic digestion test of S-(N-benzylpyrrol-2-yl)cysteine-S-oxide 
Unlike in the previous reaction, the alliinase reacted with S-(N-benzylpyrrol-2-yl)cysteine-S-
oxide as a cysteine sulfoxide (Appendix 87) and none of the expected products corresponding 
to disulfide-S-oxide (at m/z 393 [M+H]+), disulfide (at m/z 377 [M+H]+ or at m/z 528 
[M+135+H]+) were observed (Appendix 88). However, two major peaks corresponding to 
unidentified products and observable in the compound with the pyrrole ring were found at 20.9 
min (++++) (at m/z 231 [M+H]+) (Table 3.5o and Appendix 89) and 33.3 min (+++) (at m/z 
294 [M+H]+) (Table 3.5p and Appendix 90). 
 
3.10.2.5 Enzymatic digestion test of S-(2-thienyl)cysteine  
Appendix 91 illustrates the results of the HPLC-MS analysis connected to the enzymatic 
digestion test of S-(2-thienyl)cysteine. Although none of the expected products corresponding 
to disulfide-S-oxide (at m/z 247 [M+H]+), S-dithienylsulfide (at m/z 231 [M+H]+ or even at m/z 
366 [M+135+H]+) (Appendix 92) were observed, the significant peaks related to unidentified 
products were detected at 6.2 min (at m/z 155 [M+H]+) (Table 3.5q and Appendix 93), at 39.6 
min (at m/z 273 [M+H]+) (Table 3.5r and Appendix 94), and at 54.38 min (at m/z 299 [M+H]+) 
(Table 3.5s and Appendix 95). 
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3.10.2.6 HR-MS analysis of compound at m/z 136 [M+H]+ 
To identify the compound with the molecular weight of 135 g/mol, HR-MS analysis was 
conducted (Appendix 96): it showed a m/z ratio of 136.1128 [M+H]+, which indicates the 
existence of C9H14N with a theoretical value of m/z 136.1121 and a negligible difference of 0.7 
mDa (Table 3.5a). 
 
3.10.2.7 HR-MS analysis of compound at m/z 171 [M+H]+ 
HR-MS analysis was carried out to detect the compound with the molecular weight of 170 g/mol 
(Appendix 97). The results of the HR-MS analysis showed that a m/z ratio of 171,0989 [M+H]+ 
represented four different compounds, two of which contained fluoride. One did not contain 
any nitrogen and sulfur, and the other one with the molecular formula of C8H15N2S seemed to 
be the desired substance (Table 3.5t). 
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Table 3.5 Results of enzymatic digestionusing HPLC-MS on synthesized products. Alliinase was extracted from 
A. sativum for all analyses (Krest and Keusgen, 1999b). 
Substrate (m/z) [M+H]+ Retention Time 
(min.) 
Peak Intensity Intendet Molecular Structure 
a) Alliinase (negative control) a) 136 21.6 (++++) 
 
     
     
     
     
b) Alliin (positive control) b) 163 21.8 (++++) 
 
     
     
     
     
 
c) 235 25.8 (+++) 
 
     
     
     
     
     
     
S-(2-thienyl)cysteine-S-oxide d) 247 27 (+++) 
 
     
     
     
 e) 263 26 (++)  
     
     
S-(2-pyrrolyl)cysteine f) 222 17 (++++)  
     
     
     
     
 g) 231 18 (++)  
     
     
     
     
  21 (+)  
     
     
     
 h) 294 32 (++)  
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S-(N-methylpyrrol-2-
yl)cysteine 
i) 231 23.72 (+++)  
     
     
     
     
     
 j) 222 24.4 (++++)  
     
     
     
     
 k) 266 27.5 (+)  
     
     
     
     
     
 l) 294 33 (+++)  
     
     
     
S-(N-benzylpyrrol-2-
yl)cysteine 
m) 266 27 (+)  
     
     
     
     
     
 n) 294 33 (++++)  
     
     
     
S-(N-benzylpyrrol-2-
yl)cysteine S-oxide 
o) 231 20.9 (++++)  
     
     
     
     
     
 p) 294 33.3 (+++)  
     
     
     
S-(2-thienyl)cysteine q) 155 6.2 (++++)  
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 r) 273 39.6 (+)  
     
     
     
     
 s) 299 54.3 (-)  
     
     
     
 t) 171 ____ (-)  
     
     
 u) 269 ____ (-)  
     
     
     
     
     
 v) 249 ____ (-)  
     
     
     
     
     
     
 
3.10.2.8 HR-MS analysis of compound at m/z 269 [M+H]+ 
In order to identify the compound with the molecular weight of 268 g/mol (Appendix 98) the 
HR-MS analysis was carried out: it showed that a m/z of 269.0274 [M+H]+ is possible for 33 
different compounds. Moreover, the compounds containing nitrogen and sulfur with the 
molecular formulas of C12H13O3S2, and C11H13N2S3 are the most desirable compounds (Table 
3.5u). 
 
3.10.2.9 HR-MS analysis of compound at m/z 249 [M+H]+ 
In order to identify the compound with the molecular weight of 248 g/mol, the HR-MS analysis 
was conducted (Appendix 99): it revealed that m/z of 249.1094 [M+H]+ correlates with 7 
different compounds. Moreover, the compounds with the molecular formulas of C13H17N2OS 
and C10H21N2O2S2 are the most significant ones. These compounds have theoretical values of 
m/z 249.1056 and m/z 249.1090 with differences in amounts of about 3.8 mDa and 0.4 mDa, 
respectively. (Table 3.5v). 
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3.10.2.10 HR-MS analysis of compound at m/z 222 [M+H]+ 
The HR-MS analysis was conducted to identify the compound with the molecular weight of 221 
g/mol (Appendix 100): it revealed that a m/z ratio of 222.1711 [M+H]+ possibly correlates with 
three different compounds. The most plausible compound is defined by the molecular formula 
of C11H20N5 with a theoretical value of m/z 222.1713 and a difference of 0.2 mDa (Table 3.5j).
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4. Discussion 
4.1 Synthesis of heteroaromatic cysteine sulfoxides 
The synthesis of different types of five-ring heteroaromatic cysteine sulfoxides is rather 
interesting, as they are significant and naturally available in some wild species of Allium, such 
as A. giganteum (Kubec et al., 2011 and A. rosenorum (Jedelská et al., 2008), and also very 
likely available in A. carolinanum and A. macleanii (Vogt, 2008-doctoral thesis). The synthesis 
of any of the aromatic homologous compounds was also the aim of this study. These pyrrole 
compounds have been reported to have antidiabetic (Holland, 1981) and antibiotic activities, 
particularly in A. giganteum against Streptococcus sp. (Kubec et al., 2011).  
The pyrrole cysteine sulfoxides, such as S-(3-pyrrolyl)cysteine-S-oxide isolated from A. 
rosenorum subgen. Melanocrommyum by Jedelská et al. (2008), were considered as suitable 
substrates for alliinase. They affect the formation of the red pigment, the structure of which has 
to date not been fully understood. 
The main goal of this research was to synthesize S-(2-pyrrolyl)cysteine-S-oxide or S-(3-
pyrrolyl)cysteine-S-oxide and their homologs in order to understand the mechanisms as well as 
the structure of the red pigment under alliinase reaction (Jedelská et al., 2008). To synthesize 
these compounds, the TLC, ESI-MS, HR-MS, 1HNMR 13CNMR, IR, HPLC, and HPLC-MS 
analyses were implemented. Pyrrole, methyl pyrrole, benzyl pyrrole, and thiophene-2-thiol 
were selected as primary educts. 
Higher rate of reactivity, quick polymerization, oxidation, and light instability make the 
synthesis of pyrrole compounds difficult (Dennstedt and Voigtländer, 1984). Therefore, it is 
essential to find a synthesis method that can eliminate these complications. The method 
described here for the synthesis of four pyrrole compounds, including S-(2-pyrrolyl)cysteine, 
S-(N-methylpyrrol-2-yl)cysteine, S-(N-benzylpyrrol-2-yl)cysteine, and S-(N-benzylpyrrol-2-
yl)cysteine S-oxide (after Rudyakova et al., 2008) is considered essential because of the 
application of non-protected amino acids. Of all the products, S-(2-thienyl)cysteine 
demonstrated the highest yield of 93%, and S-(N-methylpyrrol-2-yl)cysteine had the lowest 
yield of 22%.  
The oxidation approach failed to synthesize the compound S-(2-pyrrolyl)cysteine-S-oxide from 
the primary educt (S-(2-pyrrolyl)cysteine) because of its high instability. Five other 
homologous products, including S-(N-methylpyrrol-2-yl)cysteine, S-(N-benzylpyrrol-2-
yl)cysteine, S-(N-benzylpyrrol-2-yl)cysteine-S-oxide, S-(2-thienyl)cysteine, and S-(2-
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thienyl)cysteine S-oxide were successfully synthesized. The effect of alliinase from A. sativum 
was tested on the abovementioned compounds.  
 
4.2 3-Chloro-L-alanine as the basic reagent for the synthesis 
In the present study, 3-chloro-L-alanine (Figure a4.1 ) was considered a fundamental product for 
the synthesis of other products. The existence of chloride, as a suitable leaving group in the 
nucleophilic substitution reactions, is one of the main advantages of 3-chloro-L-alanine. L-
serine (Figure b4.1 ), saturated with HCl (for more details see methods), was used as a primary 
educt. Despite the high structural similarity of 3-chloro-L-alanine and L-serine (the only 
difference is the presence of the Cl and OH groups, respectively), the hydrogens of methin and 
methylene groups demonstrated high variability in the chemical shifts in the 1HNMR analysis. 
This interesting phenomenon is discussed further in the continuation of this section. 
 
 
Figure 4.1 Molecular structure of 3-chloro-L-alanine (a) and L-serine(b) 
 
The 1H-NMR spectra of 3-chloro-L-alanine and L-serine are presented in Figure 4.2. L-serine 
showed one signal belonging to the hydrogen of the methin group with integral 1 (δ = 3.75 ppm, 
md) and a peak of the methylene hydrogens with integral 2 (δ = 3.9 ppm, md). Moreover, 3-
chloro-L-alanine displayed remarkable differences in chemical shifts of the diastereotic 
methylene hydrogens [integral 1 (H4, δ = 4 ppm, J = 3.43, 12.82 Hz, dd) and (H5, δ = 4.11 ppm, 
J = 4.35, 12.82 Hz, dd)] and the methin hydrogen [integral 1 (H3, δ = 4.45 ppm, J = 3.43, 4.35 
Hz, dd)] (Figure 3.2). In compression, two significant differences were observed: i) the 
exchange of the chemical shifts between methin and methylene hydrogens and; ii) the 
diastereotopic methylene hydrogens in 3-chloro-L-alanine, which was represented by two 
signals (dd).  
The difference in multiplicity of peaks could be due to the following reasons: i) D2O as a solvent 
for both substances may have caused the replacement of the hydroxyl group (OH) proton with 
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that of deuterium. Using DMSO instead of D2O as a solvent could help optimize this 
phenomenon; ii) the coupling constants of the peaks show that they can be formed very closely 
and result in a multi doublet. 
 
 
Figure 4.2  1H-NMR spectra of 3-chloro-L-alanine (a) and L-serine (b). 
 
Using EX500 instead of EX400 would optimize the visualization of this phenomenon to some 
extent. Current theories do not seem capable of explaining why chemical shifts of protons in L-
serine and 3-chloro-L-alanine differ significantly. However, the saturation of 3-chloro-L-
alanine with HCl may represent the dipolar ion in the reaction, in which the amine and the 
carboxyl appear as –NH3+ and –COOH, respectively. The difference in the chemical shift of 
these two compounds can be explained to some extent by the difference in the electronegativity 
of the chloride and hydroxyl groups. The electronegativity of the chloride group is constant, 
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while that of the hydroxyl group is relative and differentiable for each compound. In general, 
the weaker the H-bond appeared, the higher the electronegativity of the OH group was observed 
(Krygowski and Szatyłowicz, 2006). And the higher the electronegativity of the OH group in 
L-serine was observed, the higher the number of adjacent diastereotopic hydrogens that were 
shifted to downfield. Despite the theories mentioned above, it is not clear why the chemical 
shift of the hydrogens of methylene and methin should be different in two almost identical 
compounds (L-serine and 3-chloro-L-alanine).  
 
4.3 Reaction mechanisms 
To date, no acceptable mechanism has been presented for the synthesis of the three main 
products: S-(2-pyrrolyl)cysteine, S-(N-methylpyrrol-2-yl)cysteine, and S-(N-benzylpyrrol-2-
yl)cysteine. Here, it is hypothesized that the reaction mechanism may take place in following 
steps: First, during an intermediate reaction, the iodide in the mixture of KI/I2 acts as an 
oxidative and convert thiourea to sulfide dimer. As previously demonstrated, thiourea can be 
converted to sulfide dimer by using a halogen (Soroka & Goldeman, 2005; Hunter & Jones, 
1930). If this scenario explains the formation of sulfide dimer from KI/I2 and thiourea, the 
second step occurs with the reaction of disulfide and aromatic pyrrole ring in position 2, 
resulting in an electrophilic aromatic substitution (SnEAr) reaction. Also, the pseudothiourea is 
considered an intermediate product the reaction and should last for three hours under argon 
atmosphere at 30–40˚C. The temperature control throughout the reaction is critical. Since the 
pyrrole ring is highly reactive, the reaction atmosphere should be kept constant and alkalinized 
by adding hydrazine and NaOH. Hydrazine is necessary for conducting the reaction, as it 
attaches to the disulfide bonds in pseudothiourea and forms a tetraammine compound. By 
splitting the sulfur atom from the thiolate, the electron pair shifts from the amine group to sulfur. 
Lastly, 3-chloro-L-alanine is added to the mixture and heated for two hours in a highly alkaline 
environment. This condition is suitable for a simple nucleophilic substitution II reaction (SN2), 
in which the chloride acts as the leaving group and thiolate acts as the nucleophilic group. 
Afterwards, the thiolate is replaced by chloride, forming the desired product (Figure 4.3). 
The other possible but unlikely mechanism for this reaction might be as follows: the reaction is 
assumed to start with I2 binding to the pyrrole ring in position 2. Next, thiourea is replaced by 
I2 with the use of sulfide dimer due to a nucleophilic substitution reaction in aromatic 
compounds. However, this scenario does not seem feasible due to the lack of substituents with 
–M-effect. 
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Figure 4.3 Mechanisms of synthesis of pyrrolyl cysteine. The mechanism was adopted from Rudyakova et al. 
(2008) with modification. 
 
4.4 Stability and reactivity of the pyrrole compounds as educt 
The pyrrole compounds used as educts in this work can be classified based on their yield and 
reactivity in each reaction as well as the contained pyrrole, N-methyl pyrrole, N-benzyl pyrrole 
and N-boc pyrrole. 
Generally, the more electron-rich the compounds were, the more reactivity rate they showed. 
The above classification, however, follows a reverse order when the stability of these 
compounds is considered: S-(N-benzylpyrrol-2-yl)cysteine, S-(N-methylpyrrol-2-yl)cysteine, 
and S-(2-pyrrolyl)cysteine. Therefore, the synthesis of S-(N-benzylpyrrol-2-yl)cysteine is more 
feasible due to the high stability, ease of reactivity, oxidization, and purification (using 
preparative HPLC). 
Regarding the structural similarity between S-(N-methylpyrrol-2-yl)cysteine, S-(2-
pyrrolyl)cysteine, and the small methyl group linked to nitrogen, it should not have a negative 
effect on the alliinase activity. The high instability of the two latter compounds makes it nearly 
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impossible to examine them in sufficient purity using HNMR, CNMR, MS and IR. They readily 
oxidize at room temperature and polymerize to a semi-liquid, sticky, brown viscous compound. 
The oxidation and analysis are negatively affected even under argon atmosphere, vacuum, light, 
and temperature protection. 
To achieve S-(2-pyrrolyl)cysteine S-oxide from S-(N-benzylpyrrol-2-yl)cysteine S-oxide, the 
benzyl group has to be removed. Removing the benzyl group from pyrrole ring is rather difficult 
(for details, see methods). Therefore, N-Boc-pyrrole was analyzed, not resulting in the desired 
product for the following reasons: i) the protecting Boc-group has large dimensions, and its 
steric hindrance inhibits it from being placed on position 2 of the pyrrole ring; and ii) 
additionally, this reaction was not conducted in position 3 due to electron deficiency in the 
pyrrole ring. The Boc group converted the electrophilic compound to nucleophile, which could 
be explained by its electron density (Figure 4.4). 
 
 
Figure 4.4 Comparison of stability and reactivity of primary compounds used to synthesize the products: a) 
pyrrole; b) N-methyl pyrrole; c) N-benzyl pyrrole; and d) N-Boc pyrrole. 
 
4.5 Oxidation 
Various unselective oxidations were applied to oxidize the synthesized sulfur compounds (for 
details, see methods). The oxidation of S-(N-benzylpyrrol-2-yl)cysteine was more 
straightforward than that of the other compounds. We could have risked the production of 
sufodioxide instead of sulfoxide if the oxidative compound had not been gently applied to the 
reaction mixture.  
The steric hindrance of the benzyl group in oxidation of S-(N-benzylpyrrol-2-yl)cysteine may 
be disadvantageous for the following reasons: i) a strong oxidative like H2O2 in acetic acid needs 
to be used; ii) the reaction lasts approximately 15-18 h; and iii) removing the benzyl group in 
order to achieve the desired product is difficult. However, there are some advantages: i) this 
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compound is more stable than S-(N-methylpyrrol-2-yl)cysteine and S-(2-pyrrolyl)cysteine; and 
ii) the high steric hindrance of the benzyl group may result in a diastereoselective oxidative 
reaction and the inhibition of the racemates formation. The oxidation often takes place on the 
free side of the molecule, due to the steric hindrance on the opposite side. Thus, the yield product 
will be S or R, though its configurations remain unknown.  
Acetic acid and methanol have similar solubility coefficiency; however, only acetic acid was 
used for oxidation reaction. The oxidation of methanol to formic acid via H2O2 and its 
competition with the educts can underestimate the equivalent calculations. In general, despite 
some difficulties in the oxidation of the two other products, S-(2-pyrrolyl)cysteine and S-(N-
methylpyrrol-2-yl)cysteine, as a result of high instability different oxidative compounds were 
used (for details, see methods). The molecular weight of the desired compound often appeared 
two mass units lighter than the expected one (Appendices 40 and 42). Two explanations are 
possible: sulfur theoretically tends to oxidization rather than dehydrogenation, but the 
dehydrogenation of the compound and the formation of a double bond would be more likely to 
occur through MS analysis. 
 
4.6 Hydrogenation 
4.6.1 Hydrogenation of S-(N-benzylpyrrol-2-yl)cysteine S-oxide 
It is necessary to remove the benzyl group from S-(N-benzylpyrrol-2-yl)cysteine-S-oxide 
through hydrogenation to achieve the desired product S-(2-pyrrolyl)cysteine S-oxide. It is 
assumed that the catalyst is poisoned by sulfur and the reaction follows a different direction. 
Different types of sulfur such as H2S thiol and thioether are poisonous to the catalytic reaction 
(Grove, 2003). Sulfur poisoning can happen in two reaction pathways, although bulk sulfidation 
is more likely than the surface sulfidation (Dunleavy, 2006). The mechanisms can be described 
as follows: if methanol as a reaction solvent is not fully dried, the water can cause sulfur 
poisoning, similar to the reaction of thioethers with catalyzer Pd (Traeger et al., 2012).  
 
This hypothesis may be supported by the existence of a sulfur dioxide compound (2-amino-3-
[(1-benzyl-1H-pyrrol-2-yl)sulfonyl]propionic acid) and an S-(N-benzylpyrrol-2-yl)cysteine 
compound in reaction mixture. To confirm the occurrence of sulfur poisoning in the reaction 
mixture, N-benzyl pyrrole was hydrogenated under similar conditions during the next step of 
the experiment (for details, see methods). The removal of the benzyl group from the pyrrole 
ring was successfully completed (Appendix 19). It may be possible to reduce the double bonds 
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in the pyrrole ring, if the pressure is increased up to 4 bar (Adkins and Coonradt, 1941; Dress 
et al., 2005 [patent WO/2005/103003]).  
4.7 Comparison of the sulfur compounds 
The synthesis was implemented using the sulfur compounds base and the mechanisms of 
nucleophilic substitution reaction, in which the thiol group is known as one of the best 
nucleophiles and 3-chloro-L-alanine with a very suitable leaving group like chloride. According 
to the SN1 or even SN2, the reaction has to be alkalinized by using, for example, KOH and 
heated in a water-free condition.  
 
2-thiophenethiol, 2-mercaptoimidazole, 2-mercapto-1-methylimidazole and 2-thiazoline-2-
thiol (as nucleophiles) were used as primary educts in the synthesis of the five-ring 
heteroaromatic cysteine sulfoxides as homologous substances. Unexpectedly, apart from 2-
thiophenethiol, the other compounds did not result in the desired products. Two possible reasons 
can be given for this: i) alkaline, (e.g. KOH) probably competes with thiol, which enables the 
production of thionamide (Chan et al., 2014; Figure 4.5); ii) the existence of ethanolate (EtoѲ) 
as a solvent competes with thiol resulting in ether as a side product (Figure 4.6). Two solutions 
were tested for each of these problems: i) using potassium t-butilate instead of KOH to avoid 
the deformation of thionamide since high steric hindrance of potassium t-butilate inhibits its 
incorporation in the reaction; ii) using an aprotic solution like DMF instead of ethanolate 
(interrupting the solubility of 3-chloro-L-alanine). However, these solutions were not 
successful. 
 
 
Figure 4.5 The formation mechanisms of thioamide. 
 
Figure 4.6 Competition of ethanolate with thiol in SN reaction. 
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4.8 H-NMR compression of compound S-(N-benzylpyrrol-2-yl)cysteine S-oxide with 
other aromatic and aliphatic sulfoxides  
This study, its findings, and the literature review cited aimed to introduce an acceptable model 
for cysteine sulfoxides compounds. In ABX-splitting (Figure 4.5), Keusgen (1999) stated that 
the chemical shifts of protons in the methylene group differ by 0.25 ppm in (+)alliin and 
(+)propiin, although the difference between these two proton signals declines to 0.07 ppm in 
their (–)isomers. This scenario can be explained by the similarity to γ-glutamylmarasmin (Van 
den Broek et al., 1987). The methylene hydrogens can be presented in a triplet form instead of 
dd (Keusgen, 1999). γ-Glutamylmarasmin shows coupling constants (J) between the methylene 
and methin hydrogengs as JAx = 5.5/7 and JBx = 7/8.5 Hz for Ss–(+)isomer, and JAx = 3.5/4 and 
JBx = 8.5/10.5 Hz for Rs–(–)isomer (Kubota et al.,1998; Kubec & Velíšek, 2007). In (2-
pyrridinyl)cysteine S-oxide, the difference between the two diasteropic proton signals was 0.27 
ppm for (+)–isomer and 0.16 ppm for (–)isomer. In addition, coupling constants were calculated 
as 5.7/7.4 and 2.9/9.5 Hz for both positive and negative isomers, respectively (Mielke, 2015-
doctoral thesis).  
Unselective oxidation methods were implemented for the synthesis of S-(N-benzylpyrrol-2-
yl)cysteine-S-oxide, since the synthesis of either positive or negative isomers was not the 
purpose of the present dissertation. As expected, the oxidized form (racemate) of the S-(N-
benzylpyrrol-2-yl)cysteine-S-oxide and S-(2-thienyl)cysteine-S-oxide was present due to an 
unselective reaction. However, a large volume of the benzyl group may follow stereo selective 
reaction by blocking molecule from one side and form pure isomers (+ or -). 
 
Figure 4.7 Molecular structure of aliphatic part of cysteine sulfoxide. 
 
The chemical shift difference between the diastereotopic hydrogens (Ha and Hb) was calculated 
and compared with the similar products in the literature. S-(N-benzylpyrrol-2-yl)cysteine-S-
oxide showed the chemical shift difference of about 0.31 ppm between protons of the methylene 
groups and a coupling constant of JAx = 8 and JB x= 4.5 Hz. In S-(2-thionyl)cysteine-S-oxide the 
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chemical shift differed by 0.26 ppm and the coupling constant was estimated to be JAx = 2.52 
and JBx = 9.62. As a result, the formation probability for (+)–S-(N-benzylpyrrol-2-yl)cysteine-
S-oxide and (+)–S-(2-thionyl)cysteine-S-oxide increases (Table 4.1). 
 
 
Table 4.1. Comparison of diastereotopic methylene hydrogen signals of 1H-NMR of cysteine sulfoxides from 
literature including this work. 
Reference δHa-δHb (ppm) coupling constant JAx/JBx [Hz] 
SSRC-Alliin [Keusgen 1999] 0.24 6.0/7.7 
RSRC-Alliin [Keusgen 1999] 0.07 4.0/7.9 
SSRC-Propiin [Keusgen 1999]  0.25 5.7/6.6 
RSRC-Propiin [Keusgen 1999] 0 5.7/8.0 
SSRC-Petiveriin [Kubec et al. 2001] 0.29 6.9/6.77 
RSRC-Petiveriin [Kubec et al. 2001] 0.1 3.6/8.4 
RSRC-Marasmin [Kubota et al. 1998] 0.25 7.3/6.6 
SSRC-Marasmin (als -glutamyl-Derivat) [van den Broek et al. 1987]  0 3.9/10.4 
RSRC-PhCSO [Mielke. 2015- doctoral thesis] 0.15 6.0/6.6 
SSRC-PhCSO [Mielke. 2015- doctoral thesis]  0.07 3.5/8.5 
RSRC-2-PyCSO [Mielke. 2015- doctoral thesis]  0.27 5.7/7.4 
SSRC-2-PyCSO [Mielke. 2015- doctoral thesis]  0.16 2.9/9.5 
S-(N-benzylpyrrol-2-yl)cysteine-S-oxide [this work]  0.31 8/4.5 
S-(2-thienyl)cysteine-S-oxide [this work] 0.26 2.52/9.62 
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4.8.1 1H-NMR comparison of diastereotopic methylene hydrogen signals in the non-
oxidized compounds 
The comparison of aliphatic or cysteine parts of the non-oxidized compounds revealed that these 
compounds are different both in coupling constants and chemical shifts. The highest and lowest 
difference of the chemical shift of the diastereotopic methylene hydrogens were observed in S-
(N-methylpyrrol-2-yl)cysteine and S-(2-pyrrolyl)cysteine, respectively (Table 4.2). 
 
Table 4.2. Comparison of diastereotopic methylen hydrogen signals of 1H NMR of the non-oxidized compounds. 
 
Compound δHa-δHb (ppm) JBx JAx 
S-(2-pyrrolyl)cysteine 0.25 8.70 3.66 
S-(N-benzylpyrrol-2-yl)cysteine  0.43 10.53 3.21 
S-(2-thienyl)cysteine 0.45 9.80 3.60 
S-(2-pyridinyl)cysteine (Milke, 2015-
doctoral thesis) 
0.54 md Md 
S-(N-methylpyrrol-2-yl)cysteine 0.66 8.70 5.40 
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4.9 Biosynthetic pathway of S-(3-pyrrolyl)cysteine sulfoxide 
Vogt (2008, doctoral thesis) assumed that proline and ornithine are the primary compounds that 
convert to pyrrole-2-carboxylate. 
The glutathione linked to the pyrrole ring in position 3 was oxidized, and the gamma-glutamyl 
group was removed using gamma-glutamyl transferase and converted to S-(3-pyrrolyl)cysteine 
S-oxide (Figure 4.8). 
 
 
 
Figure 4.8 Possible biosynthesis pathway of S-(3-pyrrolyl) cysteine sulfoxides (Vogt, 2008-doctoral thesis). 
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4.10 Biosynthetic pathway of S-(2-pyrrolyl)cysteine sulfoxide 
It is presumed that acetate and L-serine have a large effect on the biosynthesis pathway of S-(2-
pyrrolyl)cysteine sulfoxide. Serine-kinase catalyzed the conversion of L-serine to L-serine 
monophosphate. The reaction was followed by linking oxaloacetate produced from acetate in 
the citric acid cycle to L-serine mono phosphate using a hypothetical protein.  
The function of this protein is unknown (Siebenberg et al., 2011). L-serine monophosphate was 
further converted to the precursor compound pyrrole-3-carboxylate or pyrrole-2-carboxylate 
under the reaction of decarboxylase and the dehydrogenase enzymes. To achieve the desired 
product S-(2-pyrrolyl)cysteine S-oxide, two possible pathways can be proposed: i) In 
nucleophilic substitution reaction (SN-Ar), glutathione attacks the aromatic ring and converts to 
the intermediate substance under the rearomaticity and decarboxylation. This is catalyzed by 
oxygenase. Gamma-glutamyl transferase conducts the reaction to produce the desired product; 
ii) Cysteine kinase leads to the conversion of L-cysteine to L-cysteine mono phosphate and its 
linkage to the pyrrole ring in position 2 under an electropholic substitution reaction in aromat 
SE-Ar (Figure 4.9). 
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Figure 4.9 Hypothetical biosynthesis pathway of S-(2-pyrrolyl)cysteine sulfoxides (after Vogt, 2008-doctoral 
thesis and Siebenberg et al., 2011).  
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4.11 Enzymatic digestion  
Enzymatic digestion was performed on the six synthesized products in either forms of sulfide 
and sulfoxide, using alliinase from A. sativum (Krest & Keusgen, 1999b). 
 
4.11.1 The compound at m/z 136 [M+H]+ 
Under negative control, two different compounds with the molecular formula of C9H14N and 
with pyridine content were detected. Ammonium salt, which was probably produced due to 
buffer contamination, could be one of the compounds (Figure 4.10iiia). It can link to other 
compounds such as allicin, ajoen, or S-thiophene-2-yl thiophene-2-sulfinothioate (Figure 
4.10i). A pyridoxal-phosphate derivative, considered an important co-enzyme for alliinase 
(Percudani & Preacchi, 2003), is the second possible compound (Figure 4.10iiib). 
 
4.11.2 Enzymatic digestion of S-(2-thienyl)cystein-S-oxide 
The test was comprehensively conducted under positive and negative controls for the compound 
S-(2-thienyl)cystein-S-oxide. Alliin was used in the positive control. In the positive control, 
allicin and ajoene were identified as ammonium salts. Under positive control conditions, the 
reaction of alliinase with S-(2-thienyl)cystein-S-oxide resulted in the expected products: 
disulfide-S-oxide (Figure 4.10i) as well as its oxidation product disulfide-S-S ́-dioxide, which 
is also known as the ammonium salts (Figure 4.10ii). 
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4.11.3 Enzymatic digestion of the synthesized pyrrole compounds 
The reaction of alliinase with pyrrole compounds, including S-(2-pyrrolyl)cysteine, S-(N-
methylpyrrol-2-yl)cysteine, S-(N-benzylpyrrol-2-yl)cysteine, and S-(N-benzylpyrrol-2-
yl)cysteine-S-oxide showed a high degree of compound similarity. These products, however, 
are mainly identified as side-products because of the high reactivity and instability of 
thiosulfinates (Block et al., 1993). The reaction of alliinase with any of these four compounds 
may expose the compounds with different molecular weights to molecular charge ratio as 
follows: at m/z 294 [M+H]+, corresponding to the molecular formula of C14H16NS3 (Figure 
4.10iv); at m/z 231 [M+H]+, corresponding to the molecular formula of C8H11N2S3 (Figure 
4.10v) or C8H11N2O2S2 (Figure 4.10vi); at m/z 266 [M+H]
+ corresponding to the compounds 
with the molecular formula of C11H12N3OS2 (Figure 4.10vii) or C9H16NO2S3 (Figure 4.10viii). 
 
4.11.4 Enzymatic digestion of S-(2-thienyl)cysteine 
Although the reaction of alliinase with S-(2-thienyl)cysteine resulted in several side products, 
the existence of the compound shown at m/z 299 [M+H]+ with the molecular formula of 
C11H11N2O2S3 (Figure 4.10ix) is more realistic. 
 
4.11.5 Conclusion and summary of enzymatic tests 
In summary, it can be concluded that of the six synthesized compounds in this research, only 
the reaction of S-(2-thienyl)cystein-S-oxide as a heteroaromatic cystein sulfoxide with the 
existing alliianse in A. sativum resulted in the production of the expected compounds, disulfide-
S-oxide (Figure 4.10i) and disulfide-S-S ́-dioxide (Figure 4.10ii). In contrast, the reaction of 
other five synthesized compounds with alliinase produced by-products other than the expected 
compounds. In (3.10.2) the molecular formulas of these compounds together with their possible 
molecular structures were described. 
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Figure 4.10 Molecular structure of (i) S-(2-thienyl)thiophene-2-sulfinothioate; (ii) 2,2ˊ-(1,2-dioxido-1 λ4, 2 λ4-
disulfane-1,2-diyl)dithiophene; (iii) a: 1-tert-butylpyridinium (left), N,N,N-trimethylanilinium (right); b: 5-ethyl-
2,4-dimethylpyridine; (iv) 2-({(E)-2-[(1E,3Z,5Z)-octa-1,3,5,7-tetraen-1-yldisulfanyl]ethenyl}sulfanyl)-1 H-
pyrrole; (v) (E)-2-{[(E)-2-(1H-pyrrol-2-yldisulfanyl)ethenyl]sulfanyl}ethenamine; (vi) (3E)-2-amino-4-(1H-
pyrrol-2-yldisulfanyl)but-3-enoic acid; (vii) S-[(E)-2-(5-aminopyridin-3-yl)ethenyl] 1 H-pyrrole-2-sulfinothioate; 
(viii) S-propyl 2-(1H-pyrrol-2-ylsulfinyl)ethanesulfinothioate; (ix) 5-{(E)-2-[1,2-dioxido-2-(thiophene-2-yl)-
1λ4,2λ4-disulfan-1-yl]ethenyl}pyridin-3-amine.   
 
 
Five possible explanations for the synthesis of these unexpected products are as follows: i) 
impurities in the synthesis and the contamination of the buffer; ii) instability of thiosulfinates  
such as allicin; iii) cysteine sulfoxides are the specific substrates for aliinase; iv) substrate 
specificity of alliinase; v) various enzymatic activity on (+) and (-) substrate isomers.  
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4.11.5.1 Impurity during synthesis and contamination of buffer 
The instability of the compounds S-(2-pyrrolyl)cysteine and S-(N-methylpyrrole-2yl)cysteine 
in the presence of light, room temperature, and oxygen increases the rate of side product 
formation before and after alliinase test due to the impurity of synthesized substrates. Factors 
like polymerization and oxidation, or recombination of these undesired products with the 
primary substances or other side products, can result in unexpected side products in the reaction. 
Alternatively, buffer contamination can cause side products like the compound with the 
molecular weight of 135 g/mol, which was observed in the negative control.  
 
4.11.5.2 Instability of thiosulfinates like allicin 
Thiosulfinates, which are also highly instable in the presence of high temperature, light and 
oxygen, are involved in various chemical reactions such as radicalic addition or substitution, α-
β-elimination, condensation, [3,3] and [2,3]-sigmatrope rearrangement, (i.e. from sulfoxide-
accelerated thio and dithio claisen-rearrangement) and cycloaddition with thiocarbonylcysteine 
(Block et al., 1993). Thiosulfinate including alliicin can rearrange to sulfur dioxide or diallyl-
mono-, di-, and trisulfides at RT (Brondnitz et al., 1971). 
Radical substitutions or additions under the effect of light and temperature are among the main 
factors contributing to the formation of the side products with respect to pyrrole compounds 
(Figure 4.11) (Block et al., 1993). 
 
 
Figure 4.11 Formation of the side prodcuts due to the radicalic reaction. 
 
Apart from allicin in the positive control and S-thiophene-2yl thiophene-2-sulfinothiolate 
(Figure 4.10 i), the expected product of the reaction of S-(2-thienyl)cysteine-S-oxide on 
aliinase, the other identified substances are considered side products. 
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4.11.5.3 Cysteine sulfphoxides are specific substrates for aliinase  
The alliinase reaction with sulfur or sulfur dioxide compounds did not result in the production 
of the expected compounds, as it is a naturally specific enzyme for cysteine sulfoxide 
compounds. The sulfoxide group (S=O) plays a significant role in allinase enzyme site (Kuettner 
et al., 2002). It was expected to oxidize the compounds S-(2-pyrrolyl)cysteine or S-(N-
methylpyrrol-2-yl)cysteine to sulfoxide during the reaction because of its high instability 
against light, room temperature, and oxygen. The absence of a reaction of the substrate S-(N-
benzylpyrrole-2-yl)cysteine-S-oxide with alliinase can be explained by the following 
hypothesis: the large benzyl group connected to the pyrrole ring can considerably reduce the 
possibility of coupling S-(N-benzylpyrrole-2-yl)cysteine-S-oxide with allinase in the enzyme 
site and as a result, the desired product will not be obtained. 
 
4.11.5.4 Substrate specificity of alliinase 
Considering the reactivity of substrates by alliinase, the alkyl cysteine sulfoxides are less 
reactable than the alkenyl cysteine sulfoxides (Krest, 1998-doctoral thesis). 
Similar substrates were used for the enzymatic digestion in A. sativum (alliinase used in this 
test) and alliinase of A. macleanii of subgen. Melanocrommyum (Vogt, 2008-doctoral thesis). 
Table 4.3 displays the results of this work along with the previous reports discussed here. The 
highest enzymatic activity rate in A. sativum was shown to be for alliin, while methiin substrated 
with enzymes activity of about 20%, propiin with about 36% and butiin with about 12% 
(Knobloch et al., 1991; Krest et al., 2000). 
 
By contrast, the alliinase extracted from A. macleanii containing pyrrolyl cysteine sulfoxide, as 
heteroaromatic cysteine sulfoxide, showed no activity to methiin and butiin and only 30% 
activity towards alliin. The maximum activity reported was that of the heteroaromatic pyrrole 
ring in cysteine sulfoxides (Vogt, 2008-doctroral thesis). Alliinase extracted from A. stipitatum 
appeared with low activity for pyrridinyl cysteine sulfoxide and even lower for S-pyrridinyl 
cysteine N-oxide (Mielke, 2015-doctoral thesis). In agreement with previous studies, our work 
shows that the substrate specificity is significant in enzymatic activity of A. sativum with the 
synthesized substrates. 
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4.11.5.5 Various enzymatic activities on (+) and (-) substrate isomers 
 
(+)- Isomers were found in plants (Koch & Lawson, 1996). Stereoisomers (+) or (-) largely 
affect either the reaction velocity with the enzyme or its specificity. It is more likely that (+)- 
isomers react with alliinase and that the reactivity of negative isomers is less than that of positive 
ones (e.g. by alliin: Krest & Keusgen, 1999b). However, the (-)-isomer from S-(2-
pyrridinyl)cysteine-S-oxide is an exception and is more effective than the (+) isomer in the 
reaction with alliinase from A. sativum (Mileke, 2015-doctoral thesis). 
 
Apart from S-(N-benzylpyrrol-2-yl)cysteine-S-oxide which probably contains (+)- isomers 
instead of (-)-isomers (based on the comparison made in the section 4.8), the isomer types of 
other synthesized substrates in this study are unknown. In addition, the benzyl group linked to 
the nitrogen of pyrrole prohibits the enzyme-substrate reaction at the binding site. Reactivity of 
each substrate not only depends on the compatibility of the enzyme site but also on the side 
chain of the adjacent amino acid (Vogt, 2008-doctoral thesis).  
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Table 4.3 Comparison activity of alliinase on synthesized substrates with literature. 
 
  Relative activity of enzyme    
Cysteine sulfoxide derivatives A. macleanii (%) A. sativum (%)  A. stipitatum A. sativum 
 
Vogt, 2008-doctoral thesis Knobloch Krest Mielke, 2015-doctoral thesis This work 
Pyrrole 100.00 unstudied unstudied  unstudied 
Methiin  0.20  21 20  unstudied 
Alliin 30.30  100 100  unstudied 
Propiin 36.03  36 6  unstudied 
Butiin 0.13  unstudied 12  unstudied 
Pytidin 42.42  unstudied unstudied  unstudied 
Benzyle 16.39  unstudied unstudied  unstudied 
Furan 42.50  unstudied unstudied  unstudied 
Thiazol 72.95  unstudied unstudied  unstudied 
S-(2-pyrridinyl)cysteine-S-oxide    Positive  
S-(2-pyrridinyl)cysteine-N-oxide    Positive  
Phenylcysteine-S-oxide    positive  
S-(2-pyrrolyl)cysteine 
   
 insignificant 
S-(N-methylpyrrol-2-yl)cysteine 
   
 insignificant 
S-(N-benzylpyrrol-2-yl)cysteine 
   
 insignificant 
S-(N-benzylpyrrol-2-yl)cysteine S-oxide 
   
 insignificant 
S-(2-thienyl)cysteine 
   
 insignificant 
S-(2-thienyl)cysteine-S-oxide        positive 
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5. Summary 
Cysteine sulfoxides are important secondary compounds in Allium sativum and A. cepa, and 
have been known as substrates specific for enzyme alliinase. Different types of cysteine 
sulfoxides have been identified in many of Allium species, of which methiin, alliin, propiin, 
butiin and marasmin are some of the best-known and best-studied ones. 
 
S-(2-pyrrolyl)cysteine-S-oxide is one of heteroaromatic cysteine sulfoxides containing a pyrrole 
ring. It has been largely reported in A. rosenorum, A. macleanii, A. giganteum, and A. 
carolanianum of subgen. Melanochrommyum. S-(2-pyrrolyl)cysteine-S-oxide is converted to 
the red pigment or 2,2′-epidithio-3,3′-dipyrrole under alliinase reaction. To understand the 
molecular structure, pharmacology, and medicinal usage of this interesting pigment, the 
synthesis of this type of cysteine sulfoxides and their homologues with enough similar 
characteristics is necessitated.  
 
In this work, six compounds were synthesized either as a sulfoxide or sulfide that contained: S-
(N-benzylpyrrol-2-yl)cysteine (47% yield); S-(N-methylpyrrol-2-yl)cysteine (23% yield); S-(2-
pyrrolyl)cysteine (35% yield); S-(2-thienyl)cysteine (93% yield); S-(N-benzylpyrrol-2-
yl)cysteine-S-oxide (30% yield) and; S-(2-thienyl)cysteine-S-oxide (48% yield). The first four 
compounds were synthesized as sulfides and two latter as cysteine sulfoxides. The first three 
abovementioned products were synthesized using heteroaromatic N-benzyl pyrrole, N-methyl 
pyrrole, and pyrrole in combination with thiourea and KI/I2, which was followed by alkalization 
of the reaction mixture. 3-Chloro-L-alanine, as the key primary compound, was added to the 
mixture and heated up to 100˚C for 2 h under argon protection. Final products, if stable, could 
be purified using preparative-HPLC or re-precipitated using diethylether dissolved in low 
amounts of methanol. A different method was conducted to synthesize S-(2-thienyl)cysteine, as 
compared to method used to synthesize the first three products. A nucleophilic substitution 
reaction was carried out between sulfur compounds (as nucleophile) and 3-chloro-L-alanine. 
 
The next step in obtaining cysteine sulfoxides was to oxidize the synthesized products. Out of 
six products, S-(2-thienyl)cysteine and S-(N-benzylpyrrol-2-yl)cysteine were successfully 
oxidized using H2O2 in water or acetic acid, resulting in S-(2-thienyl)cysteine-S-oxide and S-
(N-benzylpyrrol-2-yl)cysteine-S-oxide. If they were stable, the purification of these products 
was performed using preparative HPLC. The oxidation of the remaining products (S-(N-
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benzylpyrrol-2-yl)cysteine, S-(2-thienyl)cysteine, S-(N-methylpyrrol-2-yl)cysteine and S-(2-
pyrrolyl)cysteine), was not possible because of their high instability and polymerization against 
light, oxygen, and temperature. Additionally, weak oxidants, such as MMPP, were unable to 
oxidize these compounds. 
Lastly, an enzymatic test was conducted to estimate the reactivity of all the synthesized products 
to alliinase. To adjust the optimum pH  for the enzyme alliinase, alliinase buffer was added to 
the products, which were dissolved in water. The reaction was followed by adding cyclohexane 
(organic phase) to the reaction mixture and incubating the mixture for 2 h: in the end, the organic 
phase was separated, dried with MgSO4, and evaporated. Alliin was used as positive control. 
 S-(2-thienyl)thiophene-2-sulfinothioate was successfully separated and identified using HPLC-
MS. 
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• Zusammenfassung 
Cysteinsulfoxide sind wichtige sekundäre Metabolite in Allium sativum und A. cepa, die 
als spezifisches Substrat für das Enzym Alliinase bekannt sind. Verschiedene Arten von 
Cysteinsulfoxiden wurden in zahlreichen Allium-Spezies identifiziert, von denen 
Methiin, Alliin, Propiin, Butiin und Marasmin zu den bekanntesten und 
meistuntersuchten Verbindungen gehören. 
 
S-(2-Pyrrolyl)cystein-S-oxid ist ein heteroaromatisches Cysteinsulfoxid, das einen 
Pyrrolring enthält. Es wurde bisher in A. rosenorum, A. macleanii, A. giganteum und A. 
carolanianum aus der Untergattung Melanochrommyum gefunden. S-(2-
Pyrrolyl)cystein-S-oxid wird durch die Alliinasereaktion in das rote Pigment 2,2'-
Epidithio-3,3'-dipyrrol umgewandelt. Um die richtige Struktur, Pharmakologie und 
medizinische Verwendung dieses interessanten Pigments zu verstehen, ist die Synthese 
des Pyrrol-Cysteinsulfoxides und/oder seiner Homologen in ausreichenden Mengen 
erforderlich. 
 
In dieser Arbeit wurden sechs Verbindungen entweder als Sulfoxid oder Sulfid 
synthetisiert: S-(N-Benzylpyrrol-2-yl)cystein (47 % Ausbeute); S-(N-Methylpyrrol-2-
yl)cystein (23 % Ausbeute); S-(2-Pyrrolyl)cystein (35 % Ausbeute); S-(2-
Thienyl)cystein (93 % Ausbeute); S-(N-Benzylpyrrol-2-yl)cystein-S-oxid (30 % 
Ausbeute) und S-(2-Thienyl)cystein-S-oxid (48 % Ausbeute). 
 
 Die ersten vier Verbindungen wurden als Sulfide und die beiden letzteren als 
Cysteinsulfoxide synthetisiert. Die ersten drei oben genannten Produkte wurden unter 
Verwendung von heteroaromatischem N-Benzylpyrrol, N-Methylpyrrol und Pyrrol in 
Kombination mit Thioharnstoff und KI/I2 synthetisiert, woraufhin eine Alkalisierung 
der Reaktionsmischung für die weiteren Schritte notwendig ist. 3-Chloro-L-alanin als 
primäre Schlüsselverbindung wurde synthetisiert, zu dem oben genannten Gemisch 
gegeben und zwei Stunden unter Verwendung von Argon als Schutzgas auf 100 °C 
erhitzt. Wenn das Endprodukt stabil war, konnte es entweder unter Verwendung 
präparativer HPLC oder durch Ausfällung unter Verwendung von Diethylether gereinigt 
werden. 
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Daneben wurde noch ein anderes Verfahren angewandt, um S-(2-Thienyl)cystein zu 
synthetisieren. Dazu wurde eine nucleophile Substitutionsreaktion zwischen 
Mercaptoverbindungen (als Nucleophil) und 3-Chloro-L-alanin (mit Chlor als 
Abgangsgruppe) durchgeführt. 
 
Der nächste Schritt bestand darin, die synthetisierten Produkte zu oxidieren, um das 
Cysteinsulfoxid zu erhalten. S-(2-Thienyl)cystein und S-(N-Benzylpyrrol-2-yl)cystein 
wurden erfolgreich mit H2O2 in Wasser oder Essigsäure oxidiert, was zur Herstellung 
von S-(2-Thienyl)cystein-S-oxid und S-(N-Benzylpyrrol-2-yl)cystein-S-oxid führte. 
Bei ausreichender Stabilität konnte die Reinigung dieser Produkte unter Verwendung 
der präparativen HPLC durchgeführt werden. Die Oxidation der anderen Produkte (S-
(N-Benzylpyrrol-2-yl)cystein,  
S-(2-Thienyl)cystein, S-(N-Methylpyrrol-2-yl)cystein und S-(2-Pyrrolyl)cystein) war 
wegen der hohen Instabilität und Polymerisation durch Licht, Sauerstoff oder 
Temperatur unter den verwendeten Reaktionsbedingungen nicht möglich. Sogar einige 
schwache Oxidationsmittel wie MMPP waren nicht in der Lage, diese Verbindungen 
ohne Nebenreaktionen zu oxidieren. 
 
Schließlich wurde eine enzymatische Umsetzung durchgeführt, um die Reaktion aller in 
der Arbeit synthetisierten Produkte mit dem Enzym Alliinase von A. sativum zu 
untersuchen. Um das pH-Optimum für das Enzym Alliinase einzustellen, wurde 
Alliinase-Puffer zu Produkten, die im Voraus in Wasser gelöst wurden, gegeben. Die 
Reaktionsmischung wurde durch Zugabe von Cyclohexan (als organische Phase) 
ergänzt und für zwei Stunden inkubiert. Es wurde die organische Phase abgetrennt, über 
MgSO4 getrocknet und eingeengt. Alliin wurde als positive Kontrolle verwendet.  
S-(2-thienyl)thiophene-2-sulfinothioate wurde erfolgreich getrennt und unter 
Verwendung von HPLC-MS identifiziert.
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7. Supplementary data 
Appendix 1. List of chemicals used in this study. * indicates the reference substances; PRN stands for "pro re 
nata". 
Solid chemicals  Supplier Amount 
(Boc-Cys-OH)2 ≥98% (CE) Sigma-Aldrich 5 g 
2-Mercapto-1-methylimidazole TIC America 25 g 
2-Mercaptoimidazole 98% Sigma-Aldrich 1 g 
2-Mercaptothiazoline TIC America 25 g 
2-Thiophene thiol ≥97% TIC America 5 g 
2-Thiophenesulfonyl chloride 96% Sigma-Aldrich 1 g 
3-Bromofuran 97%  Sigma-Aldrich 5 g 
3-Mercapto-1,2,4-triazole 97% TIC America 25 g 
Allyl isocyanate 98% (cotanining BHI as stabilizer, 95%) Sigma-Aldrich 10 g 
Chlorotriisopropylsilane  97%  Sigma-Aldrich 1 g 
Dimethylsulfoxid p.a. Merck, Darmstadt 41 g 
Hydrazine solution 35% in H2O Sigma-Aldrich 10 g 
Imidazole 99% Sigma-Aldrich 100 g 
Kaliumjodid 99.5% Grussing 100 g 
L-Cysteine 97 % SAFC (Sigma-Aldrich), St. Louis (USA) 38 g 
L-Serine* TIC America 25 g 
Magnesiumsulfat-Anhydrat reinst Grüssing, Filsum 250 g 
N-Benzylpyrrole 97%* Sigma-Aldrich 5 g 
N-Boc-pyrrole 98% Sigma-Aldrich 25 g 
N-Bromosuccinimide ≥98% TIC America 20 g 
N-Z-L-Serine benzyl ester 97% Sigma-Aldrich 1 g 
Natriumhydroxid 99% Grussing 250 g 
Salzsäure 32 % Fisher Scientific, Schwerte 25 g 
Silica gel (pore size 60 A, 70-230 mesh, 63-200 μm, for 
column)  
Fluka or Macherey Nagel, Dueren, Germany PRN 
Thiourea, ReagentPlus® ≥99.0% Fulka 100 g 
Thiourea, ReagentPlus® ≥99.0%* Sigma-Aldrich 100 g 
Trifluoromethanesulfonic anhydride ≥98% (TFMSA) TIC America 10 g 
Trifluoromethanesulfonic anhydride 99% Sigma-Aldrich 5 g 
Triphenylphosphine Fulka 25 g 
Zirconium(IV) chloride ≥99.9% Sigma-Aldrich 5 g 
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β-chloro-L-alanine* TIC America 1-5 g 
   
Liquid chemicals 
  
2,6-Lutidine ≥ 98% TIC America 25 ml 
3-Bromothiophene Merck 50 ml 
Acetone Lenz-Chemie, Westerburg 2.5 L 
Ameisensäure reinst Riedel-de-Haen, Seelze 30 L 
Ammoniak 25 % Fisher Scientific, Schwerte 33 L 
Deuterium oxide 99.8% Roth 25 ml 
Ethanol Lenz-Chemie, Westerburg 2.5 L 
Appendix 1. continued    
Ethyl acetate 99.99% Fischer 2.5 L 
Ethylacetat Fisher Scientific, Schwerte 2.5 L 
Furan 99%  Sigma-Aldrich 100 ml 
Hydrazin solution 35 wt. % in water Sigma-Aldrich 100 ml 
Isopropanol 99,5 % Acros Organics (Thermo Fisher Scientific), 
Geel (Belgien) 
2.5 L 
Methanesulfonic acid, ≥99.5% Sigma-Aldrich 5 ml 
Methanol 99.99% Fischer PRN 
Methanol analytical reagent grade Fisher Scientific, Schwerte 2.5 L 
n-Butanol Merck, Darmstadt 1 L 
n-Butyllithium solution 2.5 M in Hexan Sigma-Aldrich 2 ml 
N-Methylpyrrole 99% Sigma-Aldrich 100 ml 
N,N,N′,N′-Tetramethylethylenediamine ReagentPlus® 
≥99% 
Sigma-Aldrich 100 ml 
Pyrrole 98% Sigma-Aldrich 100 ml 
Pyrrole reagent grade 99% Sigma-Aldrich 25 ml 
Sulfonyl chloride solution 1 M in methylene chloride Sigma-Aldrich 100 ml 
tert-Butyllithium solution 1.7 M in pentane  Sigma-Aldrich 100 ml 
THF Hochschullieferung BASF, Ludwigshafen am Rhein  2.5 L 
Thionyl chloride ReagentPlus® ≥99.0% Sigma-Aldrich 500 ml 
Triethylamine ≥99.5% Sigma-Aldrich 100 ml 
Wasserstoffperoxid 35 % Merck, Darmstadt 26 L 
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Appendix 2. List of device and relevant information  used in this study. 
Devices Compartment detail/supplier Parameter/modus 
Bruker Alpha-P FT-IR  Bruker, Ettlingen, Germany ATR-FTIR-Modus 
UV Shimadzu, Japan (UV-2401PC)   
NMR-Spektrometer Jeol, Tokyo, Japan JEOL-ECA 500  
Shimadzu Prominence 
HPLC 
Kyoto, Japan Controller (CBM-20A) 
  
Pumpe (LC-20AT ) 
  
Degaser (DGU-20As) 
  
UV/Vis-Detector (SPD-20A) 
    Software (LC solution) 
Merck-Hitachi HPLC Kyoto, Japan Interface (D-7000) 
  
Säulenofen (L-7360) 
  
Autosampler (L-7200) 
  
Peltier Sample Cooler (L-
7200) 
  
Degaser (L-7612) 
  
Pumpe (L-7100) 
    Software (D-7000 HSM) 
HPLC-MS Macherey-Nagel, Düren 
 
 
Pumpe (Shimadzu LC10ADvp) wavelenght (334 nm) 
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UV-Detector (Shimadzu SPD10Avp) Injected volumes (20 μL) 
 
Autosampler (Shimadzu SILHTC) Equilibration time (20 min) 
 
Column oven (CATO10ASvp) Flow rate (0.25 mL/min) 
 
Q Trap (LC/MS/MS System (Applied Biosystems (Thermo Fis- her Scientific), 
Darmstadt)) 
temperature in autosampler 
(10°C) 
  Software (Analyst (Applied Biosystems (Thermo Fisher Scienti- fic),  
Darmstadt)) 
Appendix 2. continued  
  
Q-Trap 
 
Ion source (Turbo Spray) 
  
Measured Modus (positive) 
  
Detection area (50 bis 500 amu) 
  
Curtain Gas (25) 
  
Interface Heater (on) 
  
Temperature (300°C) 
  
Ion spray voltage (5500 V) 
  
Declustering-Potential (55 V) 
  
Entrance potential (9 V) 
      
MS 
  
MS (Q-Trap) 
 
Ion source (Turbo Spray) 
  
Measured Modus (positive) 
  
Detection area (100 bis 500 amu) 
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Curtain Gas (10) 
  
Interface Heater (on) 
  
Temperature (300°C) 
  
Ion spray voltage (5500 V) 
  
Declustering-Potential (110 V) 
    Entrance potential (10 V) 
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Appendix 3. List of solvent and other amount for each device used in this study. 
Method Reagent/solvent Amount (g/L)/Ratio/MHz Fracion Nr. Remarks 
Column chromatography Cyclohexane 2 1–9 negative  
  
1 10–18 negative  
  
1 19–27 negative  
 
Ethylacetat 1 1–9 negative  
  
1 10–18 negative  
  
1 19–27 negative  
  
1.5 28–36 negative  
 
Methanol 0.3 19–27 negative  
  
1 28–36 negative  
  
1 37–45 positive 
  
1 46–54 negative  
  
9 55–63 negative  
  
9 64–72 negative  
 
H2O 1 55–63 negative  
  
5 46–54 negative  
    1 73–81 negative  
TLC solvents for cysteine derivative n-Butanol 28 ml 
  
 
Water 8 ml 
  
 
Acetic acid  9 ml 
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  Formic acid   2 ml     
Ninhydrin spray Ninhydrin 60 g 
  
 
Cobalt(II)-nitrate 10 ml 
  
 
Acetic acid 2 ml 
  
 
Formic acid   0.25 ml 
  
 
Collidin 1 ml 
  
  n-Butanol 10 ml     
Appendix 3. continued      
Buffer for alliinase (after Keusgen, 1999) KH2PO4 (0,026 M)  3.54 g 
  
 
Na2HPO4 (0,05 M)  7.253 g  
  
 
Sucrose (10 %)   100 g 
  
 
NaCl (0,08 M)  5 g 
  
 
Pyridoxal-5’-phosphat  55 g 
  
  H2O  ad 1L     
1H NMR 
    
2-Ben-PyrrC CD3OD 400 MHz 
  
2-Ben-PyrrCSO D2O 400 MHz 
  
2-Met-PyrrC D2O 400 MHz 
  
2-PyrrC D2O 400 MHz 
  
2-ThiophenC CD3OD 400 MHz 
  
β-Chloro alanine D2O 400 MHz     
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13C NMR 
    
2-Ben-PyrrC CD3OD 125 MHz 
  
2-Ben-PyrrCSO D2O 125 MHz 
  
2-Met-PyrrC D2O 125 MHz 
  
2-PyrrC D2O 125 MHz 
  
2-eC CD3OD 125 MHz 
  
β-Chloro alanine D2O 125 MHz     
HPLC EC 250/4 Nucleodur 100-5 C18ec     
HPLC-MS EC 250/2 Nucleodur 100-5 C18ec     
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Appendix 4. Synthesis of S-(N-benzylpyrrol-2-yl)cysteine using analytical HPLC. 
 
 
 
Appendix 5. ESI-MS analysis of S-(N-benzylpyrrol-2-yl)cysteine-S-oxide before preparative-HPLC. 
 
 
 
 
Appendix 6. Analytical HPLC method condition for enzymatic bioactivity test. 
Time Water (%) Methanol (%) 
Flow rate 
(ml/min) 
Pressure 
(mbar) 
0 95 5 1 0–400 
2 95 5 1 0–400 
20 30 70 1 0–400 
55 5 95 1 0–400 
60 5 95 1 0–400 
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Appendix 7. Chromatogram of S-(N-benzylpyrrol-2-yl)cysteine using analytical HPLC. 
 
 
 
Appendix 8. Chromatogram of S-(N-benzylpyrrol-2-yl)cysteine non-oxide after preparative HPLC. 
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Appendix 9. HPLC chromatogram of S-(N-benzylpyrrol-2-yl)cysteine-S-oxide before preparative-HPLC. 
 
 
 
Appendix 10. ESI-MS analysis of S-(N-benzylpyrrol-2-yl)cysteine-S-oxide before preparative-HPLC. 
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Appendix 11. HPLC-MS analysis of S-(N-benzylpyrrol-2-yl)cysteine-S-oxide. 
 
 
 
 
Appendix 12. HPLC-MS analysis of S-(N-benzylpyrrol-2-yl)cysteine. 
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Appendix 13. HPLC analysis of S-(N-benzylpyrrol-2-yl)cysteine-S-oxide after preparative-HPLC. 
 
 
 
 
Appendix 14. ESI-MS analysis of S-(N-benzylpyrrol-2-yl)cysteine-S-oxide after preparative-HPLC. 
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Appendix 15. Measurement of TLC spot quantification of S-(2-thienyl)cysteine-S-oxide. 
Number µg Volume Height Area Percent % 
non-ox 100 11130 20 1935 3,7 
sulfoxid 1269,461 141291 67 3375 47,3 
sulfonic acid 1312,489 146080 79 3285 48,9 
      
 
Appendix 16. 1H-NMR spectrum of 1-(triisopropylsilyl)pyrrole 
 
 
 
Appendix 17. ESI-MS analysis of 1-(triisopropylsilyl)pyrrole 
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Appendix 18. ESI-MS analysis of hydrogenation of S-(N-benzylpyrrol-2-yl)cysteine-S-oxide with pd/C and 
hydrogen. 
 
 
 
 
Appendix 19. 1H-NMR spectrum of hydrogenated N-benzyl pyrrole. 
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Appendix 20. ESI-MS analysis of S-(N-Bocpyrrol-2-yl)cysteine. 
 
 
 
 
Appendix 21. ESI-MS analysis of Cbz-serine benzylester-O-trifilate. 
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Appendix 22. ESI-MS analysis of lithium furan-2-thiolate. 
 
 
 
 
Appendix 23. ESI-MS analysis of S-(2-pyrrolyl)cysteine (+Q). 
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Appendix 24. ESI-MS analysis of S-(2-pyrrolyl)cysteine (-Q). 
 
 
 
 
Appendix 25. ESI-MS analysis of trifluoromethylsulfonyl-serine with trimethylamine 
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Appendix 26. ESI-MS  analysis of S-(3-thienyl)cysteine 
 
 
 
 
Appendix 27. ESI-MS analysis of Boc-S-(N-methylpyrrol-2-yl)cysteine (+Q). 
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Appendix 28. ESI-MS analysis of Boc-S-(N-methylpyrrol-2-yl)cysteine (-Q1) 
 
 
 
 
Appendix 29. ESI-MS analysis of 3-bromo N-methylpyrrole 
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Appendix 30. ESI-MS analysis  of N-(tert-butoxycarbonyl)-O-trifluoromethylsulfonyl-serine with 2,6-lutidine 
 
 
 
 
Appendix 31. ESI-MS analysis of S-(2-imidazolyl)cysteine (+Q). 
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Appendix 32. ESI-MS analysis of S-(2-imidazolyl)cysteine (-Q) 
 
 
 
 
Appendix 33. ESI-MS analysis of S-(N-methylimidazol-2-yl)cysteine (+Q). 
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Appendix 34. ESI-MS analysis of S-(N-methylimidazol-2-yl)cysteine (-Q). 
 
 
 
 
Appendix 35. ESI-MS analysis of S-(2-thiazolinyl)cysteine (+Q). 
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Appendix 36. ESI-MS analysis of oxidation of S-(N-benzylpyrrol-2-yl)cysteine with H2O2 in acetic acid. 
 
 
 
 
Appendix 37. ESI-MS analysis of oxidation of S-(N-benzylpyrrol-2-yl)cysteine with FeCl3/ H5IO6. 
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Appendix 38. ESI-MS analysis of oxidation with MMPP (magnesium monoperoxyphthalate). 
 
 
 
 
Appendix 39. ESI-MS analysis of oxidation of S-(N-methylpyrrol-2-yl)cysteine with H2O2 in water. 
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Appendix 40. ESI-MS analysis of oxidation of S-(N-methylpyrrol-2-yl)cysteine with H2O2 in acetic acid (+Q). 
 
 
 
 
Appendix 41. ESI-MS analysis of oxidation of S-(N-methylpyrrol-2-yl)cysteine with H2O2 in acetic acid (-Q). 
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Appendix 42. ESI-MS analysis of oxidation of S-(N-methylpyrrol-2-yl)cysteine with cumol hydroxyl peroxide. 
 
 
 
 
Appendix 43. ESI-MS analysis of oxidation of S-(N-methylpyrrol-2-yl)cysteine with MMPP 
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Appendix 44. ESI-MS analysis of oxidation of S-(N-methylpyrrol-2-yl)cysteine with TPAC. 
 
 
 
 
Appendix 45. 1H NMR spectrum of S-(N-Bocpyrrol-2-yl)cysteine. 
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Appendix 46. 1H-NMR analysis of S-(3-furanyl)cysteine. 
 
 
 
 
Appendix 47. 1H-NMR spectrum of pyrrole-2-sulfonylchloride 
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Appendix 48. 1H-NMR spectrum of furan-3-sulfonyl chloride. 
 
 
 
 
Appendix 49. 1H-NMR spectrum of S-(2-furanyl)cysteine. 
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Appendix 50. 1H NMR spectrum of S-(3-thienyl)cysteine.  
 
 
 
 
Appendix 51. 1H-NMR spectrum of S-(3-furanyl)cysteine 
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Appendix 52. ESI-MS analysis of catalytic transfer hydrogenation of S-(N-benzylpyrrol-2-yl)cysteine-S-oxide. 
 
 
 
 
Appendix 53. HPLC chromatogram of the allinase reaction on S-(2-thienyl)cysteine-S-oxide after 2 h. 
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Appendix 54. HPLC chromatogram of the allinase reaction on alliin as positive control after 2h. 
 
 
 
 
Appendix 55. HPLC chromatogram of the allinase as negative control after 2h. 
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Appendix 56. HPLC chromatogram of the alliinase reaction  on S-(2-thienyl)cysteine-S-oxide after 4h. 
 
 
 
 
Appendix 57. HPLC chromatogram of the allinase reaction on alliin as positive control after 4h. 
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Appendix 58. HPLC chromatogram of alliinase as negative control after 4h 
 
 
 
 
Appendix 59. HPLC chromatogram of the alliinase reaction on S-(2-thienyl)cysteine-S-oxide after 6h 
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Appendix 60. HPLC chromatogram of the allinase reaction on alliin as positive control after 6h 
 
 
 
 
Appendix 61. HPLC chromatogram of alliinase as negative control after 6h. 
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Appendix 62. HPLC-MS chromatogram of negative control after 2h for the peak with molecular weight 135 g/mol. 
 
 
 
 
Appendix 63. +Q-MS of the allinase reaction on alliin as positive control positive control after 2h. 
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Appendix 64. HPLC chromatogram of the allinase reaction on alliin as positive control after 2h for allicin. 
 
 
 
 
Appendix 65. HPLC chromatogram of the allinase reaction on alliin as positive control after 2h for ajoene. 
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Appendix 66. HPLC chromatogram of the allinase reaction on alliin as positive control after 2h for the peak with 
molecular weight 135 g/mol 
 
 
 
 
Appendix 67. -Q-MS of HPLC chromatogram of the allinase reaction on alliin as positive control after 2h 
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Appendix 68. HPLC-MS chromatogram of disulfide-S-oxide at 26.98 min after 2h. 
 
 
 
 
Appendix 69. HPLC-MS chromatogram of disulfide-S-S´-dioxide at 26.33 min after 2h. 
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Appendix 70. HPLC chromatogram of alliinase reaction on S-(2-pyrrolyl)cysteine after 2h. 
 
 
 
 
Appendix 71. HPLC-MS chromatogram of alliinase reaction on S-(2-pyrrolyl)cysteine after 2h 
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Appendix 72. HPLC-MS chromatogram of allinase reaction on the S-(2-pyrrolyl)cysteine at 17.32 min after 2h. 
 
 
 
 
Appendix 73. HPLC-MS chromatogram of allinase reaction on S-(2-pyrrolyl)cysteine at 18 min after 2h. 
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Appendix 74. HPLC-MS chromatogram of allinase reaction on S-(2-pyrrolyl)cysteine at 21.77 min after 2h. 
 
 
 
 
Appendix 75. HPLC-MS chromatogram of allinase reaction on S-(2-pyrrolyl)cysteine at 26.91 min after 2h 
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Appendix 76. HPLC-MS chromatogram of allinase reaction on S-(2-pyrrolyl)cysteine at 32.87 min after 2h. 
 
 
 
 
Appendix 77. HPLC chromatogram of allinase reaction on S-(N-methylpyrrol-2-yl)cysteine  
after 2h. 
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Appendix 78. HPLC-MS chromatogram of allinase reaction on S-(N-methylpyrrol-2-yl)cysteine after 2h. 
 
 
 
 
Appendix 79. HPLC-MS chromatogram of allinase reaction onS-(N-methylpyrrol-2-yl)cysteine at 23.72 min after 
2h. 
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Appendix 80. HPLC-MS chromatogram of allinase reaction on S-(N-methylpyrrol-2-yl)cysteine at 24.44 min after 
2h. 
 
 
 
Appendix 81. HPLC-MS chromatogram of allinase reaction on S-(N-methylpyrrol-2-yl)cysteine at 27.52 min after 
2h. 
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Appendix 82. HPLC-MS chromatogram of allinase reaction on S-(N-methylpyrrol-2-yl)cysteine at 33.38 min after 
2h. 
 
 
 
 
Appendix 83. HPLC chromatogram of allinase reaction on S-(N-benzylpyrrol-2-yl)cysteine after 2h. 
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Appendix 84. HPLC-MS chromatogram of allinase reaction on S-(N-benzylpyrrol-2-yl)cysteine after 2h. 
 
 
 
 
Appendix 85. HPLC-MS chromatogram of allinase reaction on S-(N-benzylpyrrol-2-yl)cysteine at 27.33 min after 
2h. 
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Appendix 86. HPLC-MS chromatogram of allinase reaction on S-(N-benzylpyrrol-2-yl)cysteine at 33.28 min after 
2h. 
 
 
 
 
Appendix 87. HPLC chromatogram of allinase reaction on S-(N-benzylpyrrol-2-yl)cysteine-S-oxide after 2h. 
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Appendix 88. HPLC-MS chromatogram of allinase reaction on S-(N-benzylpyrrol-2-yl)cysteine-S-oxide after 2h. 
 
 
 
 
Appendix 89. HPLC-MS chromatogram of allinase reaction on S-(N-benzylpyrrol-2-yl)cysteine-S-oxide at 20.93 
min after 2h. 
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Appendix 90. HPLC-MS chromatogram of allinase reaction on S-(N-benzylpyrrol-2-yl)cysteine-S-oxide at 33.37 
min after 2h. 
 
 
 
 
Appendix 91. HPLC chromatogram of allinase reaction on S-(2-thienyl)cysteine after 2h. 
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Appendix 92. HPLC-MS chromatogram of allinase reaction on S-(2-thienyl)cysteine after 2h. 
 
 
 
 
Appendix 93. HPLC-MS chromatogram of allinase reaction on S-(2-thienyl)cysteine at 6.2 min after 2h. 
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Appendix 94. HPLC-MS chromatogram of allinase reaction on S-(2-thienyl)cysteine at 39.64 min after 2h. 
 
 
 
 
Appendix 95. HPLC-MS chromatogram of allinase reaction on S-(2-thienyl)cysteine at 54.38 min after 2h. 
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Appendix 96. HR-MS analysis of compound m/z 136 [M+H]+. 
 
 
 
 
Appendix 97. HR-MS analysis of compound m/z 171 [M+H]+ 
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Appendix 98. HR-MS analysis of compound m/z 269 [M+H]+ 
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Appendix 99. HR-MS analysis of compound m/z 249 [M+H]+ 
 
 
 
 
Appendix 100. HR-MS analysis of compound m/z 222 [M+H]+ 
 
 
